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SUMMARY 
Spaceflight induces physiological deconditioning, despite extensive exercise 
countermeasures. Furthermore, post-flight orthostatic intolerance (OI) and 
visual impairment and intracranial pressure (VIIP) syndrome; possibly related 
to venous congestion (VC) suggest more holistic countermeasures, such as 
artificial gravity (AG) short-arm human centrifugation (SAHC) are warranted. 
SAHC may reduce OI and VIIP incidence through headward fluid 
shift/pressure reversal; and thus beneficial effects on cerebral hemodynamics. 
Therefore, this thesis examined how peripheral fluid shifts, induced by various 
orthostatic challenges, affect central, peripheral, and cerebral hemodynamics, 
including indices of VC, in healthy participants.  
Study one induced 5 min bilateral lower-limb venous cuff occlusion (VCO) up 
to 120mmHg in nine participants. VCO produced significant increments in leg 
volume (41-158mL;p<0.05); however, HR and cerebral tissue oxygenation 
(cTSI) were unchanged, suggesting an inadequate orthostatic challenge. Study 
two involved twenty participants experiencing 10 min SAHC to 2.4+Gz foot-
level with increased g-gradients; specifically, moving rotational axis position 
(RAP), independent of g-level, towards the body. Increasing SAHC g-gradients 
reduced the HR response and increased g-tolerance (χ2(1, 
n=20)=8.57;p=0.003), similar to decreasing g-level. Heart-level-RAP did not 
improve cTSI as hypothesised, possibly due to VC. Thus, study three used 5 
min head-down tilt (HDT) to -24° and -40mmHg lower body negative pressure 
(LBNP) on sixteen participants to evaluate VC during headward fluid shifts. 
- vi - 
 
HDT induced significant VC below -12° (p<0.05), abolished with -40mmHg 
LBNP (107±11 vs. 51±5mm2;p<0.05), and increased cerebral blood flow when 
LBNP-peripheral and HDT-headward fluid shifts balanced (-0.71±0.56 vs. 
4.12±1.36cm.s-1;p=0.013).  
This thesis suggests that VCO is a poor model of gravitational fluid shifting but 
large g-gradient SAHC, via heart-level-RAP, is effective; and crucially, more 
tolerable at higher g-levels. VC may play an important role in microgravity 
fluid shift related OI and VIIP, which -6° bed rest studies fail to induce. Thus, 
AG with optimal RAP and VC amelioration, may be a tolerable and effective 
spaceflight countermeasure. 
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1.1 Spaceflight deconditioning  
There are a multitude of risks associated with human spaceflight from the high g-forces 
experienced during vehicle launch and psychological isolation, to cosmic radiation and 
weightlessness. Extensive knowledge has been gained over the last 56 years humans 
have been travelling into space, since the first manned launch of Russian cosmonaut 
Yuri Gagarin into orbit on 12th August 1961 to current day International Space Station 
(ISS) operations. Since Gagarin’s successful 108 minute orbit of our planet much 
research has been conducted on the almost 600 subsequent individuals who have gone 
into space. The Fédération Aéronautique Internationale (FAI) defines a spacefarer as 
anybody whose flight exceeds an altitude of 100 km (62 mi) Kármán line, but not 
necessarily achieve orbit, and may be as short as 15 minutes sub-orbital. Except for the 
launch and re-entry, it is longer-term spaceflight that poses the greatest risk 
physiologically, with the body continually unloaded. 
In general, alterations in different body systems reach a point of general adaptation 
around one and a half months into a mission (Figure 1.1A). However, this is not the 
case for radiation exposure (Chancellor et al., 2014), bone loss (Sibonga, 2013), and 
visual problems (Mader et al., 2011). Future missions, of longer duration, are required 
to fully examine the implications of periods in weightlessness exceeding the current 6-
month standard ISS on-board stay. Health effects of prolonged spaceflight duration, 
exceeding the current 438 consecutive day record by Russian cosmonaut Valeri 
Polyakov in 1994-5, are unknown.  
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Figure 1.1 Spaceflight adaptations, on multiple organ systems, over the course 
of a 6-month mission. Adapted from Davis et al. (2008) 
 
 
A, Inflight deviations from normal function (0-6 months); and  
B, post-flight recovery (up to 3 months). 
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Even though the body may adapt well and rapidly to the new environment of space 
problems are seen on return when re-entering and experiencing gravitational loading 
once again (Buckey Jr et al., 1996; Baisch & Beck, 1997; Tank et al., 2011). 
Furthermore, longer periods of unloading require more time in which to reach a pre-
flight baseline, and parameters such as visual acuity may never fully recover (Marshall-
Bowman et al., 2013) (Figure 1.1B). Astronauts returning to Earth in a deconditioned 
state are immediately attended to by large rescue crews, consisting of doctors, 
engineers, and scientists; mitigating any immediate health risk (Clément, 2011). 
However, the same will not be true for a future visit to the Marian surface and, although 
the gravity on Mars is only one third of that on Earth, an autonomous spacecraft egress 
would present a substantial challenge.  
 
 
Figure 1.2 Microgravity deconditioning, on multiple organ systems. 
Adapted from beaudaniels.com. 
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NASA have current plans for a manned mission to Mars in the 2030s (NASA, 2015b), 
with an estimated round-trip duration, dependant on trajectory opportunities, of between 
16-42 months (Tito et al., 2013). In order for manned interplanetary travel to be 
realised, the microgravity induced health implications affecting almost all body systems 
(Figure 1.2) must be studied, understood, and mitigated against. The focus of this 
research was the cardiovascular system. 
1.1.1 Cardiovascular deconditioning 
The cardiovascular system is immediately affected upon entering weightlessness, 
demonstrating a headward fluid shift that increases central volume (Diedrich et al., 
2007) and cause the cardiac chambers to distend (Buckey et al., 1996a). The system 
responds with a cascade to bring about a total reduction in circulating blood volume by 
10-17% after 14 days (Alfrey et al., 1996). Within the first two weeks these changes 
stabilise and a new “space normal” is reached; however, the sudden reintroduction of 
gravity on return to Earth can manifest itself as orthostatic intolerance (OI) (Buckey Jr 
et al., 1996; Baisch & Beck, 1997). Around half of all returning astronauts suffer from 
OI (Lee et al., 2015); which is characterised by an inability to sufficiently maintain 
stroke volume, blood pressure, and ultimately cerebral perfusion (Maillet et al., 1993; 
Maillet et al., 1995). 
Cardiovascular deconditioning is a major concern, not just on return but also during a 
mission, where the ability of an astronaut to respond in an emergency situation may be 
impeded (Greenleaf et al., 1989; Convertino & Sandler, 1995). Additionally, current 
missions on-board the ISS usually require bouts of strenuous, prolonged exertion in the 
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form of extravehicular activity (EVA) or spacewalks (Moore Jr et al., 2008). It is 
therefore crucial cardiovascular function, and specifically maximal aerobic capacity 
(VO2 max), is maintained through suitable exercise countermeasures in order to mitigate 
any potential risk or unforeseen situation during and post-flight. Other spaceflight 
physiological adaptations include reductions in the functioning of the vestibular otolith 
organs; with this deconditioning also thought to contribute to post-flight astronaut OI 
(Hallgren et al., 2016). Considerable evidence has been conducted on human subjects 
demonstrating that otolith receptor inputs participate in blood pressure regulation 
(Shortt & Ray, 1997; Hume & Ray, 1999; Ray, 2000; Ray & Monahan, 2002). 
Furthermore, prior research has shown that the vestibulosympathetic reflex and the 
baroreceptor reflex interact and are mediated by common neuronal circuitry (Yates et 
al., 1991; Yates et al., 1995). Current countermeasures are primarily used to prevent 
muscle atrophy, bone loss, and maintain aerobic capacity (Loehr et al., 2015). However, 
the high incidence of OI in returning astronauts suggests current exercise regimes could 
benefit from improvement. 
OI is characterised by a diminished venous return, leading to inadequate cardiac pre-
load and inability to maintain stroke volume (SV); however, the specific causative 
factor, as a result of spaceflight, remains unclear. Significant cardiac muscle atrophy has 
been shown to occur with only two weeks of unloading in simulated microgravity 
(Levine et al., 1997) and, coupled with muscle atrophy and associated vascular 
compliance increases (Convertino et al., 1989), demonstrates the importance of 
maintaining muscle mass and function during a mission. The effectiveness of the leg 
muscle-pump may also be diminished as weight-bearing muscles atrophy in space 
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(LeBlanc et al., 1995; LeBlanc et al., 2000); potentially lessening their role, on deep 
peripheral venous contractions, aiding venous return. A reduced blood volume is 
thought to be linked to OI and ingestion of a large volume of saline immediately before 
re-entry has been shown to increase astronaut orthostatic tolerance (Bungo et al., 1985). 
However, a more recent pharmacological intervention with fludrocortisone, restoring 
post-flight plasma levels to those pre-flight, did not change OI incidence (Shi et al., 
2004); suggesting that both centrally available blood volume, as well as cardiac 
contractility are essential (Jeong et al., 2012).  
Prolonged exposure to periods of increased central volume, induced by head-down bed 
rest (HDBR), may desensitise stretch baroreceptors (Fritsch et al., 1992; Fritsch-Yelle et 
al., 1994) tasked with providing short-term control of blood pressure. However, Di 
Rienzo et al. (2008) measured no deconditioning of baroreceptor control of the heart 
after a 16-day short-duration spaceflight. Nevertheless, more recent research has shown 
agreement with HDBR data with Eckberg et al. (2010) observing impairment of vagal 
baroreflex function in space after 10-days. Increased baroreceptor sensitivity occurs in 
the initial microgravity exposure, perhaps due to the centralisation of circulating fluid 
(Eckberg et al., 2010); however, longer-term data are less clear. It seems likely that an 
immediate sensitivity peak, upon entering weightlessness, then diminishes as exposure 
time increases; yet whether or not that proceeds to insignificance, from pre-flight 
baroreceptor functions, remains to be seen. 
Under significant orthostatic stress, the total peripheral resistance (TPR) of an 
individual increases whilst the mean arterial pressure (MAP) remains relatively 
unchanged. It has been postulated that blood pressure is maintained, in part, by an 
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enhancement of the carotid baroreceptor reflex in the presence of a challenge (Cooper & 
Hainsworth, 2001). Furthermore, subsequent research suggests this positive mechanism 
augmentation may be occurring due to an increase in carotid baroreceptor sensitivity; 
and a failure to do so may lead to a reduced orthostatic tolerance (Cooper & 
Hainsworth, 2002). A predisposition to orthostatic intolerance, as observed in returning 
astronauts, may be affected by other baroreceptor factors such as reduced sensitivity in 
aerobically fit individuals (Ogoh et al., 2003); or a currently unknown interaction 
between cardiopulmonary and carotid baroreceptors. 
Recently, vision impairment in astronauts has been observed during spaceflight (Mader 
et al., 2011) that persists after return to Earth (Stenger et al., 2016). The so-called visual 
impairment and intracranial pressure (VIIP) syndrome has led some to call it the first 
true “space sickness”, as current attempts to maintain astronaut health have not reduced 
occurrence (Wiener, 2012). Increased intraocular pressure (IOP), choroidal folds, optic 
disc edema and globe flattening have all been observed during long-duration missions; 
with spinal fluid opening pressure also found increased in a number of astronauts post-
flight (Mader et al., 2011). It is therefore suggested that elevated intracranial pressure 
(ICP) may be responsible for reduced visual acuity. Several working hypotheses on the 
cause of VIIP have been and are currently being investigated; including (i) elevated 
spacecraft CO2 levels (Ursino & Lodi, 1997; Ainslie & Duffin, 2009); (ii) high salt diet 
(Fogarty et al., 2011); (iii) excessive resistive exercise (Fogarty et al., 2011); (iv) 
venous congestion (Wiener, 2012); and (v) a genetic predisposition (Kramer et al., 
2012). However, the initiating factor behind VIIP, regardless of the exact mechanism of 
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action, is considered by many to be directly related to the pronounced headward fluid 
shifts in weightlessness (Fogarty et al., 2011; Mader et al., 2011; Kramer et al., 2012). 
1.1.2 Spaceflight fluid shifts 
Humans have evolved, as bipedal animals on Earth, with an innate ability to maintain 
suitable blood pressure and cerebral perfusion, despite rapid postural changes on a daily 
basis affecting pressure along the vascular column (Gradwell & Rainford, 2016). The 
hydrostatic gradient was recognised over 100 years ago as integral to cardiovascular 
control by providing a natural pressure reference (Blumberg, 1885; Wagner, 1886) and 
led to the development of simple physical models of the hydrostatic indifference 
concept (Gauer & Thron, 1965). However, significant alterations, to gravitational force 
and direction across the body, may bring the validity of these historical models into 
question. 
Exposure to weightlessness removes the hydrostatic gradient completely, as venous and 
arterial pressures roughly equalise across the body; and blood volume, normally present 
in the peripheral and splanchnic regions (Petersen et al., 2011), is shifted into the thorax 
and towards the head (Figure 1.3A to B). Astronauts often report a feeling of “facial 
fullness” similar to the common cold and have been described as having a “puffy face” 
and “chicken legs” (Thornton et al., 1977). It is normal for these initial symptoms to 
subside after a few days of adaptation as aortic and carotid stretch receptors upregulate 
the glomerular filtration rate (GFR), increasing excretion and thus reduce circulating 
volume (Norsk, 1992) (Figure 1.3C).  
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Figure 1.3 Schematic representation of blood volume fluid shift on Earth and in 
space. Adapted from Clément (2011). 
 
 
A, Earth (pre-flight): with blood pooling in the lower extremities; B, Microgravity 
(immediate): fluid shifted towards the head; C, Microgravity (prolonged): overall 
volume reduced, relieving headward pressure; and D, Earth (post-flight): reduced 
volume shifted to the periphery. 
 
 
Interestingly, a decrease in central venous pressure (CVP) has been observed despite a 
concurrent increase in left atrial diameter (Buckey et al., 1996a). Subsequent research 
by Videbaek and Norsk (1997) demonstrated, during transient periods of microgravity, 
that interpleural pressure decreased to a greater extent than CVP; suggesting transmural 
CVP increases are in fact causing cardiac chamber distension. Furthermore, these 
increases may explain increased in-flight cardiac output (CO) of up to 41%, in 
adherence to the Frank-Starling law (Norsk et al., 2015). 
Spaceflight fluid shifts eventually reach a euvolemic state appropriate for 
weightlessness, where the rate of change subsides (Davis et al., 2008) (Figure 1.1A); 
with little known about time-course of adaption during longer duration flights (> 6-
months). Nevertheless, with the re-introduction of Earth’s gravity after long-term 
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spaceflight, previous clinically irrelevant in-flight alterations now appear maladaptive 
(Figure 1.3D). Recent research has shown elevated headward pressures may, despite 
stabilised blood redistribution, induce irreversible pathological changes affecting visual 
acuity (Mader et al., 2011). Additionally, microgravity-induced pressure increases, 
concurrent in venous and arterial vasculature, may affect cerebral hemodynamics; 
specifically, through an irreversible venous congestion initiated pathology cascade in 
space (Wiener, 2012). 
1.1.3 Jugular venous congestion 
Blood congestion in the jugular veins, as a direct result of hydrostatic gradient abolition 
in space, and the ensuing cephalic fluid shift, has been measured through quantification 
of internal jugular vein (IJV) distension in many astronauts (Grigoriev et al., 2011; 
Arbeille et al., 2015) (Figure 1.4). It has been suggested that microgravity induced 
venous congestion is the start of a cascade phenomenon, leading to increases in 
intracranial pressure (ICP) and intraocular pressure (IOP), and directly related to VIIP. 
Specifically, the mismatch between the two during spaceflight may be of importance to 
the aetiology of VIIP (Rowell, 1993; Watenpaugh & Hargens, 1996; Zhang, 2013). 
Approximately two thirds of returning astronauts have experienced degradation in 
visual acuity following long-term spaceflight; whilst, only one third have reported 
problems after a short-term flight (≤ 16 days) (Mader et al., 2011). In general, astronaut 
visual problems get worse as a function of time spent in space; however, the role of 
venous congestion, and the effect this has on cerebral hemodynamics, and more 
specifically ICP and IOP remains unclear. Ground-based spaceflight analogues may 
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prove useful in elucidating the underlying mechanisms of VIIP; with previous research 
unable to replicate degradation in visual acuity on Earth. 
 
 
 
Figure 1.4 Ultrasound of right internal jugular vein (IJV) cross-sectional area (CSA) pre- 
and during spaceflight. Adapted from Grigoriev et al. (2011). 
  
A, pre-flight recording; and B, during spaceflight (launch + 5 months). IJV, 
internal jugular vein. Russian cosmonaut data. 
 
 
1.2 Spaceflight analogues 
Access to space remains limited and to date there have been less than 600 astronauts in 
space examined physiologically (Clément, 2011). Mechanisms of spaceflight 
deconditioning can be simulated on Earth in order to investigate microgravity effects. 
However, no method is entirely effective without the universal unloading of 
weightlessness. Common techniques in humans include water immersion (Figure 1.5D), 
favoured by the Roscosmos State Corporation for Space Activities (Roscosmos), and 
head-down bed rest (HDBR) studies (Figure 1.5F) favoured by the National Aeronautics 
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and Space Administration (NASA) and the European Space Agency (ESA) 
(Watenpaugh, 2016). 
 
 
 
 
Figure 1.5 Different methodologies of simulated and actual weightlessness exposure. 
Adapted from Watenpaugh (2016). 
  
A, upright standing posture on Earth; B, weightlessness in space; C, water 
immersion; D, dry immersion; E, horizontal bed rest; and F, -6° head-down bed 
rest (HDBR). 
 
 
1.2.1 Head-down bed rest (HDBR) 
Unloading achieved through bed rest is effective, at removing the daily gravitational 
forces experienced on weight bearing limbs, resulting in significant reductions in 
muscle mass  (Akima et al., 1997; Akima et al., 2000; Kawakami et al., 2000; Akima et 
al., 2003) and bone density (Watanabe et al., 2004; Rittweger et al., 2005) in a similar 
manner to spaceflight. Headward fluid shifts are replicated by head-down tilt (HDT) 
and now specifically standardised to -6° HDT (Sundblad & Orlov, 2015). Combined 
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HDT and bed rest (HDBR) followed observations of a Russian scientist in returning 
cosmonauts who complained of a feeling they were “slipping off the foot of the bed” 
when lying down (Pavy-Le Traon et al., 2007). Cosmonauts were tilted head-down in 
order to feel more comfortable when sleeping and it was thought perhaps HDBR was a 
better simulation of spaceflight. Research conducted at various HDT angles (-5 to -15°) 
concluded -6° was a suitable compromise between the most comfortable tilt with an 
acceptable magnitude of response similar to spaceflight (At'kov & Bednenko, 1992). 
HDBR reduces muscle mass, aerobic capacity and plasma volume to a similar degree 
when compared to microgravity (Table 1.1). Therefore, the HDBR model is thought to 
simulate the physiological effects of spaceflight very well and remains the most 
common experimental technique with international standardisation guidelines in order 
to compare and contrast different HDBR datasets (Sundblad & Orlov, 2015). However, 
observations of VIIP syndrome during spaceflight have so far not been replicated by 
HDBR and it is postulated that a -6° tilt may be insufficient to replicate fluid shifts in 
totality. Furthermore, the discrepancy between HDBR and actual microgravity, in 
relation to visual acuity degradation, may prove useful in the discovery of new targets 
for improved spaceflight countermeasures. 
 
 
 
 
Chapter One  General introduction 
- 38 - 
 
 
Table 1.1 Comparison of physiological deconditioning in spaceflight and head-down bed 
rest (HDBR). Adapted from Nicogossian et al. (1994). 
   
 
      
 
  
Weightlessness 
(μG) 
Head-down bed rest 
(HDBR) 
 
 
Height ↑ ± 1.3 cm ↑ ± 1.0 cm 
 
Body mass / weight ↓ 3-4 % ↓ 2-4 % 
 
Maximal aerobic capacity ↓ 17-24 % ↓ 25 % 
 
Plasma volume ↓ 10-15 % ↓ 10-15 % 
 
Muscle mass ↓ ↓ 
 
Muscle Strength ↓ ↓ 
 
Nausea (mild to severe) 65% 10% 
 
Visual problems (VIIP) 50% None 
 
 
1.3 Spaceflight countermeasures  
On-board the ISS an intensive workout program is scheduled for each astronaut 
consisting of two hours aerobic/resistive exercise each day (Figure 1.6); however, 
significant reductions in muscular (Gopalakrishnan et al., 2010), skeletal (Orwoll et al., 
2013), and aerobic capacity (Moore Jr et al., 2014) have all been recently been 
observed. Current exercise regimes were developed with the aim of targeting specific 
weight bearing muscle groups, provide a re-introduction of ground-reaction forces, and 
maintain VO2 max (Loehr et al., 2015). However, spaceflight countermeasures on-board 
the ISS fail to directly reverse the cephalic fluid shift present in microgravity. It is 
postulated that combining current exercises, with a method to specifically reverse fluid 
shifts, would provide a holistic, and more efficient approach.  Crucially, it may allow 
for reduced exercise duration, freeing up valuable crew time, with no degradation in 
physiological function. 
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Figure 1.6 Current spaceflight countermeasures on-board the International Space Station 
(ISS). Adapted from NASA (2013). 
 
  
A, Combined Operational Load Bearing External Resistance Treadmill (COLBERT); B, 
Cycle Ergometer with Vibration Isolation and Stabilization System (CEVIS);  
C, Advanced Resistive Exercise Device (ARED). 
 
 
Several other countermeasures have been explored in the past including thigh cuffs to 
prevent headward fluid shifts (Arbeille et al., 1995; Herault et al., 2000), altered 
nutrition to increase protein consumption (Lane et al., 2013), fluid-loading before re-
entry (Bungo et al., 1985), pharmacological interventions to reduce bone loss (Leblanc 
et al., 2013), and various in-flight suits to promote venous return (Kozlovskaya et al., 
1995) and prevent spinal elongation (Carvil et al., 2017). Crucially, these 
countermeasures specifically target a particular body system/mechanism, when an 
integrated approach may be more resourceful and beneficial. 
There is a growing trend for increased spaceflight duration that is evident from the 
recent one-year mission launched in March 2015 to the ISS (NASA, 2015a) and 
NASA’s strategy of sending humans to Mars in the 2030s (NASA, 2015b). The 
inadequacies of current exercise regimes are likely to become more apparent with 
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increasing mission duration; and improved countermeasures with a holistic approach, 
such as artificial gravity (AG) may increase effectiveness. 
1.4 Artificial gravity (AG) 
The conceptual idea of AG has been around as long as the idea of manned spaceflight 
itself; with several futuristic suggestions on how gravitational forces can be created 
when absent, long before spaceflight negative health effects were fully known. In 1883 
Konstantin Tsiolkovsky, the influential Russian space visionary, sketched a design for a 
“space vehicle” with AG created when running along the internal walls. Additionally, 
Tsiolkovsky discussed the possibility of “spinning space vehicles”; however, never 
lived to see his designs materialise. In the 1970s NASA commissioned an artist to 
visualise a “self-sustaining habitat with gravitational forces in space”, with the result 
being a large rotating torus in which inhabitants lived on the outer edges (Figure 1.7). 
Current technological limitations render this concept virtually impossible; however, the 
basic principle of achieving gravitational force through centrifugation has persisted 
(Clement & Pavy-Le Traon, 2004). The use of a short-arm human centrifuge (SAHC, ~ 
< 3 m radius) is currently the most technically feasible, as opposed to long-arm human 
centrifugation (LAHC) in order to achieve AG in space, with all required hardware 
possible to launch in one payload (Clément & Bukley, 2007). 
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Figure 1.7 Artist’s impression inside the Stanford Torus with a diameter 
of 1.8 km. Adapted from NASA (1976). 
 
  
 
 
1.4.1 Short-arm human centrifugation (SAHC) 
Centrifugal force generated by rotation during SAHC is likely to be used as an 
intermittent spaceflight countermeasure, in contrast to continual AG, and specifically 
tailored to an individual’s orthostatic tolerance (Goswami et al., 2015b). Repeated 
SAHC exposure has been shown to improve orthostatic tolerance on Earth (Iwasaki et 
al., 1998) with similar expected observations in-orbit; however, empirical data 
confirming this has not yet been collected. 
1.4.1.1 Force generation 
SAHC presents a unique challenge to the body, with a smaller distance from the centre 
of rotation, leading to a greater difference in g-level between the head and foot. For a 
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SAHC of approximately 2 m radius the g-level would be ~0 +Gz at the head when ~2 
+Gz is experienced at the feet; resulting in a gravitational gradient of >100% (Figure 
1.8). Spaceflight headward fluid shift reversal can be elicited through generation of 
AG/centrifugal force (Yang et al., 2007); however, the use of SAHC means greater 
angular velocity is required to achieve the same g-level (Equation 1.1i). Greater angular 
velocity increases the magnitude of Coriolis forces (Equation 1.1ii), which have been 
shown to induce neurovestibular disturbances and negatively affect g-tolerance 
(Hargens et al., 2013). However, with the head at the centre of rotation and with no 
linear velocity (v = 0 m.s-1) the Coriolis force is 0 G, despite a >100% g-level gradient 
(Ggradient) experienced across the body (Equation 1.1iii). 
 
 
 
 
Figure 1.8 Gravitational gradient as a function of rotational axis position (RAP). 
  
Radius from centre of rotation to foot (m). Plotted for average individual of 173 cm 
height with feet positioned outwards and expressed as a gradient from head to foot g-
level. 
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𝐴𝐺𝑓𝑜𝑜𝑡 = 𝜔
2𝑟𝑓𝑜𝑜𝑡 (i) 
𝐹𝐶𝑜𝑟𝑖𝑜𝑙𝑖𝑠 = 2𝑚𝜔𝑣 (ii) 
𝐺𝑔𝑟𝑎𝑑𝑖𝑒𝑛𝑡 = 1 −
𝛼ℎ𝑒𝑎𝑑
𝛼𝑓𝑜𝑜𝑡
= 1 −
𝜔2𝑟ℎ𝑒𝑎𝑑
𝜔2𝑟𝑓𝑜𝑜𝑡
= 1 −
𝑟ℎ𝑒𝑎𝑑
𝑟𝑓𝑜𝑜𝑡
 (iii) 
 
Equation 1.1 Equations for forces generated during short-arm human 
centrifugation (SAHC). 
 
  
Where AGfoot, artificial gravity level at foot (+Gz); ω, angular velocity 
(rad.s-1); rfoot, radius to foot (m); v, linear velocity (m.s-1); and rhead, 
radius to head (m). 
 
 
 
1.4.1.2 Future implementation 
Various proposals have been made to implement SAHC in space, including the most 
recent Artificial Gravity with Ergometric Exercise (AGREE) project (Figure 1.9). 
However, prohibitive costs and insufficient vibration isolation disruption in the 
microgravity environment has meant no SAHC has ever flown (Clément & Bukley, 
2007). 
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Figure 1.9 Proposed Artificial Gravity with Ergometric Exercise (AGREE) project in 
the permanent multipurpose module (PMM). Adapted from ESA (2011). 
 
  
A, AGREE hardware segment; B, installed into one of four slots in the PMM. 
 
 
 
The potential countermeasure benefit of SAHC in space would likely be further 
increased when combined with daily exercise. Specifically, exposing weight-bearing 
limbs to gravitational loading, with concurrent fluid shifts, may prove synergistic; and 
lower-limb muscle-pump activation would increase venous return, g-tolerance, and thus 
safety (Diaz et al., 2015). 
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1.5 Orthostatic challenge  
Any prolonged orthostatic challenge inducing central hypovolemia will eventually lead 
to syncope. This remains the case so long as the legs are passive and fluid shifted to the 
periphery is allowed to accumulate free from activation of the lower limb muscle-pump 
(Miller et al., 2005). When blood is redistributed in healthy individuals towards the 
legs, there is a decrease in cardiac return (cardiac pre-load), cardiac filling pressure and 
cardiac output (CO). With normal regulatory capability, arterial pressure at heart-level 
remains unaltered or even slightly increased. Cerebral autoregulation acts to prevent 
hyper- or hypo-perfusion of the cerebral tissue under differing orthostatic challenge. For 
mean arterial pressure (MAP) changes within the 50-150 mmHg range, cerebral 
perfusion remains relatively constant. However, prolonged orthostatic challenge is 
likely to disrupt the normal regulatory capabilities (Claydon et al., 2005). Once 
disrupted, relatively small changes in MAP may have a greater effect on cerebral 
perfusion and thus lead to pre- or total syncope. 
There are several ways to elicit varying degrees of central hypovolemia experimentally. 
These include the following orthostatic challenges: (i) venous cuff occlusion (VCO; 
simulated); (ii) long- and short- arm human centrifugation (L- and SAHC), also termed 
artificial gravity (AG); (iii) head-up tilt (HUT); and (iv) lower-body negative pressure 
(LBNP). 
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1.5.1 Hydrostatic gradients 
On Earth, venous and arterial pressures vary greatly across the body and with postural 
changes (Figure 1.10); and, immediately upon entering microgravity the hydrostatic 
gradient is abolished.  
 
 
 
 
Figure 1.10 Venous and arterial pressures across the body when standing and 
supine. Adapted from Gradwell and Rainford (2016). 
  
A, supine; and B, standing. Solid line, arterial vasculature; and dotted lines, 
venous vasculature. 
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Without gravity acting on the central blood column, arterial pressure equalises in a 
similar manner to supine; however, pressure changes on the venous side are less clear 
and provide topic for debate. Central venous pressure (CVP) has been shown to 
decrease in the initial moments of microgravity exposure despite a concurrent increase 
atrial diameter (Buckey et al., 1996a); potentially explained by a greater comparative 
interpleural pressure decrease (Videbaek & Norsk, 1997). Cardiac chamber distension, 
as a result of this increased transmural CVP, has been shown to increase microgravity 
stroke volume (SV) (Norsk et al., 2015). Paradoxically, spaceflight sympathetic nervous 
activity does not change (Levine et al., 2002; Christensen et al., 2005) or is even 
increased (Norsk et al., 2015), despite an immediate decrease in systemic vascular 
resistance (Norsk & Christensen, 2009) increasing systemic vasodilation (Norsk et al., 
2006). Furthermore, the role of hydrostatic gradient removal is not fully understood but, 
with the cephalic fluid shift and increased CO, may exacerbate venous congestion and 
have a disruptive effect on cerebral hemodynamics. 
1.5.2 Cerebral hemodynamics 
Little research exists into the effect of spaceflight on cerebral hemodynamics and in 
particular the regulation of cerebral blood flow (CBF). CBF is measured using a 
transcranial Doppler (TCD) device, typically measuring flow in the middle cerebral 
artery (MCA) of both or one cerebral hemisphere. There are several conflicting findings 
with regards to CBF and cerebral blood blow velocity (cBFV). Data from astronauts 
early on in flight have shown no change in cBFV (Bagian & Hackett, 1991; Iwasaki et 
al., 2007). Similar observations were made by Arbeille et al. (2001) and also a 
concurrent increase in common carotid artery blood flow; however, after 1 week and 3 
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months in space, cBFV was found to be no different from pre-flight values. It is likely 
CBF increases at the start of spaceflight, returning to pre-flight values after 1-week, 
assuming cerebral vasculature remains constant. However, there has been no research 
directly measuring cerebral blood vessel diameter in spaceflight and it is likely 
significant changes occur which may affect cerebral autoregulation. 
Cerebral autoregulation acts to maintain suitable cerebral blood flow (CBF) despite 
altered cerebral perfusion pressure (CPP) (Strandgaard & Paulson, 1984; Aaslid et al., 
1989; Paulson et al., 1989; Panerai, 1998). Specifically, a change in mean arterial blood 
pressure (MAP), within a normal range of 50-150 mmHg (Figure 1.11), has been shown 
to elicit a rapid autoregulatory response within 2-5 seconds, in order to maintain CBF 
(Folino, 2007; Gradwell & Rainford, 2016). Therefore, suitable cerebral perfusion, 
despite postural changes possibly transiently affecting MAP, can be maintained. 
 
 
 
Figure 1.11 Cerebral autoregulation curve. Adapted from Lassen (1959) 
  
Red line, representing normal cerebral autoregulation to changing mean arterial 
pressure (MAP); green line, autoregulatory curve shifted to the right with acute 
sympathetic activation. This shift helps to protect the brain from the damaging effects 
of elevated pressure; and A, normal physiological operating point. 
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More generally, the control of CBF is complex and multifactorial (Willie et al., 2014). 
In addition to cerebral autoregulation, where CBF is buffered with changes in blood 
pressure (Lassen, 1959), two other contributory concepts have been suggested. Firstly, 
the metabolic regulation of CBF which is centred on the high sensitivity of brain 
perfusion to altered arterial partial pressures of CO2 (PaCO2). Research using 
transcranial Doppler (TCD) of the middle cerebral artery (MCA) shows an approximate 
3-6% increase and/or 1-3% decrease to increasing/decreasing PaCO2, respectively (Ide et 
al., 2003; Battisti‐Charbonney et al., 2011). Finally, the role of the sympathetic nervous 
system (SNS), with the entire cerebrovasculature innervated by adrenergic and 
cholinergic fibres throughout (Willie et al., 2014). Research has shown the extensive 
sympathetic activation of the larger cerebral arteries is especially important in providing 
sufficient buffering to large transient increases in perfusion pressure (Cassaglia et al., 
2008a, b; Ainslie, 2009; Tzeng et al., 2010). 
Surprisingly, Iwasaki et al. (2007) demonstrated preservation of human cerebral 
autoregulation, in six astronauts following a 16-day mission, with a suggestion it may 
even have been improved. However, a caveat to these findings was that all astronauts 
tested did not experience post-flight OI; and the implication of these findings on 
common post-flight development of OI remains unclear. More recent research has 
shown that microgravity exposure may possibly disrupt cerebral autoregulation and it 
has been suggested impairment may explain a greater incidence of OI in returning 
astronauts (Blaber et al., 2011; Zuj et al., 2012). Blaber et al. (2011) examined 27 
astronauts from shuttle missions lasting 8 to 16 days and crucially examined 
autoregulatory response in two groups: (i) astronauts able to complete a 10 min post-
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flight stand test; and (ii) those unable. It was found astronauts unable to complete a 
stand test, indicative of post-flight OI, displayed impaired cerebral autoregulation; 
perhaps contributing to the reduced orthostatic tolerance. Nevertheless, these findings 
were during short-term missions and the effects of altered cerebral hemodynamics 
during long-term spaceflight requires further research. 
Different orthostatic challenges elicit various degrees of fluid shifts, through several 
possible mechanisms, and it is postulated that autoregulation may be differentially 
affected by orthostatic challenge type. When taken in isolation, VCO reduces lower-
limb outflow whilst arterial inflow is maintained; thus, increasing localised peripheral 
fluid shifts with minimal systemic primary stimulus. This is in contrast to SAHC which 
involve changes to the gravitational gradient across the body. Therefore, altered 
hydrostatic gradients, within the arterial and venous vasculature, are likely to have a 
resultant effect on cerebral autoregulation. Specifically, it is postulated discrepancies in 
fluid shift mechanisms, between spaceflight and HDT, may differentially affect 
emergence of internal jugular vein (IJV) congestion; with a significant effect on cerebral 
hemodynamics (Figure 1.12). 
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Figure 1.12 Schematic overview of cerebral autoregulation cascade. 
 
  
ICP, intracranial pressure; CVP, central venous pressure; CPP, cerebral 
perfusion pressure; TPR, total peripheral resistance; and CO, cardiac output. 
Adapted from Tzeng (2012). 
 
 
 
Transient microgravity with parabolic flight has been shown to immediately increase 
CBF and it is postulated that changes in systemic arterial resistance and/or increased 
intracranial pressure (ICP) may contribute to greater CBF (Bondar et al., 1990). 
Additionally, elevated ambient pCO2 levels in the confined environment of a spacecraft 
may have a contributory role in increased CBF, through altered ICP (Hughson et al., 
2016). 
There is less agreement in the literature for HDT research. CBF during -6° HDT has 
both been shown to increase (Kawai et al., 1993), decrease (Frey et al., 1993; Arbeille 
et al., 2001; Hirayanagi et al., 2005; Sun et al., 2005), and stay the same (Zhang et al., 
1997; Arbeille et al., 2001; Traon et al., 2002). It has been suggested measured CBF 
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variances are due to different HDT durations (Blaber et al., 2013b); however, we 
postulate that interindividual anatomical differences in venous vasculature, and 
specifically the IJV, possibly exhibit a causative effect. Anatomical differences may 
place an individual under greater susceptibility due to an inflow/outflow mismatch 
(Wilson et al., 2011). Little is known about venous drainage of cerebral tissue; however, 
idiopathic intracranial hypertension, with visual acuity degradation similar to VIIP 
(Suzuki et al., 2001), exhibit similar venous insufficiencies akin to congestion (Wilson 
et al., 2011). There is an indication of a link between peripheral and central fluid shifts 
to venous congestion and cerebral hemodynamics; however, direct concurrent 
measurements during orthostatic challenge have yet to be made. 
1.6 Aims and hypothesis 
The principle objective of this thesis is to characterise the role of orthostatic challenge 
induced blood volume shifts on central, peripheral, and cerebral hemodynamics; and 
based on this, to assess the suitability of future holistic spaceflight countermeasures. 
Experiments detailed in this thesis will use four types of orthostatic challenge, namely 
venous cuff occlusion (VCO); short-arm human centrifugation (SAHC); head-down tilt 
(HDT); and lower-body negative pressure (LBNP) to manipulate circulating volume 
from central to peripheral compartments and vice versa. VCO induced fluid shifts will 
be determined in relation to orthostatic challenge magnitude. SAHC, with multiple 
rotational axis positions (RAP) across the body, will be investigated in an attempt to 
understand whether an altered hydrostatic gradient affects systemic response, and 
cerebral hemodynamics. 
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In addition, due to the lack of knowledge of venous congestion importance in cerebral 
hemodynamics, this thesis will investigate headward fluid shifts on Earth in an attempt 
to understand the underlying mechanisms involved in venous congestion associated 
visual acuity pathology in space. 
Hence, the studies reported in this thesis aim to investigate: (i) VCO induced fluid shift 
effects, on systemic cardiovascular response, and quantifying central blood relocation 
importance to orthostatic challenge; (ii) to determine the effect of an altered 
gravitational gradient, as an orthostatic challenge, on central, peripheral, and cerebral 
response; and finally (iii) to evaluate the importance of venous congestion in 
microgravity and spaceflight analogues; and assess suitable amelioration methods. 
The unifying hypothesis of these studies is: 
Orthostatic challenge induced peripheral fluid shifts offer protection to headward 
pressure increases and cerebral hemodynamics, by restoring hydrostatic gradients 
to Earth-like upright norms. 
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2 MATERIAL AND METHODS 
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2.1 Experimental methods 
The focus of this thesis is the headward and peripheral fluid shifts that occur in response 
to different simulated and actual orthostatic challenges. Several differing methodologies 
were employed to manipulate participant compartmental fluid shifts (central and 
peripheral), with the associated systemic, peripheral, and cerebral hemodynamic 
responses recorded. 
2.1.1 Bilateral lower-limb venous cuff occlusion (VCO) 
Manufacturer: SC12D (13 x 85 cm), Hokanson Inc., Bellevue, WA, USA. 
Venous cuff occlusion (VCO) sequentially reduces venous outflow with increasing 
pressures whilst arterial inflow is maintained. As a non-invasive method, this posed 
minimal risk to the subjects and, whilst participants were asked to remain still and silent 
throughout, they were also encouraged to vocalise any discomfort felt (see section 
2.5.1). 
VCO is a mechanical method to shift fluid to the periphery and can be classed as a 
‘simulated’ orthostatic challenge. Namely, VCO has the ability to alter hemodynamics 
independent of postural or gravitational changes across the body. External pressure was 
applied to both limbs, at the proximal end of the thigh (Figure 2.1), using a 13 cm 
lower-limb cuff and digitally controlled pressure valve for accuracy. Use of a high-
pressure gas canister ensured each VCO level could be delivered rapidly (< 10 s) and 
safely. Furthermore, incremental cuff pressures were used to stratify volume shifted to 
the periphery. 
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Figure 2.1 Example bilateral lower-limb venous cuff 
occlusion (VCO) applied to the proximal end of the 
thigh. Credit: occlusioncuff.com. 
  
Additionally, cuff size has been shown important (Loenneke et al., 2011) and in the 
present study kept the same for all individuals, as was the positions at the most proximal 
end of the thigh. 
2.1.2 Short-arm human centrifugation (SAHC) 
Manufacturer: Custom-built, AMST Systemtechnik GmbH, Ranshofen, Austria. 
The German Aerospace Center (DLR) custom-built short-arm human centrifuge 
(SAHC) was completed in 2013 (Figure 2.2). After operational, safety, and functional 
tests the research carried out as part of this thesis was the first full-scale utilization of 
the newly built hardware. The unique modular design allowed for an increase in the 
mass capacity of measurement devices and made SAHC experimentation with large 
mass devices possible. Furthermore, maximum angular velocity was 38 rpm allowing 
for a sufficient g-level to be delivered, to the feet when supine, even with a small radius 
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(Table 2.1). An ability to alter the center of rotation, and thus the gravitational gradient 
experienced across the body, was crucial to this part of data collection.  
 
 
Figure 2.2 Short-arm human centrifuge (SAHC) at the German 
Aerospace Center (DLR) :envihab in Cologne. 
  
 
 
 
 
Table 2.1 German Aerospace Center (DLR) short-arm human centrifuge (SAHC) 
dimensions and performance. 
  
G, g-level; CW, clockwise; CCW, counter-clockwise; AC, alternating current; 
and DC, direct current. 
 
 
 
Radius 0 – 380 cm (at outside perimeter) 
Radial acceleration 6 G (maximum) 
Angular velocity 4 rad/s (~ 38 rpm) 
Maximum angular acceleration 0.133 rad/s2 from 0 – 6 G in 30 s 
Spinning direction CW and CCW 
Noise level < 40 dBA 
Power distribution 115 / 230 V (AC) and 12 / 24 V (DC) 
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The participant was secured safely to the centrifuge by a parachute harness and 
suspended on the nacelle in a bicycle seat to ensure they remained as passive as 
possible, without lower-limb ‘muscle-pump’ activation. 
2.1.2.1 Associated risks 
The centrifuge run, at the maximum g-levels used (2.4 +Gz) can potentially cause 
orthostatic hypotension. If so, the test can lead to a fall in heart rate and blood pressure, 
paleness, sweating, and sometimes also to nausea, vomiting and in rare cases 
gravitational loss of consciousness (GLOC) (Whinnery & Whinnery, 1990). An altered 
gravitational gradient, due to a change in rotation axis position (RAP), produces a 
unique orthostatic challenge across to the body. This stimulus, and the specific 
hemodynamic response to it, forms the focus of part of the research; with a greater 
challenge likely providing a clearer difference between changing gravitational gradients. 
However, challenge intensity must be balanced against participant safety and complete 
hemodynamic collapse. The present SAHC experimental set-up and profiles are based 
on an extensive literature review and own investigations within our research group and 
institute. 
During prolonged SAHC, the response of the autonomic nervous system is not 
sufficient to prevent a peripheral fluid shift, maintain venous return to the heart, cardiac 
output and ultimately cerebral perfusion (Grasser et al., 2009). Present research is aimed 
to specifically determine the limitations of SAHC protocols, and response to differing 
gravitational gradients, that could be used in future spaceflight settings.  
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Should hypotension or one of the termination criteria (see section 2.1.5) occur the 
centrifuge would be immediately stopped, which promptly normalises the circulation 
state. The test will also be aborted with the emergence of a severe presyncopal episode, 
based on the professional opinion of the study physician. However, if need be, measures 
necessary to maintain cardiorespiratory function during these experiments can be 
carried out, with reanimation facilities on standby. Additionally, heart rate and blood 
pressure were continuously monitored and trained personnel, together with a physician 
skilled in cardiopulmonary resuscitation (CPR), were present if needed. 
Prior to experimentation on the centrifuge a venous cannula was inserted into the arm of 
each participant in case of an emergency. Whilst no specific protocols involving the 
venous cannula were planned, this pre-emptive measure allowed for a faster emergency 
response time, by negating the need to locate a vein, if intravenous fluids were required. 
2.1.2.2 Additional SAHC measurements 
The integrity of the expected g-level was monitored using a tri-directional 
accelerometer at foot level (SS26LB, Biopac Systems, Goleta, CA, USA), with specific 
heart-level +Gz values calculated for each participant. Integral hardware monitoring 
produced data files at the end of experimentation which included centrifuge revolutions 
per minute (RPM), temperature, and mechanical torque produced. 
At all times an infrared camera was pointed at the participant’s head, chest, and face to 
monitor signs of presyncope, continuous blood pressure device placement, and leg 
muscle-pump activation, respectively. All camera feeds were recorded and catalogued 
for further analysis if the collection of anomalous data warranted it. 
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2.1.2.3 Operational personnel 
During experimentation the participant was sealed and safety locked inside the 
centrifuge spin area. Lights were turned off and the participant monitored on infrared 
camera by personnel in the adjacent control room (Figure 2.3). All experimental 
hardware was either fixed onto multiple shelves in the moving centrifuge arm or 
wirelessly connected through Bluetooth to the control room. 
 
 
Figure 2.3 Short-arm human centrifuge (SAHC) control room with 
operator stations for scientists, doctors, and engineers. 
  
EO1-3, experimental operators 1 to 3; PI, principal investigator; MM, medical 
monitor (physician); and CO, centrifuge operator. 
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2.1.3 Electronic head-down/up tilt-table (HDT and HUT) 
Manufacturer: Custom-built, Medical University Graz, Graz, Austria. 
The electronic tilt-table at :envihab German Aerospace Center (DLR; Figure 2.4) is 
fully programmable to deliver precise, reproducible angles of tilt in a desired timeframe. 
Participants were sufficiently held in place due to the ribbed, rubberized surface, 
preventing slippage during angles of head-down tilt (HDT) to -30°. Furthermore, the 
ability to tilt without any harness prevents shoulder discomfort and potential 
interference of physiological responses. 
 
 
Figure 2.4 Electronic tilt table installed at :envihab German Aerospace 
Center (DLR) in Cologne. Credit: DLR, 2014. 
 
  
2.1.3.1 Associated risks 
HDT, especially at steeper angles, may produce discomfort and an unusual feeling of 
“facial fullness” and it was possible participants would have experienced a mild 
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headache. However, upon returning to a supine position this sensation was expected to 
resolve itself and any HDT was immediately terminated if requested. During other 
studies within our research group, severe back pain has been experienced but for a much 
longer duration (up to four hours) than the current study duration. It was therefore 
anticipated at a maximum HDT of -24° for five minutes would be tolerable. The 
maximum angle of tilt is an increased divisible multiple of the currently used -6° HDT. 
-18° was deemed sufficient from the literature but -24 tested to ensure a further 
response could be quantified; whether that was an expected plateau, in terms of fluid 
shifted from the periphery, or an increase in the headward fluid shift. 
2.1.3.2 Additional HDT/HUT measurements 
Each protocol on the electronic tilt table was fully programmed prior to experimentation 
and a record of each profile catalogued for further use. Additionally, room temperature, 
precise tilt angle and time were synchronised for reference. 
2.1.4 Lower-body negative pressure (LBNP) chamber 
Manufacturer: Custom-built, German Aerospace Center (DLR), Cologne, Germany. 
The lower-body negative pressure (LBNP) chamber is a custom-built, temperature, 
humidity, and pressure-controlled device. This hardware is integrated for use with the 
electronic tilt-table simultaneously and was run from the same programmable script. 
Participants were inserted into the chamber and distance/height adjusted to ensure a 
comparable portion of the body was exposed to the pressure and therefore response; as 
this has been shown to affect cardiovascular response (Goswami et al., 2009). 
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Participants were sealed into place using a neoprene ‘skirt’ to achieve a suitable 
pressure seal and lower-body movements could be visually monitored through the 
transparent Perspex dome (Figure 2.5). 
 
 
Figure 2.5 Lower-body negative pressure (LBNP) transparent 
Perspex chamber. 
  
2.1.4.1 Associated risks 
The LBNP device run can potentially cause orthostatic hypotension. Prolonged LBNP 
may lead to a fall in heart rate and blood pressure, paleness, sweating, and sometimes 
also to nausea, vomiting and in rare cases (at only -40 mmHg) loss of consciousness. 
Due to the reduced pressure in the periphery, and a localised stimulus, the response of 
the autonomic nervous system may eventually lead to a failure in maintaining venous 
return to the heart, cardiac output and ultimately cerebral perfusion (Levine et al., 
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1994). However, the experimental set-up is based on an extensive literature review, and 
current research group experience in the institute, further minimising the risks. 
 
If hypotension or one of the termination criteria (see section 2.1.5) occur the LBNP 
device would be immediately stopped and the tilt table angle returned to supine, which 
would promptly normalises the circulation state (Van Lieshout et al., 2003). 
Additionally, any test would be aborted if the medical doctor deemed it necessary 
through the emergence of a visible presyncopic episode. Measures necessary to 
maintain cardiorespiratory function during these experiments can be carried out with 
reanimation facilities on standby. Furthermore, heart rate and blood pressure were 
continuously monitored by trained personnel, together with a physician skilled in 
cardiopulmonary resuscitation (CPR), to perform any medical interventions if needed. 
2.1.4.2 Additional LBNP measurements 
Similar data to the electronic tilt table is collected and catalogued on the same file, but 
with the addition of LBNP chamber temperature, humidity, and pressure at a given time. 
2.1.5 Orthostatic challenge termination criteria 
Unless the subject directly requests the cessation of centrifugation/LBNP, the medical 
monitor will determine a stopping point if the subject displays presyncopal signs. These 
signs could be subjective: grey-out, head vacuum feeling, daze feeling, omnidirectional 
vertigo, sudden sensation of heat, nausea, sweating, non-responsiveness; as well as 
objective: a systolic blood pressure drop-off > 15mmHg, and/or a sudden decline in 
heart rate > 15 bpm, or a sustained tachycardia > 1 min > 90% maximum age-predicted 
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heart rate. An overview of the termination criteria in which the medical doctor on duty 
will follow is outlined and summarised below in three main classes: 
2.1.5.1 Significant cardiac arrhythmia 
a. Supraventricular or ventricular tachycardia; 
b. Indication of atrioventricular node conduction blockade (AV-blockade > 
Degree I); 
c. Premature ventricular contractions (PVCs) that correspond to any one of 
the following criteria:  
i. 6 or more PVCs per minute; 
ii. Prematurity index [(QNormal beat - QPVC)/QT timeNormal beat] < 0.9 (R-
on-T phenomenon); 
iii. PVCs which occur repeatedly (> 2×) in couplets or in salvos 
(≥ 3); 
iv. Polymorphous PVCs. 
 
2.1.5.2 Haemodynamic criteria 
a. Decrease in the continuously recorded mean arterial blood pressure by 
40% of the baseline value in supine position or to values < 60 mmHg 
without increase in heart rate within 10-sec; 
b. Increase in heart rate to > 70% of the maximum heart rate over 10-sec; 
c. Decrease in heart rate to < 50% of the plateau heart rate in the first 
minute after the tilt maneuver or to rates of < 50/min over 10-sec; 
d. A continuous decrease in heart rate and mean arterial blood pressure over 
15-sec or the achievement of a minimum value for one or both 
parameters. 
 
2.1.5.3 Clinical criteria 
a. Nausea, pronounced sweating, paleness, dizziness, paraesthesias; 
b. Angina pectoris; 
c. Slow auditory response. 
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2.2 Cerebral measurements  
2.2.1 Transcranial Doppler (TCD) 
Manufacturer: DWL Multi-Dop T digital, Compumedics GmbH, Singen, Germany. 
Transcranial Doppler (TCD) ultrasound provides a non-invasive method for 
examination of the intracranial arteries measuring the velocity of blood flowing through 
the cerebral vasculature. The TCD device was securely attached to the participant’s 
forehead (via an elastic strap) causing no discomfort (Figure 2.6). 
 
 
 
Figure 2.6 Transcranial Doppler (TCD) device focused on the middle 
cerebral artery (MCA) to determine cerebral blood flow velocity 
(cBFV). Credit: Cedars-Sinai Medical Center. 
 
  
Mean cerebral blood flow velocity (cBFV) of the middle cerebral artery (MCA) was 
measured, through either the right or left temporal window, with 4 MHz pulsed 
transcranial Doppler ultrasound (Compumedics GmbH, Singen, Germany). A major 
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limitation of the TCD method is that the measured velocity being used to provide an 
inference on cerebral flow is based on an assumption of constant/unchanging diameter 
of the MCA (Purkayastha & Sorond, 2012). 
The temporal window was determined to produce the best signal during pre-testing and 
used on all test days. The analogue signals from these devices were recorded 
simultaneously, with other synchronised data, using multi-channel hardware and 
software (MP100, Biopac System Inc., CA, USA). Beat-by-beat analysis of these data 
was performed offline. 
2.2.2 Cerebral near-infrared spectroscopy (cNIRS) 
Manufacturer: PortaLite, Artinis Medical Systems, Einsteinweg, The Netherlands. 
The PortaLite device, uses near-infrared spectroscopy (NIRS) to measure local cerebral 
tissue saturation as well as oxyhemoglobin (O2Hb), deoxyhemoglobin (HHb), and total 
hemoglobin (THb) concentrations. Jobsis (1977) demonstrated that biological tissues 
were relatively transparent to near-infrared light (700-1300 nm) making it possible to 
non-invasively measure changes in the light absorption properties of hemoglobin as the 
main innate chromosphere. If the absorption is known, the chromosphere’s absorption 
can be calculated using the Beer-Lambert law (Equation 2.1i). However, this applies 
only to a transparent non-scattering medium and a correction factor must be applied for 
a scattering medium. A modification of the Beer-Lambert law, using a differential 
pathlength factor (DPF), allows for the increase in optical pathlength as a result of 
scattering that occurs in body tissue (Equation 2.1ii). Equation 2.1ii remains valid for a 
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medium consisting of one chromophore; however, when measuring O2Hb, HHb, and 
THb several wavelengths need to be utilised concurrently (Figure 2.7). 
ODλ = log (
Io
I
) = ελ ∙ c ∙ L (i) 
Δc =
ΔODλ
ελ ∙ L ∙ DPF
 (ii) 
 
Equation 2.1 Equations of optical density and chromophore concentration 
for calculating near-infrared spectroscopy (NIRS) measurements. 
  
(i), Lambert-Beer law; and (ii), Lambert-Beer law for a scattering 
medium. Where ODλ is the optical density of the medium; Io is the 
incident light; I, transmitted light; ελ the chromophore extinction 
coefficient (in µM-1.cm-1); c, chromophore concentration (µM); L, 
distance between entry and exit points (cm); and λ wavelength used 
(nm). 
 
 
  
Figure 2.7 Schematic of transmission and absorption, of near-
infrared light wavelengths (700-1300 nm), in a scattering 
medium. Adapted from Artinis Medical Systems. 
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The PortaLite separated probe is small, non-invasive and easy to attach (Figure 2.8) and 
operated using dedicated Oxysoft software (V6.0, Artinis Medical Systems, The 
Netherlands). It was attached to the participant’s forehead on the right-side, using 
adhesive tape, and prior to fixation the area was cleaned with a mild abrasive and 
alcohol. At the start of experimentation the Oxysoft software allowed for the real-time 
quality check of signal integrity and the input of participant age, which has been shown 
to affect cranium thickness (Yoshitani et al., 2007) and therefore NIRS readings. The 
PortaLite has three light sources and is therefore capable of measuring tissue saturation 
index (TSI), which is an absolute measure of O2Hb and the favoured overall measure in 
previous studies (Matcher et al., 1995; Naulaers et al., 2007; Murkin & Arango, 2009).  
 
  
Figure 2.8 Prefrontal cortex cerebral near-infrared spectroscopy 
(NIRS) consisting of emitter and receiver attached to the participant 
forehead. Credit: Artinis Medical Systems. 
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This method requires accurate measurement of rapid changes in arterial O2Hb 
concentrations by a NIR spectrometer; with limitations of this monitor contributing to 
errors in measurement of perfusion and the calculated TSI (Elwell et al., 1992). 
Additionally, measured changes in O2Hb concentration do not differentiate between 
arterial inflow and venous outflow and there is an assumption of a steady-state in O2 
consumption of the cerebral tissue being measured (Pellicer & del Carmen Bravo, 
2011). Reproducibility of measured results is highly dependent on placement of the 
light probes; with pictures taken between measurements on different days and 
placement of the probe on one day was unmoved to mitigate against this. An index of 
perfusion (TSI) was used to measure changes experienced over a given period as 
opposed to absolute values. 
2.2.3 Internal jugular vein (IJV) cross-sectional area (CSA) ultrasonography 
Manufacturer: MyLab Gamma, Esoate SpA, Genoa, Italy. 
Ultrasonography is a common imaging technique used across medical fields to image 
organs and tissues. Boundaries between tissues, using high frequency sound waves and 
their echoes, can be imaged; as can changes in venous cross-sectional area (CSA) 
(Bellazzini et al., 2009). Ultrasound was performed on the internal jugular vein (IJV) to 
evaluate venous distention through CSA quantification as evidence of congestion 
(Figure 2.9). 
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Figure 2.9 Internal jugular vein (IJV) cross-sectional area (CSA) 
determination using ultrasonography. 
 
  
The jugular vein section was measured on B-mode echographic transversal views of the 
neck at the cricoid level parallel to the clavicle. The probe was placed at an angle of 
approximately 90° on the participant's neck as lightly as possible and large amounts of 
ultrasonic gel was used to avoid significant venous compression and/or change the 
shape and dimension of the vein. The use of surplus gel also ensured the absence of 
black cones and dark areas in the images. Short video sequences were stored and offline 
measurements, of the pulse-triggered maximal right and left IJV-CSA, were made using 
the manual area trace function of the machine (MyLab Gamma, Esoate SpA, Genoa, 
Italy). 
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2.3 Peripheral measurements  
2.3.1 Strain gauge plethysmography (SGP) 
Manufacturer: SC6 with Indium-Gallium gauges, Hokanson Inc., Bellevue, WA, USA. 
To date, strain gauge plethysmography (SGP) is a valuable non-invasive, practical and 
low-cost tool for assessing volumetric changes, for instance during venous compliance 
and orthostatic testing experiments. In the present study, strain gauges were fixed 
around the calf midpoint (directly between the tibiae tuberosity and medial malleolus 
bony prominences) and then stretched to a standard tension, so that any increases in 
circumference would be encompassed within the linear part of the strain gauge range 
(Figure 2.10). 
Changes in calf volume result in a corresponding change in calf circumference and thus 
strain gauge length, which is detected as an alteration in electrical resistance of the 
gauge and thus potential difference. Since the gauge length is made equal to the resting 
circumference of the limb, any changes in gauge resistance are related to the changes in 
limb volume during orthostatic challenge (Equation 2.2). Crucially, the strain gauges 
used were calibrated using the custom-built calibration tool described below. 
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Figure 2.10 Strain gauge plethysmography (SGP) attached to calf 
mid-point. Credit: Hokanson Inc. 
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)
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1
 
(iii) 
 
Equation 2.2 Calculation of volumetric peripheral fluid displacement percentage increase 
from calf circumference percentage increase. 
  
(i), leg volume before VCO; (ii), leg volume after VO; and (iii), leg 
volume percentage increase due to VCO. Where C is the measured 
percentage increase in calf circumference. 
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2.3.1.1 Gauge calibration 
Manufacturer: Custom-built, German Aerospace Center (DLR), Cologne, Germany. 
The gauge calibration device was designed to encompass all calf circumferences to 
provide a specific two point calibration for each participant. Additionally, 26 grooves 
were milled 13 mm apart and to a depth of 3 mm, matching precisely the diameter of the 
Indium-Gallium gauges (Figure 2.11). Each milled groove was of a known 
circumference and, based on machine precision (German Aerospace Center, Cologne, 
Germany), accurate to the nearest one hundredth of a millimeter (± 0.01 mm).  
 
 
Figure 2.11 Custom-built strain gauge plethysmography (SGP) 
calibration device for absolute circumference determination. 
  
Computer aided design (CAD) with decreasing circumference (of known size) up the 
funnel shaped rod. Final device was precision cut on a lathe out of Polymethyl 
methacrylate (PMMA) acrylic cylinder (diameter: 200 x width: 400 cm). 
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On experimentation day each participant’s calf midpoint was roughly determined using 
a standard tape measure and two circumferences on the calibration tool selected for the 
two point calibration. After calibration, the gauge was transferred to the participant for 
the duration of testing. Finally, following experimentation the gauge was transferred 
back to the cone to ensure there had been no deviation in the initial calibration. 
2.3.2 Muscle near-infrared spectroscopy (mNIRS) 
Manufacturer: PortaMon, Artinis Medical Systems, Einsteinweg, The Netherlands. 
Muscle NIRS (mNIRS) was used to assess localised calf tissue saturation index (TSI) 
and relied upon similar technology described in section 2.2.2. The PortoMon is a 
slightly larger device, than what was used to assess cerebral TSI, and without the 
corrective algorithm for cranium thickness (Yoshitani et al., 2007). The device was 
fixed to the medial head of the gastrocnemius muscle belly using adhesive tape and a 
light-blocking, black covering. Prior to fixation the area was shaved, cleaned with a 
mild abrasive, and rubbed with alcohol. Data was continuously collected using Oxysoft 
software (V6.0, Artinis Medical Systems, The Netherlands), with cNIRS as an 
additional channel, and synchronised by networked time to other parameters. 
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2.4 Systemic measurements  
2.4.1 Heart rate and continuous blood pressure 
Manufacturer: Finometer, Finapres Medical Systems, Enschede, The Netherlands. 
Systolic, diastolic and mean arterial blood pressure (MAP) and pulse pressure (PP) were 
measured using the Finometer device. The Finometer is a non-invasive device for 
measuring continuous blood pressure on the second phalanx of the second and/or third 
finger of either hand. The current systolic/diastolic pressures were measured with the 
help of a cuff containing an integrated pressure and volume sensor placed on the finger 
phalanx. As part of this process a pulse pressure graph was recorded, the maxima and 
minima of which correspond to the systolic and diastolic blood pressures. Specifically, 
the volume of blood in the finger arteries, over the entire cardiac cycle, was determined 
by a cuff pulse oximeter and kept constant by a matched resultant counter-pressure 
(Figure 2.12). Constant blood volume over time results in a finger cuff pressure that 
equals the intra-arterial pressure and can be corroborated by a standard medical 
sphygmomanometer. 
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Figure 2.12 Vascular unloading technique used by the Finometer 
device to measure continuous beat-by-beat blood pressure and 
heart rate. Credit: ProfBondi CC-BY-SA 3.0. 
  
 
2.4.2 Additional measurements 
From the continuous signal, beat-to-beat systolic, diastolic, pulse pressure and mean 
blood pressure was recorded, as well as model flow estimates for beat-to-beat cardiac 
output (CO), stroke volume (SV) and total peripheral resistance (TPR), as described by 
Wesseling et al. (1993). 
2.5 Discomfort and presyncopal symptoms (PSS) 
2.5.1 Discomfort definition 
At any point during bilateral lower-limb venous cuff occlusion (VCO) each participant 
was encouraged to remain still and silent unless experiencing discomfort. Any instance 
of participant registering pain associated to the occlusion pressure was recorded. 
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Participants were separated into those experiencing discomfort (PAIN+) and those not 
(PAIN-), at a particular VCO level. 
2.5.2 PSS definition 
During each SAHC run, a participant was classified as having experienced presyncopal 
symptoms (PSS+) if, during the run or post-run offline analysis, they satisfied any one 
or more of the criteria in sections 2.5.2.1 and 2.5.2.2. However, a participant was 
recorded as not having experienced presyncopal symptoms (PSS-) if none of the five 
conditions were met. 
2.5.2.1 Hemodynamic criteria (post-run, offline script) 
a. MAP decrease >40% of baseline supine value; 
b. MAP <60 mmHg without HR increase in 10 s; 
c. Continuous decrease in HR and MAP over 15 s. 
2.5.2.2 Clinical criteria or participant withdrawal (during-run, recorded) 
a. Nausea, pronounced sweating, paleness, dizziness, paresthesia; 
b. Immediately on participant request. 
 
 
2.6 Participant selection & medical monitoring 
2.6.1 Participant selection 
A total of 45 participants (23 male; 22 female) were recruited and took part in at least 
one of the main studies and gave their written informed consent to participate. Selected 
participants were physically active, healthy, non-smoking and normotensive and 
required to pass a medical screening for participant safety reasons. The medical 
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screening process is outlined below and similar to that of a commercial pilot (see 
section 2.6.1.1); with participants also required to satisfy the following inclusion (see 
section 2.6.1.2) and exclusion criteria (2.6.1.3). 
2.6.1.1 Medical screening 
The medical screening examination consists of a clinical-chemical blood analysis 
consisting of: glucose, creatinine, urea, uric acid, serum glutamic oxaloacetic 
transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), serum gamma 
glutamyl transferase (γ-GT), total cholesterol (high density lipoprotein, HDL; and low 
density lipoprotein, LDL), and haematology (blood count). Further analysis included: 
urine (glucose, protein, urobilinogen), resting electrocardiogram (ECG), adapted Bruce 
Protocol with cycle ergometry to verify appropriate aerobic fitness (for age and gender) 
and cardiac function (Bruce et al., 1963), standing test for orthostatic tolerance 
assessment, and a medical history. Female volunteers additionally had to test negative 
on a standard pregnancy test before each experiment. 
Tests for HIV and hepatitis B and C were carried out. Before these tests, all participants 
were advised about the possible consequences of a positive test result. In the case of a 
hepatitis infection (in Germany), we would present a report including the name of the 
participant to the Health Department. In the case of an HIV infection, an anonymous 
report would be submitted and affected participants advised to seek further guidance 
from their regular doctor. 
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2.6.1.2 Inclusion criteria 
All of the following inclusion criteria were satisfied in order to participate: 
a. Healthy male or female participants aged between 20 and 45 years old; 
b. Mass: 65-85 kg; 
c. Height: 158-190 cm; 
d. Body Mass Index (BMI) of 20-26 kg/m2; 
e. Not a competitive athlete; 
f. Non-smoker, for at least six months before the start of the study; 
g. In the position to participate in the complete study; 
h. Demonstrable social insurance and official certificate of absence of 
criminal record; 
i. Successful completion of screening examination; 
j. Provision of Declaration of Consent at the start of the study. 
2.6.1.3 Exclusion criteria 
If any one of the following conditions were true then a participant was excluded: 
a. Drug or alcohol abuse (regular consumption of 20-30 g alcohol / day); 
b. Smoking; 
c. Obesity (BMI > 26); 
d. Diabetes mellitus; 
e. Muscle or joint diseases; 
f. Herniated disc; 
g. History of epileptic seizures; 
h. Heart disease or a cardiac pacemaker; 
i. Severe orthostatic intolerance or impaired neurovestibular function; 
j. Chronic back pain; 
k. Pregnancy; 
l. Any other condition deemed unsuitable by the Medical Director for study 
inclusion. 
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2.6.2 Medical monitoring 
Throughout the experiment, intervallic systolic (SBP) and diastolic blood pressure 
(DBP) was measured by oscillometry (IntelliVue MMS X2, Amsterdam, Netherlands) 
on the upper arm. The blood pressure measurements served to medically monitor all 
participants. 
Continuous recording of the ECG and heart rate were made via a 3-lead attached to the 
chest. Participants were observed throughout by the medical monitor who observed 
strict adherence to the defined orthostatic challenge termination criteria (see section 
2.1.5). 
2.7 Data handling  
2.7.1 General study design 
The VCO study (first) consisted of incrementally increasing occlusion pressures with 
the repetition of -60 mmHg, at the end, to assess reproducibility. However, the SAHC 
and HDT±LBNP studies (second and third) were entirely randomised (random.org, 
2016) meaning experimental conditions experienced were completely different between 
participants. All experiments within this thesis took the format of an orthostatic 
challenge, of various types and length, followed by a recovery period in order for 
hemodynamic responses to return to baseline. The parameters outlined above fall into 
one of three categories: cerebral, peripheral, and systemic hemodynamic measures; and 
all were continuously recorded during baseline, challenge and recovery.  
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Data for each main study were collected on one session apart from the second study 
(SAHC) which was spread over two months. Multiple sessions were exactly one month 
apart to ensure responses to the orthostatic challenge were unaffected by women 
participant’s menstrual cycle. Additionally, all studies as part of this thesis conformed to 
the declaration of Helsinki and was approved by the Ethics Committee of the North 
Rhine Medical Association in Düsseldorf, Germany (lfd. Nummer 2014123 and 
2015381). 
2.7.2 Statistical approaches 
Software:G*Power (Erdfelder et al., 1996); R (R Foundation for Statistical Computing, 
Vienna, Austria) and lme4 (Bates et al., 2012); and Matlab (R2015a, The Mathworks 
Inc., MA, USA). 
Power calculations, with cerebral tissue saturation index (cTSI) as the key end-point, 
were carried out using G*Power. After data collection, all continuously recorded data 
were analysed and processed in accordance with a custom Matlab script. Specifically, 
the following processes were carried out: (i) removal of implausible physiological data 
points (Table 2.2); (ii) removal of maximal percentage change in relation to the standard 
deviation of the signal; and (iii) data resampled at 4Hz (piecewise cubic spline 
interpolation) assuming >95% data integrity. 
R (R Foundation for Statistical Computing, Vienna, Austria) and lme4 (Bates et al., 
2012) were used to perform linear mixed effect (LME) analysis of the relationship 
between cardiovascular parameters and the time course of each orthostatic challenge. 
Furthermore, 2 and 3-way interactions were entered into the model with intercepts for 
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each participant as a random effect, with secondary models incorporating participant sex 
to explore gender effects. P-values were obtained by likelihood ratio tests of the full 
model with the effect in question, against the model without that effect. 
 
Table 2.2 Implausible physiological data limits of all measured parameters; for 
data processing, using a custom-made Matlab script. 
  
TCD, transcranial Doppler: cerebral blood flow velocity; cNIRS, cerebral near-
infrared spectroscopy (NIRS): cerebral tissue saturation index; SGP, strain-gauge 
plethysmography: calf circumference; mNIRS, calf muscle NIRS: muscle tissue 
saturation index; HR, heart rate; MAP, mean arterial pressure; SV, stroke volume; 
and TPR, total peripheral resistance. 
 
 
 
 Lower limit Upper limit 
   
Central   
TCD > 5 cm.s-1 < 100 cm.s-1 
cNIRS > 50 % < 100 % 
   
Peripheral   
SGP > 100 mm < 400 mm 
mNIRS > 50 % < 100 % 
   
Systemic   
HR > 20 bpm < 220 bpm 
MAP > 20 mmHg < 155 mmHg 
SV > 20 mL < 200 mL 
TPR > 300 dyn.s.cm-5 < 3000 dyn.s.cm-5 
   
 
 
Matlab (R2015a, The Mathworks Inc., MA, USA) was also used to perform statistical 
analysis. Visual inspection of residual plots did not reveal any obvious deviations from 
homoscedasticity or normality of residuals. The tests applied were one-way analysis of 
variance (ANOVA, repeated measures), post hoc tests with preventative post hoc 
control of the type I error rate (Tukey’s Honestly Significant Difference, HSD) and t-
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test (independent, by groups). Linear and non-linear regression analysis was used to 
estimate the relationships among variables. Additionally, hemodynamic responses 
between groups were compared, for all participants, using Bland-Altman plots (Bland & 
Altman, 1986) and reproducibility was quantified as the standard deviation of the 
difference between both groups. The data are presented as mean (±SEM) unless 
otherwise stated with the level of significance set at p≤0.05. 
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3 BILATERAL LOWER-LIMB VENOUS CUFF 
OCCLUSION AS A SIMULATED ORTHOSTATIC 
CHALLENGE AND ITS EFFECT ON CENTRAL 
HYPOVOLEMIA AND CEREBRAL TISSUE 
OXYGENATION 
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3.1 Introduction 
Fluid shifted to the lower extremities, coupled with insufficient venous return, gives rise 
to orthostatic intolerance (OI) which is characterised as an inability to maintain 
adequate cerebral perfusion (Van Lieshout et al., 2003). Healthy individuals during a 
prolonged orthostatic challenge, or those with a deconditioned cardiovascular system, 
are most susceptible to OI. Around half of all returning astronauts suffer from OI on 
return to Earth’s gravity (Buckey et al., 1996b) due to one of the four following 
hypotheses: (i) reduced circulating blood volume; (ii) increased vascular compliance; 
(iii) cardiac hypo-function; and (iv) alterations in baroreflex function. Additionally, 
reduced functioning of the otolith system has been shown to prevent blood pressure 
stability during an orthostatic challenge (Hallgren et al., 2015); and this presents as a 
potential target, as a driver of the autonomic reflex, to mitigate OI (Yates & Bronstein, 
2005). Periodic exposure to venous cuff occlusion (VCO) may ameliorate OI if it is able 
to effectively challenge the cardiovascular system and thus prevent deconditioning. An 
orthostatic challenge without a sufficient response will lead to eventual syncope, thus 
repeated challenge to the cardiovascular system must be balanced against a safe level of 
exposure. 
VCO is routinely used diagnostically to assess reactivity of vasculature, through altered 
perfusion pressures of occluded limbs, and evaluate general health of blood vessels 
(Hull et al., 1976; Wilkinson & Webb, 2001). Occlusion with plethysmography is a 
well-established technique, capable of detecting small volume increases to accurately 
record blood flow non-invasively (Litter & Wood, 1954). Limiting venous blood flow, 
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whilst maintaining unaltered arterial flow, leads to an increase in volume of the 
occluded limb which can be measured using a fluid filled plethysmograph (Figure 3.1).  
 
 
Figure 3.1 The Burette-plethysmograph apparatus used by Litter and Wood (1954) to explore 
the effects of graded external pressure on volume and distribution of blood in the leg. 
  
A, pressurising valve; B, water fluid column; C, opening stopcock; D, drainage 
tube; E, thermometer, F, electric heater; G, propeller, H, narrow blood 
pressure cuff; and 1,2,3 and 4, multiple pressure cuffs along thigh. 
 
VCO elicits a mechanical movement of blood without an actual change in position or 
force along the limbs or body. As such, VCO may be used to experimentally simulate 
an orthostatic challenge, with minimal systemic influences, by rapid fluid relocation. 
Sarin et al. (1992) demonstrated a mean external cuff pressure of ~110 mmHg was 
required to entirely occlude both deep and superficial venous vasculature; even though 
internal venous pressures were likely much lower. However, Groothuis et al. (2003) 
suggested external occlusion pressures from 30 mmHg to expected diastolic pressure 
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(80 mmHg) elicited the greatest arterial inflow; with pressures above this potentially 
also compressing arteries. 
Factors shown to affect internal pressures, elicited by VCO, include calf circumference 
(Loenneke et al., 2011) and cuff width (Loenneke et al., 2012); with other research 
suggesting inter-individual differences can be resolved by basing occlusion pressures on 
individual systolic blood pressure (SBP) (Cook et al., 2007). Utilisation of VCO, as a 
simulated orthostatic challenge, requires the consideration of potential diminished 
internal pressures from externally applied VCO. Therefore, VCO pressures required to 
elicit total venous occlusion are likely greater than the measured mean resting lower-
limb venous pressure of ~95 mmHg; which has also been shown to have large inter-
individual variability (Kügler et al., 2001). VCO pressures from 0 to above, and not far 
beyond 95 mmHg, are likely to sequentially affect arterial filling in all individuals. 
Specifically, for the purposes of attempting to simulate an orthostatic challenge, an 
upper occlusion pressure must not exceed the limiting point where arterial flow begins 
to be impeded. 
3.1.1 Orthostatic challenge 
Whilst VCO is not an orthostatic challenge per se it affords the ability to shift fluid, in a 
similar manner to alterations of body position from lying to upright, from one body 
compartment to another (central to peripheral). Healthy individuals maintain suitable 
blood pressure during an orthostatic challenge through sensitive baroreceptors feedback 
response to small changes in blood pressure affecting the stretch stress of carotid and 
aortic regions (Gabrielsen et al., 1996; Pump et al., 2001). Crucially acting to maintain 
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blood pressure within acceptable parameters (50-150 mmHg) and ensuring sufficient 
cerebral perfusion is achieved in agreement with the cerebral autoregulation curve 
(Figure 1.11). However, Giller et al. (1992) demonstrated a significant reduction in 
cerebral blood flow during, lower-body negative pressure (LBNP) induced, 
normotensive central hypovolemia. It is clear the relationship between mean arterial 
pressure (MAP) and cerebral blood flow is important; however, the autoregulatory 
response may not entirely explain the complex relationship between blood pressure and 
cerebral hemodynamics during orthostatic challenge. 
Disruption of this innate process directly challenges the limits of individual homeostatic 
capability. VCO as a localised challenge elicits peripheral fluid shifts to the detriment of 
central blood volume; and central hypovolemia, without other systemic mechanisms 
playing a part, is likely to affect cerebral hemodynamics. Any deviations, from expected 
cerebral autoregulatory responses, may provide an insight into the ability of VCO to 
simulate an orthostatic challenge. 
3.1.2 Peripheral fluid displacement 
Blood shifted outside of the central compartment, sequestered in the periphery or 
splanchnic circulation, has been shown to impede mechanisms responsible for 
maintaining sufficient cerebral tissue oxygenation (Van Lieshout et al., 2003). A 
universal characteristic of an orthostatic challenge is progressive central hypovolemia; 
however, the role of the splanchnic circulation in this fluid relocation shows a diametric 
response between LBNP and HUT (Taneja et al., 2007). Taneja et al. (2007) 
demonstrated splanchnic blood pooling and emptying during HUT and LBNP 
Chapter Three  Bilateral lower-limb venous cuff occlusion 
- 90 - 
 
respectively but, despite these findings, both postural challenges resulted in similar 
reductions in central volume. Similarly, increased sympathetic outflow has been shown 
during both long- and short-arm human centrifugation (LAHC and SAHC) leading to 
splanchnic bed constriction (Blomqvist & Stone, 1983). These findings demonstrate a 
corrective mechanistic response to prevent clinically significant central hypovolemia, 
maintain blood pressure, and ultimately preserve cerebral perfusion.  
Within the literature, peripheral fluid shifts were estimated and compared based on 
published individual mean data (Clauser et al., 1969); with an assumption of total 
circulating blood volume (~5000 mL) segmented with 15% in the lower periphery 
(Karpeles & Huff, 1955) and 30% in the central compartment (Nylin & Celander, 
1950). Several studies and methodologies, reporting percentage change in fluid volume 
in either region, were compiled and calculated based on the mean individual 
assumption.  
The estimations of fluid shifted to the periphery, during different orthostatic challenges, 
revealed  similar values between altered challenge magnitudes in a sit-to-stand (STS) 
test, head-up tilt (HUT), and graded SAHC with cycle ergometry. Fluid displacement 
from central to peripheral compartments was measured by thoracic impedance and 
estimated at: ~217 mL following 5 min STS (Frey et al., 1994), ~192 mL after 30 min 
HUT to 53° (Laszlo et al., 2001), and ~203 mL after 25 min 1.2 +Gz graded SAHC 
with exercise (Iwase, 2005). 
The volumes of fluid shifted under different orthostatic challenges differ greatly from 
one another as does tolerance (Watenpaugh et al., 2004); however as shown, 
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comparable fluid shifts may be elicited when exposure magnitude is adjusted between 
differing challenge types.  These calculated estimations indicate either: (i) volume 
shifted is more important than challenge type; or (ii) large changes in fluid 
displacement, along with challenge type, is affecting tolerance.  
VCO involves a purely passive mechanical stimulus whereby fluid accumulation is 
elicited without concurrent input from other body systems. Specifically, blood 
redistribution occurs without any altered forces across the body or postural change. A 
better understanding of VCO induced hemodynamic responses, and the role of fluid 
displacement, on Earth may prove beneficial in the development of future effective and 
safe occlusion-based spaceflight countermeasures. However, the effect of VCO induced 
peripheral fluid shifts on cerebral hemodynamics remain unclear. 
3.1.3 Cerebral hemodynamics 
During an orthostatic challenge fluid is shifted towards the periphery and, under 
insufficient cardiovascular control eventual, syncope occurs. Immediately prior 
presyncopal symptoms are experienced, which are characterised by a significant drop in 
cerebral blood flow and localised cerebral oxygenation.  
Cerebral hemodynamics are measured in many ways including transcranial Doppler 
(TCD), magnetic resonance imaging (MRI), and transcranial cerebral near-infrared 
spectroscopy (cNIRS).  cNIRS is outlined in several studies as an appropriate key 
measure indicating orthostatic tolerance in healthy participants (Krakow et al., 2000) 
and patients with sympathetic failure (Harms et al., 2000). In normal healthy 
individuals, cerebral hemodynamics should remain fairly constant; however, under 
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significant challenge or prolonged central hypovolemia clinically relevant and 
measurable cerebral oxygenation reductions occur (Van Lieshout et al., 2003). 
The present non-invasive study was conducted in order to contribute towards a better 
understanding of cardiovascular responses to a simulated orthostatic challenge of VCO 
(up to 120 mmHg); with an inference on its suitability as an intermittent spaceflight 
countermeasure. Fluid shifted to the periphery is discussed considering the relationship 
between systemic and cerebral hemodynamics, and contrasted to previously published 
classical orthostatic challenge responses. 
3.1.4 Aims 
The aim of this study was to assess the effect and reproducibility of bilateral lower-limb 
venous cuff occlusion (VCO), at pressures up to 120 mmHg (0, 20, 40, 60, 80, 100 and 
120 mmHg), in simulating an orthostatic challenge whilst supine. Changes in systemic 
(heart rate, HR; and mean arterial pressure, MAP), peripheral (calf circumference, CC; 
and calf muscle tissue oxygenation, mTSI), and cerebral (cerebral oxygenation, cTSI) 
measurements, to increasing occlusion pressures, were compared to baseline (BL, 0 
mmHg). To assess reproducibility of VCO responses, specific occlusion pressure 
measurements were performed twice.  
3.1.5 Hypothesis 
It was hypothesised that five minutes bilateral lower-limb VCO would show a directly 
proportional relationship, of significant increases, in systemic cardiovascular response 
and fluid shifted to the periphery. Secondly, cerebral tissue oxygenation would reduce 
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in response to increasing occlusion pressures and be proportional to fluid shifted to the 
periphery. Furthermore, it was postulated that VCO induced responses would be 
reproducible in relation to systemic, peripheral, and cerebral hemodynamics. 
3.2 Methods 
3.2.1 Study design and participants 
Nine (5 male) healthy normotensive, non-smoking participants (Table 3.1) gave written 
informed consent to participate in the study that conformed to the declaration of 
Helsinki and was approved by the Ethics Committee of the North Rhine Medical 
Association in Düsseldorf, Germany. 
 
Table 3.1 Participant individual data. 
  
Age on first experimental day; height and weight measured immediately 
before centrifuge run. 
 
 
 
            
 
 
  Sex Age (yrs) Height (m) Weight (kg) BMI (kg/m2) 
 
  
 
P01 M 25.8 1.83 76 22.7 
 
 
P02 F 26.7 1.69 56 19.5 
 
 
P03 M 28.5 1.79 80 25.1 
 
 
P04 F 27.1 1.61 62 23.7 
 
 
P05 F 23.8 1.70 59 20.4 
 
 
P06 M 25.3 1.78 75 23.7 
 
 
P07 M 18.5 1.74 64 21.1 
 
 
P08 M 28.4 1.66 62 22.4 
 
 
P09 F 26.2 1.71 64 21.9 
 
 
Mean ± 
SD 
- 25.6 ± 3.1 1.72 ± 0.07 66 ± 9 22.3 ± 1.8  
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3.2.2 Experimental protocol 
Prior to testing each participant was familiarized with all aspects of the study, including 
the methodology, experimental setup, and personnel involved (Figure 3.2A). 
Participants underwent passive rapid inflation bilateral lower-limb venous cuff 
occlusion (VCO, 13 cm width, Hokanson Stopler E-20, Bellevue, WA, USA) in the 
supine position (Figure 3.2B) at increasing external pressures of 0, 20, 40, 60 (repeated), 
80, 100, and 120 mmHg for a period of five minutes with rest periods (cuff deflation) of 
at least ten minutes between occlusions (Figure 3.3A). All participants were tested in 
the same conditions either in the morning (from 0900) or afternoon (from 1300). Prior 
to venous occlusion participants were instructed to eat a light breakfast or lunch one 
hour before and, in the preceding 24-hour period, consume no alcohol or caffeine. 
Participants were asked to remain silent and completely still throughout and asked after 
each run if they had experienced pain (PAIN+) or not (PAIN-). 
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Figure 3.2 Experimental overview. 
  
A, Temperature controlled physiology lab with testing table (DLR, Cologne, 
Germany); B, Bilateral lower-limb venous cuff occlusion (VCO) position to the 
end of the thigh, as proximal as possible.  
 
 
Each of the seven occlusions consisted of three phase: (i) five minute baseline 
immediately before, (ii) five minute cuff inflation (occlusion), and (iii) five minute 
recovery where the cuff was rapidly deflated (Figure 3.3B). The 60 mmHg pressure was 
repeated, between the 100 mmHg and 120 mmHg levels, to assess if there was an 
altered response to the same pressure at different points in the protocol. 
Thirty minutes prior to the start of the first baseline recording subjects positioned 
themselves in the supine position (0°) with arms and legs 10° and 20° abducted from the 
body, respectively. Previous research has shown thirty minutes to be sufficient for fluid 
redistribution to occur in the body following postural change (Drummer et al., 2000). 
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Figure 3.3 Protocol duration with constituent occlusion, baseline and recovery phases. 
  
A, protocol consisting of five randomised occlusion profiles (15 min each), with 
no less than 10 min rest between them, thus constituting a protocol of 1 h 45 
min; B, single profile over 15 min consisting of three phases: baseline, 
occlusion, and recovery. 
 
 
3.2.2.1 Systemic cardiovascular measurements 
Continuous beat-by-beat heart rate (HR) via a standard 3-lead electrocardiogram (ECG; 
Biopac Systems, Goleta, CA, USA) and mean arterial finger blood pressure (MAP) 
were recorded with a Finometer (Finapres Medical Systems, Amsterdam, The 
Netherlands). The Finometer finger cuff was placed around the third finger of the right 
hand and kept at heart-level relative to the supine participant (Figure 3.4E). Finometer 
BP measurements were corroborated with absolute arterial BP measurements obtained 
by an automated sphygmomanometer (Intellivue MMS X2, Philips, Best, The 
Netherlands) prior to starting the profile. Stroke volume (SV) and total peripheral 
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resistance (TPR) were estimated from the arterial BP waveform using the Modelflow 
method (Leonetti, et al. 2004) via Beatscope software (TNO-TPD, Biomedical 
Instrumentation, Amsterdam, The Netherlands). 
3.2.2.2 Peripheral fluid displacement 
A Burette-plethysmograph (Figure 3.1) effectively measures limb volume increases up 
to the point where the equivalent cuff pressure in the limb equals the localised venous 
pressure. However, nowadays it is more common to use VCO with small indium-
gallium-filled silicon tube strain gauge plethysmography (SGP) which still measures 
fluid displacement but is technically very different from a large water filled chamber 
(Pointel et al., 1981; Roberts et al., 1986; Altenkirch et al., 1989b; Hiatt et al., 1989). 
Therefore, movement of fluid to the lower extremities, and away from the central 
compartment, was quantified using SGP (EC6 Strain Gauge Plethysmograph, Hokanson 
Inc., Bellevue, WA, USA); positioned around the calf midpoint (directly between the 
tibiae tuberosity and medial malleolus bony prominences) of each participant (Figure 
3.4D). 
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Figure 3.4 Experimental setup. 
  
A, electronically controlled pressure gauge; B, data acquisition hardware; C, 
near infrared spectroscopy (NIRS) of the calf muscle; D, strain gauge 
plethysmography around the mid-calf; E, Finapres continuous blood pressure 
monitor; F, bilateral lower-limb venous occlusion cuffs; G, NIRS control arm 
muscle; H, 3 lead electrocardiogram (ECG); and I, prefrontal cortex cerebral 
NIRS. 
 
 
3.2.2.3 Cerebral perfusion 
Cerebral near-infrared spectroscopy of the left prefrontal cortex immediately below the 
forehead hairline of each participant (cNIRS; PortaLite, Artinis Medical Systems, The 
Netherlands; Figure 3.4I) was used to determine the absolute ratio of oxy- (O2HB) and 
deoxyhemoglobin (HHb). Taking into account participant frontal cranium thickness, 
based on age and gender, the cerebral tissue saturation index (cTSI) was deduced 
(Lynnerup et al., 2005) providing a measure of global cerebral perfusion (Weiss et al., 
2005). 
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3.2.2.4 Estimation of peripheral fluid shifts 
Peripheral fluid shift estimations were based on expected circulating blood volume 
(~5000 mL) with 15% in the lower limbs and 30% in the thoracic compartment (Clauser 
et al., 1969). A direct relationship was assumed between altered thoracic impedance (Ω) 
and fluid displacement (Mohapatra & Arenson, 1979; Taneja et al., 2007); with uniform 
inflation assumed based on measured calf circumference and a simple cylindrical model 
(Heymsfield et al., 2008). Estimations were calculated based on percentage change in 
circumference of the idealised cylindrical model (Equation 2.2). 
3.2.3 Statistical analysis 
All continuously recorded data were analysed in 10 s frames and artefacts removed with 
a Matlab (R2015a, The Mathworks Inc., MA, USA) function using the following 
criteria (i) conservative and plausible physiological limits (Table 2.2); and (ii) maximal 
percentage of change in relation to the standard deviation of the signal. Data was 
resampled at 4Hz (piecewise cubic spline interpolation) as long as >95% of data were 
valid yielding 9 complete sets of data for further analysis. 
Firstly, occlusion effects are presented as changes from a last minute baseline (BL) 
mean to the last minute (min 5) at each occlusion pressure (0-120 mmHg). Therefore, 
pressure effects on response, with the assumption of the largest response following the 
greatest period of occlusion, were determined. Secondly, the time course responses of 
the highest occlusion pressure, in which no participant experienced pain (100 mmHg), 
are presented. Specifically, changes from a last minute BL mean, to each 1 min mean of 
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all 10 min measurements (5 min occlusion; and 5 min recovery) following the start of 
occlusion.  
Matlab (R2015a, The Mathworks Inc., MA, USA) was used to perform statistical 
analysis. Visual inspection of residual plots did not reveal any obvious deviations from 
homoscedasticity or normality of residuals. The tests applied were one-way analysis of 
variance (ANOVA, repeated measures), post hoc tests with preventative post hoc 
control of the type I error rate (Tukey’s Honestly Significant Difference, HSD) and t-
test (independent, by groups). Two-way ANOVA for unbalanced design were 
performed to explore the main effect of pain related responses to occlusion pressure and 
any interaction between them. Linear regression analysis was used to estimate the 
relationships among variables. Hemodynamic responses from the first and second 60 
mmHg VCO (min 5) were compared for each participant using Bland-Altman plots 
(Bland & Altman, 1986) and reproducibility was quantified as the standard deviation of 
the difference between the first and second. The data are presented as mean (±SEM) 
unless otherwise stated with the level of significance set at p≤0.05. 
3.3 Results 
Nine participants completed all bilateral lower-limb venous cuff occlusion (VCO) 
pressures (0 to 120 mmHg); with four participants expressing pain at the highest 
pressure used (120 mmHg). However, all participants were able to tolerate 120 mmHg 
for the entire five minutes. Baseline values, prior to the start of experimentation, for all 
participants are outline in  
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Table 3.2. 
 
 
 
Table 3.2 Participant absolute mean baseline (BL) values for all parameters. 
  
Measured BL is a mean of the last minute immediately before start of the 
experiment in all participants (n=9). 
 
HR, heart rate; SV, stroke volume; TPR, total peripheral resistance; MAP, 
mean arterial pressure; CC, calf circumference; mTSI, muscle tissue 
saturation index; cTSI, cerebral tissue saturation index. 
 
 
    
 
  Parameter 
Absolute mean  
baseline (BL) ± SEM  
  
 
HR 66 ± 2 bpm 
 
 
SV 72.4 ± 5.7 mL 
 
 
TPR 1562 ± 126 dyn.s.cm-5 
 
 
MAP 81± 2 mmHg 
 
 
CC 326 ± 5 mm 
 
 
mTSI 71.05 ± 0.42 % 
 
 
cTSI 72.03 ± 1.10 % 
     
 
 
3.3.1 Occlusion pressure effect on cardiovascular response 
The effect of pressure was significantly positive for the changes from baseline (BL) in 
mean heart rate (ΔHR: F(6,54)=2.44, p=0.036; Figure 3.5A), and total peripheral 
resistance (ΔTPR: F(6,54)=3.29, p=0.008; Figure 3.5D); and significantly negative for 
mean stroke volume (ΔSV: F(6,54)=2.60, p=0.027; Figure 3.5C). No significant 
differences were observed for changes from BL in mean arterial pressure (ΔMAP) 
across VCO pressures (F(6,54)=1.06, p=0.399; Figure 3.5B). Absolute MAP of all 
participants was 82 ± 9 mmHg (at BL) to 87 ± 6 mmHg (at 120 mmHg VCO). Systolic 
blood pressure (SBP) was 118 ± 18 mmHg (at BL) to 137 ± 12 mmHg (at 120 mmHg 
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VCO); and diastolic blood pressure (DBP) was 66 ± 9 mmHg (at BL) to 72 ± 6 mmHg 
(at 120 mmHg VCO). 
Post hoc analysis revealed ΔHR was no different compared to BL up to 100 mmHg 
VCO (0.082<p<0.949), but significantly positive in the final minute of 120 mmHg VCO 
(7 ± 2 bpm, p=0.020; Figure 3.5A). ΔSV was no different compared to BL up to 100 
mmHg VCO (0.052<p<0.608), but significantly negative during 120 mmHg VCO (-
20.3 ± 4.9 mL, p=0.014; Figure 3.5C). Conversely, ΔTPR was significantly positive at 
100 and 120 mmHg (p<0.026) compared to BL with the greatest significance at 120 
mmHg (366 ± 91 dyn.s.cm-5, p=0.016; Figure 3.5D). 
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Figure 3.5 Mean (±SEM) changes from baseline (BL) for cardiovascular measures in the final 
minute (min 5) of bilateral lower-limb venous cuff occlusion (VCO, 0 to 120 mmHg). 
  
A, mean heart rate (ΔHR); B, averaged mean arterial pressure (ΔMAP); C, 
mean stroke volume (ΔSV); and D, mean total peripheral resistance (ΔTPR). 
 
Mean at each pressure calculated as a final minute (min 5) delta from the final minute 
(min 5) mean of the baseline (BL) immediately before each respective occlusion. vs. 
Baseline: * p < 0.05, n = 9. 
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3.3.2 Peripheral fluid displacement 
An analysis of variance showed that the effect of pressure was significant for the 
changes from baseline (BL) in calf circumference (ΔCC: F(6,54)=8.96, p<0.001; Figure 
3.6A) and near-infrared spectroscopy (NIRS) measured calf muscle tissue saturation 
index (ΔmTSI: F(6,54)=7.18, p<0.001; Figure 3.6B).  
 
 
 
Figure 3.6 Mean (±SEM) changes from baseline (BL) for calf circumference (ΔCC) and 
mean calf muscle tissue saturation index (ΔmTSI) in the final minute (min 5) of bilateral 
lower-limb venous cuff occlusion (VCO, 0 to 120 mmHg). 
  
A, mean calf circumference (ΔCC); B, near-infrared spectroscopy (NIRS) 
measured calf muscle tissue saturation index (ΔmTSI). 
 
Mean at each pressure calculated as a final minute (min 5) delta from the final minute 
(min 5) mean of the baseline (BL) immediately before each respective occlusion. Grey 
line, nonlinear regression sigmoidal (f = a/(1+exp(-(x-x0)/b))). vs. Baseline: * p < 0.05, n 
= 9. 
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Post hoc analysis revealed ΔCC during all VCO pressures at 40 mmHg and above were 
significantly positive compared to BL (p<0.05) with the largest delta recorded at the 
highest occlusion pressure (120 mmHg: 2.9 ± 0.4 mm, p=0.001). No significant 
differences in ΔCC were measured at 20 mmHg VCO (p=0.210). A significant (0-120 
mmHg: R2=0.99, F(6,54)=239.6, p<0.001) positive non-linear sigmoidal model was 
observed as the best fit between ΔCC and VCO pressure  (Figure 3.6A).  
Conversely, ΔmTSI at 60 mmHg VCO and above was significantly negative (p<0.05) 
with the largest delta also recorded at the highest occlusion pressure (120 mmHg: -8.28 
± 1.04 %, p=0.002). At 40 mmHg VCO and below no significant differences compared 
to BL were measured (0-40 mmHg: 0.042<p<0.715). Despite this, a significant 
(R2=0.99, F(6,54)=68.6, p<0.001) negative non-linear sigmoidal model was observed as 
the best fit between ΔmTSI and all VCO pressures (0-120 mmHg; Figure 3.6B). 
Additionally, as ΔCC increased, a negative linear relationship to ΔmTSI was observed 
(R2=0.99, F(6,54)=337.47, p<0.001; Figure 3.7). 
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Figure 3.7 Linear relationship between changes from baseline (BL) in mean calf muscle 
tissue saturation index (ΔmTSI) and mean calf circumference (ΔCC) in the final minute 
(min 5) of bilateral lower-limb venous cuff occlusion (VCO) pressures up to 120 mmHg. 
  
Mean at each pressure (± SEM) calculated as a final minute (min 5) delta from 
the final minute (min 5) mean of the baseline (BL) immediately before each 
respective occlusion. Each point with labelled VCO pressure (mmHg). Grey line, 
linear regression (f = y0+a*x). n = 9. 
 
3.3.2.1 Estimated peripheral fluid shifts 
Orthostatic challenge data was tabulated and the volume of peripheral fluid shifts were 
calculated for: (i) venous cuff occlusion (VCO) during spaceflight (Thornton & Hoffler, 
1974); (ii) sit-to-stand (STS) tests (Frey et al., 1994); (iii) head-up tilt (HUT) tests 
(Laszlo et al., 2001); (iv) lower-body negative pressure (LBNP) (Lundvall et al., 1993); 
(v)  short-arm human centrifugation (SAHC) (Iwase, 2005); and (vi) VCO on Earth in 
the present study (Table 3.3). 
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Table 3.3 Relative estimations of peripheral fluid shifts based on previously published data. 
  
VCO, venous cuff occlusion; STS, sit-to-stand test; HUT, head-up tilt; LBNP, lower-body negative pressure; and SAHC, short-arm human 
centrifugation. Experimental methodology include: (i), Increased flow and percentage change in limb size measured by strain gauge 
plethysmography; and (ii), percentage change in central/thoracic volume measure by bioelectrical impedance. 
 
 
 
 
            
   
 
Research 
paper 
Thornton and 
Hoffler (1974)  
Frey et al. 
(1994) 
Laszlo et al. (2001) 
Lundvall et al. 
(1993) 
Iwase (2005) 
 
Present study 
 
 
Orthostatic 
challenge type 
VCO during 
spaceflight 
STS HUT LBNP SAHC 
 
VCO 
 
 
No. of 
participants 
(n) 
3 47 7 16 12 
 
9 
 
 
Magnitude 30 > 50 mmHg Sit > stand 0⁰ > 12⁰ > 30⁰ > 53⁰ > 70⁰ -70 mmHg 
1.2 +Gz                
at heart                 
(not passive) 
 
20 > 40 > 60 > 80 > 100 > 120  mmHg 
 
 
Duration 5 min 5 min 30 min 10 min 25 min 
 
5 min 
 
 
Method 
Strain gauge 
plethysmography 
(flow) 
Thoracic 
bioelectrical 
impedance 
Thoracic bioelectrical impedance 
Strain gauge 
plethysmography 
(flow) 
Thoracic 
bioelectrical 
impedance 
 
Strain gauge plethysmography (Δ%) 
 
 
Measured 
difference 
+8% > +15% -10% > -14% 0% > -2% > -7% > -12% > -16% +69% -13% 
 
+0.1 > +0.3 > +0.5 > +0.7 > +0.8 > +0.9 % 
 
 
Peripheral 
fluid 
displacement 
estimation 
(~mL) 
288 > 326 157 > 217 -7 > 34 > 117 > 192 > 249 710 203 
 
7 > 41 > 73 > 115 > 135 > 158 
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3.3.3 Cerebral tissue oxygenation 
An analysis of variance showed that the effect of pressure was non-significant for the 
changes from baseline (BL) in NIRS measured prefrontal cortex cerebral tissue 
saturation index (ΔcTSI; 0-120 mmHg: F(6,54)=1.36, p=0.248; Figure 3.8). 
 
 
Figure 3.8 Mean (±SEM) changes from baseline (BL) for prefrontal cortex cerebral tissue 
saturation index (ΔcTSI) in the final minute (min 5) of bilateral lower-limb venous cuff 
occlusion (VCO, 0 to 120 mmHg). 
  
Mean at each pressure calculated as a final minute (min 5) delta from the final minute 
(min 5) mean of the baseline (BL) immediately before each respective occlusion. vs. 
Baseline: * p < 0.05, n = 9. 
 
3.3.4 Pain related responses 
The main effect of experiencing pain during occlusion was significantly positive in 
ΔHR (F(6,54)=6.34, p=0.045; Figure 3.9A), and ΔTPR (F(6,54)=5.23, p=0.048; Figure 
3.9D); whilst ΔSV (F(6,54)=9.33, p=0.022; Figure 3.9C) was significantly negative. 
Experiencing pain had no effect on ΔMAP (F(6,54)=0.15, p=0.711; Figure 3.9D).  
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An analysis between occlusion pressure and incidence of pain revealed significant 
interaction effects (Pressure:Pain±) in ΔHR (F(6,54)=2.44, p=0.041; Figure 3.9A); but 
none in ΔMAP (F(6,54)=0.28, p=0.944; Figure 3.9B), ΔSV (F(6,54)=1.21, p=0.321; 
Figure 3.9D), and ΔTPR (F(6,54)=1.45, p=0.216; Figure 3.9D). 
 
 
Figure 3.9 Comparison of mean (±SEM) changes from baseline (BL) for cardiovascular 
measures in the final minute (min 5) of bilateral lower-limb venous cuff occlusion (VCO, 0 to 120 
mmHg) in participants verbally reporting pain and not (PAIN+ vs. PAIN-). 
  
A, mean heart rate (ΔHR); B, averaged mean arterial pressure (ΔMAP); C, 
mean stroke volume (ΔSV); and D, mean total peripheral resistance (ΔTPR). 
 
Mean at each pressure calculated as a final minute (min 5) delta from the final minute 
(min 5) mean of the baseline (BL) immediately before each respective occlusion. Solid 
line, no pain verbally reported; dotted line, pain verbally reported. PAIN+ vs. PAIN-: # 
p < 0.05, PAIN+: n = 4; and PAIN-: n=5. 
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Post hoc analysis revealed, in participants experiencing pain compared to those not 
(PAIN+ vs. PAIN-), significantly greater ΔHR (15 ± 2 vs. 4 ± 2 bpm, p=0.029; Figure 
3.9A) and ΔTPR (629 ± 128 vs. 177 ± 82 dyn.s.cm-5, p=0.035; Figure 3.9D) during 120 
mmHg VCO. Conversely, ΔSV was significantly lower in PAIN+ (-9 ± 6 vs. -33 ± 5 
mL, p=0.049; Figure 3.9C). 
3.3.5 Insufficient simulated orthostatic challenge and duration 
Occlusion pressures up to 120 mmHg were used; however, due to the pain experienced 
by almost half of participants at the highest level, 100 mmHg has been selected as the 
highest pressure tolerated by all without pain. Further minute-by-minute analysis was 
conducted during the entire ten minute profile (VCO: min 0-5; and recovery, RR: min 
5-10) in all participants. 
3.3.5.1 Cardiovascular 
No significant differences were found in changes from baseline (BL) of ΔHR and 
ΔMAP at the mean final minute (min 5) during 100 mmHg occlusion; however, during 
the entire ten minute profile (min 0-10) significant differences in ΔHR (F(10,88)=2.56, 
p=0.009, Figure 3.10A) were observed. Across all minutes (min 0-10) no significant 
differences were found in ΔMAP (F(10,88)=0.80, p=0.625,Figure 3.10B). Post hoc 
analysis revealed ΔHR was significantly positive in the last minute of VCO (min 5: 
p=0.030) compared to BL but no different during the rest of the profile (0.082<p<0.923; 
Figure 3.10A). 
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Figure 3.10 Mean (±SEM) changes from baseline (BL) for heart rate (ΔHR) and averaged 
mean arterial pressure (ΔMAP) during five minutes bilateral lower-limb venous cuff 
occlusion (VCO: min 0-5, 100 mmHg) and recovery (RR: min 5-10, 0 mmHg). 
  
A, mean heart rate (ΔHR); and B, averaged mean arterial pressure (ΔMAP). 
 
Each 60 s data point is a mean delta from the final minute (min 5) mean of the baseline 
(BL) immediately before 100 mmHg occlusion. Dark grey, during 100 mmHg VCO; light 
grey, recovery (RR) immediately following VCO (0 mmHg). vs. Baseline: * p < 0.05, n = 
9. 
 
3.3.5.2 Increased peripheral fluid displacement 
Significant differences during the entire ten minute 100 mmHg VCO profile (min 0-10) 
were observed in changes from baseline (BL) of calf circumference (ΔCC; F(10,88)11.79, 
p<0.001; Figure 3.11A) and NIRS measured calf muscle tissue saturation index 
(ΔmTSI: F(10,88)=10.32, p<0.001; Figure 3.11B). 
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Figure 3.11 Mean (±SEM) changes from baseline (BL) for calf circumference (ΔCC) and calf 
muscle tissue saturation index (ΔmTSI) during five minutes bilateral lower-limb venous cuff 
occlusion (VCO: min 0-5, 100 mmHg) and recovery (RR: min 5-10, 0 mmHg). 
  
A, mean calf circumference (ΔCC); and B, mean calf muscle tissue saturation 
index (ΔmTSI). 
 
Each 60 s data point is a mean delta from the final minute (min 5) mean of the baseline 
(BL) immediately before 100 mmHg occlusion. Dark grey, during 100 mmHg VCO; light 
grey, recovery (RR) immediately following VCO (0 mmHg). vs. Baseline: * p < 0.05, n = 
9. 
 
Post hoc analysis revealed ΔCC was significantly positive at min 1-6 (p<0.046) with the 
greatest difference compared to BL in the final minute of VCO (min 5: 2.6 ± 0.4 mm, 
p=0.002); with ΔCC from min 7-10 no different from BL (0.137<p<0.876; Figure 
3.11A). Conversely, ΔmTSI was significantly negative at min 2-6 (p<0.05) with the 
greatest difference compared to BL also in the final minute of VCO (min 5: -6.69 ± 1.15 
%, p=0.002); with ΔmTSI from min 7-10 no different from BL (0.403<p<0.708; Figure 
3.11B). 
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3.3.5.3 Unchanged cerebral perfusion 
No significant differences during the entire ten minute 100 mmHg VCO profile (min 0-
10) were observed in changes from baseline (BL) of prefrontal cortex cerebral tissue 
saturation index (ΔcTSI: F(10,88)=1.02, p=0.435; Figure 3.12). 
 
 
Figure 3.12 Mean (±SEM) changes from baseline (BL) for near-infrared spectroscopy 
(NIRS) pre-frontal cortex cerebral tissue saturation index (ΔcTSI) during five minutes 
bilateral lower-limb venous cuff occlusion (VCO: min 0-5, 100 mmHg) and recovery 
(RR: min 5-10, 0 mmHg). 
  
Each 60 s data point is a mean delta from the final minute (min 5) mean of the 
baseline (BL) immediately before 100 mmHg occlusion. Dark grey, during 100 
mmHg VCO; light grey, recovery (RR) immediately following VCO (0 mmHg). vs. 
Baseline: * p < 0.05, n = 9. 
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3.3.6 Test-retest reproducibility of 60 mmHg VCO 
A comparison of changes from BL, at the last minute of occlusion (min 5), between the 
first and second 60 mmHg VCO revealed a moderate correlation in ΔHR (R2=0.42, 
F(1,7)=4.98, p=0.061; Figure 3.13A). There was a strong correlation between ΔcTSI 
(R2=0.66, F(1,7)=13.66, p=0.008; Figure 3.16A) and ΔCC (R2=0.99, F(1,7)=1787, 
p<0.001; Figure 3.15A) measurements; however no correlation between ΔMAP 
(R2=0.02, F(1,7)=0.14, p=0.718; Figure 3.14A). 
Bland-Altman plots (Bland & Altman, 1986) of the difference between the two delta 
values vs. the mean of both are displayed (Figure 3.13B; Figure 3.14B; Figure 3.15B; 
and Figure 3.16B). The standard deviation of the difference between measurements for 
the two occlusions was large in ΔHR (4 bpm), ΔMAP (3 mmHg), and ΔcTSI (0.45 %) 
compared to the respective mean changes from BL during 60 mmHg (ΔHR: 1 bpm; 
ΔMAP: 0 mmHg; and ΔcTSI: -0.28 %). However, this value in ΔCC (0.4 mm) was 
relatively low compared to the mean delta during 60 mmHg (1.6 mm).  
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Figure 3.13 A, Relationship between changes from baseline (BL) in heart rate (ΔHR) 
during first and second 60 mmHg bilateral lower-limb venous cuff occlusion (VCO) in 
the final minute (min 5); and B, Bland-Altman plot of paired differences in ΔHR against 
a mean of both, in all participants (n=9). 
  
Black line, linear regression (f = y0+a*x); dotted red line, upper: mean +1.96 SD; 
lower: mean -1.96 SD, each with 95% CI. n = 9. 
 
 
 
 
Figure 3.14 A, Relationship between changes from baseline (BL) in mean arterial 
pressure (ΔMAP) during first and second 60 mmHg bilateral lower-limb venous cuff 
occlusion (VCO) in the final minute (min 5); and B, Bland-Altman plot of paired differences 
inΔMAP against a mean of both, in all participants (n=9). 
  
Black line, linear regression (f = y0+a*x); dotted red line, upper: mean +1.96 SD; 
lower: mean -1.96 SD, each with 95% CI. n = 9. 
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Figure 3.15 A, Relationship between changes from baseline (BL) in calf circumference 
(ΔCC) during first and second 60 mmHg bilateral lower-limb venous cuff occlusion 
(VCO) in the final minute (min 5); and B, Bland-Altman plot of paired differences in ΔCC 
against a mean of both, in all participants (n=9). 
  
Black line, linear regression (f = y0+a*x); dotted red line, upper: mean +1.96 SD; 
lower: mean -1.96 SD, each with 95% CI. n = 9. 
 
 
 
Figure 3.16 A, Relationship between changes from baseline (BL) in prefrontal cortex 
cerebral tissue saturation index (ΔcTSI) during first and second 60 mmHg bilateral 
lower-limb venous cuff occlusion (VCO) in the final minute (min 5); and B, Bland-Altman 
plot of paired differences in ΔcTSI against a mean of both, in all participants (n=9). 
  
Black line, linear regression (f = y0+a*x); dotted red line, upper: mean +1.96 SD; 
lower: mean -1.96 SD, each with 95% CI. n = 9. 
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3.3.7 Invalid simulated orthostatic challenge 
There was a moderate effect size between fluid shifted to the periphery, measured by 
changes from baseline (BL) in mean calf circumference (ΔCC) and mean heart rate 
(ΔHR, R2=0.61, F(5,48)=9.36, p=0.041; Figure 3.17A).  
 
 
Figure 3.17 Non-existent relationship between changes from baseline (BL) in mean 
heart rate (ΔHR) and mean prefrontal cortex cerebral tissue saturation index 
(ΔcTSI), and mean delta calf circumference (ΔCC) in the final minute (min 5) of 
bilateral lower-limb venous cuff occlusion (VCO) pressures up to 100 mmHg. 
  
A, mean heart rate (ΔHR) vs. mean calf circumference (ΔCC); and B, mean 
pre-frontal cortex cerebral tissue saturation index (ΔcTSI) vs. ΔCC. 
 
Mean at each pressure (±SEM) calculated as a final minute (min 5) delta from the final 
minute (min 5) mean of the baseline (BL) immediately before each respective 
occlusion. Each point with labelled VCO pressure (mmHg). Grey line, linear 
regression (f = y0+a*x). n = 9. 
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Surprisingly, there was no relationship between ΔCC and cerebral tissue oxygenation, 
measured by prefrontal cortex cerebral tissue saturation (ΔcTSI, R2=0.04, F(5,48)=0.17, 
p=0.703, p=0.557; Figure 3.17B).  
In general, bilateral lower-limb venous cuff occlusion (VCO) significantly shifted fluid 
to the periphery at occlusion pressure 40 mmHg and above. However, unexpectedly this 
significant fluid shift had only a moderate effect on systemic cardiovascular response 
(ΔHR) and no effect on cerebral perfusion (ΔcTSI). 
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3.4 Discussion 
The main findings of the study were that venous occlusion pressure had no significant 
effect on systemic cardiovascular response until 120 mmHg; despite significant 
increases in peripheral fluid displacement from 40 mmHg. A significant positive linear 
relationship between systemic cardiovascular responses (heart rate, HR) and decreasing 
central volume (peripheral fluid displacement to calf circumference, CC) was observed. 
However, there was no significant relationship between cerebral tissue oxygenation 
(cTSI) and CC. 
3.4.1 Bilateral lower-limb venous cuff occlusion pressures 
VCO had no significant effect, on all measured cardiovascular parameters, up to an 
externally applied pressure of 100 mmHg; apart from a positive change from baseline 
(BL) in total peripheral resistance (ΔTPR) in the last minute of occlusion. Similarly, 
ΔTPR and heart rate (ΔHR) at 120 mmHg were significantly positive, whilst stroke 
volume (ΔSV) was negative with respect to BL.  
Research has shown large external VCO pressures at the skin translate to significantly 
reduced pressure exerted on the deep venous structures (Shaw & Murray, 1982; Partsch 
& Partsch, 2005). In fact, external VCO pressures of 80 mmHg to 140 mmHg were 
required to entirely occlude the popliteal and great saphenous vein (Sarin et al., 1992). 
Large inter-individual differences, between externally applied cuff and known internal 
venous pressures of 80-100 mmHg, are thought to arise due to anthropometric 
differences of the lower-limb; and anatomical position of the venous vasculature (Keen, 
1961; Altenkirch et al., 1988). This presumably caused external pressure, applied to the 
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proximal end of the thigh, to be significantly larger than those exerted on internal 
venous structures in the present study. Furthermore, internal pressure differences are 
likely to vary widely between individuals (of differing age, height, and weight), with leg 
muscle mass and inter-individual anatomical differences in deep venous structures 
thought to play a role (Kügler et al., 2001). Participants of the present study were all 
around the same age, height, and weight (Table 3.1); thus, diminishing the possibility of 
differing individual anthropometric measurements affecting results. Nevertheless, the 
lack of significant systemic response in ΔHR, ΔMAP, ΔSV, and ΔTPR may be 
explained by varied resting venous pressures, and greater leg muscle mass preventing 
correct VCO pressure application and complete occlusion. 
It is postulated that an increase in ΔHR, ΔMAP, ΔSV, and ΔTPR response to 120 
mmHg (except mean arterial pressure, ΔMAP) can be explained by substantial 
sympathetic activation as a result of the pain experienced by four participants. Muscle 
sympathetic nervous activity (MSNA) has been shown to be significantly correlated to 
TPR (Charkoudian et al., 2005) and, in the present study, it was significantly higher at 
100 mmHg and 120 mmHg. Furthermore, ΔHR was significantly higher and ΔSV lower 
in participants who verbally expressed pain, compared to those who did not at 120 
mmHg. Additionally, only four individuals verbally reported pain and it is likely all 
experienced reduced comfort as VCO pressures increased. It is also interesting to note 
that, whilst pain was only ever registered at 120 mmHg, a divergence in response can be 
seen at lower VCO pressures. In particular ΔHR and ΔTPR were significantly higher in 
participants experiencing pain; however, it was only significant at 120 mmHg. In 
addition, an interaction effect between pressure and pain (Pressure:Pain±) was only 
significant in ΔHR. 
Chapter Three  Bilateral lower-limb venous cuff occlusion 
- 121 - 
The highest level of bilateral lower-limb VCO tested, in which all participants 
experienced no pain, was 100 mmHg. Strain gauge plethysmography measured calf 
circumference demonstrated arterial inflow was not impeded at the measured pressures; 
and the rate of calf inflation only started to decrease following a period of venous 
pooling, even at 100 mmHg. At this level ΔHR in the last minute (min 5) was 
significantly positive (with respect to BL). Increased HR has been observed to be 
rapidly induced (~1-2 beat) by central hypovolemia (i.e. significant loss of fluid), such 
as in haemorrhagic shock sympathetic compensation (Cooke et al., 2004). ΔCC in the 
present study was significantly positive from the first minute of 100 mmHg VCO 
onwards (Figure 3.11A) with concurrent increases in ΔHR anticipated. However, ΔHR 
was no different than BL up until the last minute of 100 mmHg. It is postulated during 
VCO challenge blood is being sequestered elsewhere, such as the splanchnic circulation 
(Taneja et al., 2007); leading to the discrepancy of response between ΔCC and ΔHR in 
the first four minutes of 100 mmHg occlusion. 
3.4.2 Peripheral fluid displacement 
Changes from BL in calf circumference (ΔCC), induced by graded VCO, followed a 
sigmoidal curve from BL to 120 mmHg. A reduction in the slope was observed at VCO 
pressures above 100 mmHg and demonstrate venous filling was nearing capacity, in 
agreement with the pressure-volume curve (Guyton, 1965). A similar observation was 
made in calf muscle tissue oxygenation (ΔmTSI); but instead decreasing as occlusion 
pressure increased. Furthermore, a significant correlation between ΔCC and ΔmTSI is 
indicative of either measure being a good indicator of central to peripheral relocation of 
blood. Similarly, previous research has shown strain gauge plethysmography 
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measurements of flow to have a strong correlation to Doppler measures of blood 
velocity when undergoing limb occlusion (Tschakovsky et al., 1995). 
The majority of fluid shifted to the periphery, at VCO levels of 20-100 mmHg, can be 
attributed to deep venous filling (Buckey et al., 1988). Furthermore, it is postulated five 
minute VCO was short enough to prevent significant fluid movement into the interstitial 
space; with a longer duration orthostatic challenge, demonstrating a greater volume 
accumulation, attributed to this compartment (Fortney, 1991). 
Research has shown that calf circumference is an important determining factor of 
suitable pressures for occlusion (Loenneke et al., 2011) and even the width of the VCO 
cuff itself (Loenneke et al., 2012); whilst other research has still based suitable 
occlusion pressure selection on individual systolic blood pressure (SBP) (Cook et al., 
2007). Further research is required to determine the influence of resting blood pressure, 
apparatus used, and lower-limb size on venous occlusion. However, in the present 
study, the same equipment and pressures were tested and was deemed sufficient in order 
to examine orthostatic challenge capacity of VCO, in all participants. 
Fluid accumulation reveals an indication of orthostatic challenge magnitude and a 
comparative analysis with VCO may reveal its effectiveness as a simulated orthostatic 
challenge. Orthostatic challenges sit-to-stand (STS) (Levine et al., 1994), head-up tilt 
(HUT) (Madsen et al., 1995), lower-body negative pressure (LBNP), and short-arm 
human centrifugation (SAHC) (Smith et al., 2013) all exhibit significant fluid shifted to 
the periphery with systemic hemodynamic responses; and crucially, significant 
alterations in cerebral hemodynamics. In the present study, the peripheral fluid 
displacement estimated (Table 3.3) was between ~7-158 mL at VCO pressure of 0-120 
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mmHg; with a comparable estimated fluid shift, in healthy individuals, of ~157 mL in a 
STS test during 5 min sit (Frey et al., 1994) and greater than the ~117 mL estimated 
volume during HUT to 30° for 30 min (Laszlo et al., 2001) (Table 3.3). Prolonged 
orthostatic challenge, leading to eventual syncope, involves significant movement of 
fluid to the periphery to bring about central hypovolemia (Cooke et al., 2004). 
However, the precise role of smaller initial volumes of fluid shifted to the periphery is 
unclear; and specifically, the effect on significant changes in systemic and cerebral 
hemodynamics.  
3.4.3 Cerebral hemodynamics 
Surprisingly, no significant difference was measured in changes from BL in prefrontal 
cortex cerebral tissue saturation index (ΔcTSI), a good indicator of overall cerebral 
blood flow (Kirkpatrick et al., 1998; Hirofumi et al., 2003). A significant reduction, 
during a prolonged orthostatic challenge, would have been expected. The fact that no 
such reduction was measured suggests either: (i) insufficient fluid was shifted to the 
periphery to elicit a response; (ii) fluid shifted was sufficient but other compensatory 
mechanisms were involved; or (iii) ΔcTSI as a measure of localised cerebral perfusion 
was unable to measure globalised changes present during VCO. 
In fact, it appears likely that fluid volume shifted to the periphery was insufficient to 
elicit changes in cerebral hemodynamics. In the present study, cerebral oxygenation 
(cTSI) was measured using near-infrared spectroscopy (NIRS) and research has shown 
this to correlate well to cerebral blood flow velocity (cBFV) during surgery (Kurth et 
al., 1995; Pigula et al., 2000). Rickards et al. (2015) demonstrated that 1000 mL blood 
volume removed directly from the antecubital vein (equating to a 150 mL peripheral 
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fluid shift, ~15% total) over a 15 min period, did not lead to significant differences in 
middle cerebral artery (MCA) blood flow velocity (cBFV; 69.5 ± 5.1 vs. 66.6 ± 5.2 
cm/s, p>0.05). However, during the same protocol cBFV was shown to decrease from 
baseline after 5 min LBNP at -45 mmHg (70.0 ± 4.2 vs. 61.5 ± 5.8 cm/s, p<0.05) with 
an estimated peripheral fluid shift of ~ 450 mL.  
A limitation of this study is that end-tidal CO2 (PETCO2) was not measured as a potential 
influencing factor on cerebral perfusion. Previous research has shown that carotid 
baroreceptor reflex control not only acts to maintain blood pressure but is a potent 
regulator of ventilator response in dogs (Brunner et al., 1982) and humans (Stewart et 
al., 2011). In addition, Stewart et al. (2011) showed that ventilator baroreceptor 
sensitivity is not modulated by chemoreceptor activation; but rather increases/decreases 
in MAP resulted in decreased/increased ventilator response, respectively. The current 
study results show MAP remains unchanged so it is unlikely to have had an effect on 
PETCO2 through any ventilatory baroreceptor activation; however, future studies would 
benefit from this consideration and measuring either ventilation rate or PETCO2. 
Unaltered cerebral hemodynamics in the present study may also be explained by the 
role of the splanchnic circulation as a buffer to central and peripheral fluid displacement 
(Fu et al., 2005). Research has shown emptying and pooling of the splanchnic 
circulation in response to LBNP and HUT, respectively (Taneja et al., 2007); however, 
the precise role of this region in VCO is unknown. It is postulated that unaffected 
cerebral tissue oxygenation, may be due to systemic compensatory mechanisms 
constricting peripheral vasculature, aiding venous return and maintaining cerebral tissue 
oxygenation. 
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3.4.4 Reproducability 
ΔHR, ΔMAP, and ΔcTSI after VCO testing does not have short-term test-retest 
reproducibility within the current participant cohort of nine. However, results indicate a 
far better reproducibility of ΔCC measurements in individuals when exposed to 
repeated VCO at 60 mmHg. This study demonstrates the ability of VCO to elicit 
reproducible shifts of fluid to the periphery measured by ΔCC; however, calls into 
question the benefit when ΔHR, ΔMAP, and ΔcTSI differ greatly between identical 
VCO occlusion pressures. 
Our results indicate that hemodynamic variables (ΔHR, ΔMAP, and ΔcTSI) were not 
reproducible when measured twice at 60 mmHg VCO; however, ΔCC was. Research 
has shown that different occlusion cuff width significantly alter the response to VCO 
between individuals (Loenneke et al., 2012) and disregarding this finding is likely to 
impede the reproducibility of results on different days and between individuals. 
However, in the present study this is not applicable as all testing was completed in one 
day and expressed as delta values. Additionally, cuff inflation was automated and this is 
likely to have also reduced the error. Research has shown a high degree of 
reproducibility when measuring occlusion and calf blood flow (Kooijman et al., 2007); 
however, earlier research has shown the opposite (Altenkirch et al., 1989a). It is likely 
the findings of Altenkirch et al. (1989a) are mirrored in the current research; namely, 
that low reproducibility was due to a high degree of random biological variability. 
Baseline periods between testing, set at 10 min for each 5 min occlusion, may not have 
been of sufficient duration to allow for a complete return to pre-occlusion values. 
Previous research has set sufficient initial baseline duration of >30 min quiet rest in the 
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supine position and at 1-2 times the period of orthostatic challenge (Fu et al., 2005; 
Rickards et al., 2015; Patel et al., 2016). The present study adhered to this 
methodological commonality; however, the reproducibility of measured hemodynamic 
responses in future VCO studies may benefit from an increased recovery phase 
duration. Thus, negate the possibility of a cumulative effect on measured responses, due 
to an incomplete return to BL, following occlusion (Linden & Mary, 1982; Tonino & 
Driscoll, 1988; Bootsma et al., 1996). 
3.4.5 Insufficient simulated orthostatic challenge 
It is proposed there is a diminished mechanistic response to VCO in comparison to STS, 
HUT, LBNP or SAHC orthostatic challenges; and, as previous discussed, the role of the 
splanchnic circulation is heavily implicated. From a purely mechanical point of view 
this seems logical as VCO elicits a fluid shift passively without the recruitment or 
stimulus to other body systems. Perhaps the greatest distinguishing factor is the 
presence of high pressure cuffs at the proximal end of both legs having only an isolated 
effect of fluid accumulation. In contrast to HUT and SAHC, which involve a changing 
gravitational vector, producing a holistic challenge and greater resultant systemic 
response. 
Nevertheless, the positive linear relationship between ΔHR and ΔCC in the current 
research demonstrates a close link between central hypovolemia and systemic response. 
This suggests fluid shifted to the periphery, during VCO, is directly related to fluid 
removed from the central compartment. This observation suggests the role of the 
splanchnic circulation in VCO is independent of occlusion pressure; however, further 
research is required. 
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The present research outlines VCO as an insufficient orthostatic challenge; however, 
within the literature attempts have been made with the VCO technique to alter central 
and cerebral circulation by the periphery fluid shift. VCO has also been used in space on 
board Salyut-6/Soyuz in an attempt to prevent the headward fluid shift seen in 
microgravity. An occlusion cuff applied to the upper thigh and worn for twenty minutes 
at 40 to 60 mmHg was shown to decrease the sensation of “head pulsation” providing 
an early indication of this method as a potential spaceflight countermeasure (Matsnev et 
al., 1983; Gorgiladze & Bryanov, 1989). However, these reports were lacking objective 
data and, to our knowledge, no further work on intermittent spaceflight VCO as an 
effective countermeasure has been conducted with data collection. Additionally, past 
VCO spaceflight-related use includes assessment of calf compliance during 
weightlessness (Watenpaugh et al., 2001) and also during 18 days of bed rest (Bleeker 
et al., 2004). 
Furthermore, continuous daytime occlusion cuff wearing by astronauts, between 1995 
and 1999 on-board the Russian space station MIR station, was shown to have a 
beneficial effect on reduced facial oedema and loss of vascular tone (Arbeille et al., 
1995; Herault et al., 2000).  However, vascular deconditioning was not tested and 
adherence to the experimental protocol, with exact durations of time worn, were not 
reported. 
In the present study, results suggest an insufficient fluid shift is the likely factor in VCO 
as a poor simulated orthostatic challenge. However, any attempt to increase fluid 
displacement, through increased occlusion pressure, would prove counterproductive due 
to diminished arterial flow caused by partial occlusion (Greenfield et al., 1963). 
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ΔMAP changes from BL were not significant during VCO and recovery. This is in 
contrast to several occlusion studies that show an immediate significant reduction of 15-
22 mmHg following cessation of VCO (Tiecks et al., 1995; Jünger et al., 1997; White 
& Markus, 1997). It is possible that the smaller than expected drop in MAP, 
immediately following VCO, was due to a reduced demand on the autoregulatory 
system further discreditng VCO as a sufficent orthostatic challenege in the participants 
tested. 
3.4.6 Conclusion 
Our results suggest that bilateral lower-limb VCO at external pressures up to 120 
mmHg, at the proximal end of the thigh, were insufficient at eliciting an increased and 
comparable response to HUT/HDT, and low-level LBNP and LAHC/SAHC. 
Specifically, in relation to the magnitude of cerebral tissue oxygenation decrease, 
peripheral, and systemic hemodynamic response. In addition, hemodynamic responses 
without significant pain during VCO (up to 100 mmHg) were even less capable of 
simulating an orthostatic challenge. Further research into the external/internal cuff 
pressure relationship, on VCO-induced fluid shifts and resultant hemodynamic 
response, may better characterise VCO orthostatic challenge potential. 
The change in peripheral fluid displacements (ΔCC) during VCO were significant and 
reproducible but there were no notable changes from baseline in cerebral tissue 
oxygenation. Furthermore, ΔHR, ΔMAP, and ΔcTSI responses were not reproducible 
within the nine participants at 60 mmHg VCO. To our knowledge, this is the first study 
to: (i) investigate cardiovascular responses and cerebral tissue oxygenation to increasing 
levels of bilateral lower-limb VCO; and (ii) provide results that demonstrate the 
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insufficiencies of VCO as a simulated orthostatic challenge, and to elicit a reproducible 
systemic response, despite comparable peripheral fluid shifts. 
Previous research suggest daily intermittent VCO, on the proximal end of the thighs, as 
a potential spaceflight countermeasure (Matsnev et al., 1983; Gorgiladze & Bryanov, 
1989). However, in the present study, we demonstrate VCO is unlikely to provide any 
physiological benefit, due to an insufficient orthostatic challenge devoid of any potential 
training effect, during intermittent use in spaceflight. 
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4 EFFECT OF NOVEL SHORT-ARM HUMAN 
CENTRIFUGATION INDUCED GRAVITATIONAL 
GRADIENTS UPON CARDIOVASCULAR RESPONSE, 
CEREBRAL TISSUE OXYGENATION AND OVERALL 
ORTHOSTATIC TOLERANCE 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Four  Short-arm human centrifugation 
- 131 - 
4.1 Introduction 
Exposure to microgravity induces a number of deleterious effects on humans as a result 
of gravitational unloading; including muscle atrophy (Aaslid et al., 1989), bone loss 
(Mack & LaChance, 1967), and cardiorespiratory deconditioning (Trappe et al., 2006). 
In addition to unloading, such effects may also relate to a headward fluid shift following 
the negation of the normal hydrostatic pressure gradient (Hargens & Richardson, 2009). 
In fact, astronauts are often referred to be suffering from “puffy face” (Figure 4.1B) and 
“skinny leg” syndrome which is not only associated with sinus congestion (Greenleaf, 
1984), but has recently been implicated in visual impairment and intracranial pressure 
(VIIP) syndrome (Donoviel & Sutton, 2013; Marshall-Bowman et al., 2013). 
 
 
 
 
Figure 4.1 A, astronaut Timothy Peake before his space mission on Earth; and B, during 6 
month mission to the International Space Station showing fluid shift seen here by facial 
edema. Adapted from European Space Agency (ESA). 
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4.1.1 Spaceflight countermeasures 
Current spaceflight countermeasures on-board the International Space Station (ISS) 
attempt to ameliorate the effects of gravitational unloading through an extensive daily 
exercise program (Clément, 2011). Training consists of treadmill running, cycle 
ergometry and resistive exercise, which has been shown to be effective at reducing loss 
of muscle mass (Trappe et al., 2009), bone density (Shackelford et al., 2004) and 
cardiorespiratory function (Loehr et al., 2011). However, despite such current 
countermeasures, typically 30-50% of all returning astronauts demonstrate orthostatic 
intolerance (OI) on return (Moore et al., 1996; Blaber et al., 2011). It is postulated that 
high OI incidence arises from current countermeasures targeting gravitational unloading 
without concurrent headward fluid shift reversal and combining the two may prove 
synergistic. 
4.1.1.1 Artificial gravity 
Long arm human centrifuges (LAHC) and high-performance aircraft g-exposure 
research has shown a relatively predictable dose-dependent effect of +Gz upon the 
cardiovascular system and thus g-tolerance, which is limited by the ability to maintain 
cerebral perfusion when coupled with a foot-ward fluid shift (Scott et al., 2007). 
Repeated exposure to LAHC can improve orthostatic tolerance (Scott et al., 2013) but 
remains impractical for an artificial gravity (AG) application during spaceflight due to 
technical limitations (Clement & Pavy-Le Traon, 2004).   
Prolonged exposure to LAHC is associated with OI but this is without a g-gradient (i.e. 
almost constant gravitational forced experienced at head and feet). This is whilst short-
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arm human centrifugation (SAHC) leads to a g-gradient where a far greater +Gz level is 
experienced at the feet in comparison to the head (Clement & Pavy-Le Traon, 2004). 
Recent research on Earth has shown that periodically shifting central blood volume to 
the periphery, via SAHC at 2.4 +Gz, leads to significant improvements in subsequent 
standing orthostatic tolerance (Goswami et al., 2015b). However, whilst these results 
are promising, benefits need to be balanced against the risk of mild central hypovolemia 
and syncope during SAHC. 
For LAHC and SAHC the orthostatic challenge is commonly defined in the literature as 
the g-level experienced at the feet for a particular duration. However, a third factor of 
body position with respect to the axis of rotation (rotational axis position; RAP) differs 
between LAHC and SAHC, leading to greater g-gradients in the latter. For instance the 
g-gradient, defined as the percentage difference between g-level at the head and feet, is 
approximately +22% for an 8 m radius LAHC and +72% (Figure 1.8) for the 2.4 m 
radius SAHC at the German Aerospace Center (DLR) in Cologne. 
4.1.2 Hydrostatic gradient 
Gravitational forces significantly alter the cardiovascular system even during every day 
postural movements. However, centrifugal force elicits an additional challenge, to a 
suitable cardiovascular response, through variations in the g-level experienced across 
the length of the body. On Earth there is a large pressure gradient from the head to the 
feet and this is almost entirely removed upon entering space; in a similar manner to 
supine (Figure 4.2). 
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Figure 4.2 Hydrostatic pressure gradient from head to foot on Earth when A, standing 
and; B, supine. Adapted from (Clément, 2011). 
  
Veins in the lower-limbs experience pressure of ~200 mmHg. Transition into 
weightlessness abolished the effective gradient, similar to what is observed when supine. 
 
 
 
The hydrostatic gradient under constant 1 +Gz on Earth is fundamental to maintaining 
cardiovascular homeostasis and cardiopulmonary and carotid baroreceptors play an 
important role (Gabrielsen et al., 1996; Pump et al., 2001). Cardiovascular mechanisms 
evolved under a constant g-level and the resultant hydrostatic pressure changes across 
the body, from standing to supine on Earth, pose no significant orthostatic challenge to 
healthy individuals. Interestingly, during SAHC the pressures across the body are 
changed in a new way not seen in standing or supine on Earth, or in weightlessness. It is 
postulated that the differential hydrostatic pressures, between aortic and carotid regions, 
is critical to appropriate hemodynamic control. SAHC, with the ability to alter the 
hydrostatic gradient, may prove useful as a novel experimental paradigm in 
cardiovascular research. Specifically, SAHC presents an opportunity to examine the 
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interrelationship between different baroreceptors and the resultant hemodynamic 
response. 
4.1.3 Gender effects 
Several studies have shown a significantly different response between genders in 
response to an orthostatic stress. Convertino et al. (1998) showed woman had a greater 
heart rate (HR) response during LAHC with other research recording an overall reduced 
tolerance to SAHC (Fong et al., 2007). Similarly, a greater HR response to LBNP in 
females, leading to reduced tolerance, has been reported (Montgomery et al., 1977; Frey 
& Hoffler, 1988; White et al., 1996). Research shows marked gender differences to an 
orthostatic challenge exist; however, anthropometrical differences between sexes has 
been shown as a non-contributory factor in LBNP (Lawler et al., 1998). An observed 
reduced tolerance to an orthostatic stress has been attributed to females having a lower 
sympathetic outflow to peripheral vasculature (Shoemaker et al., 2001) with Convertino 
(1998) demonstrating a reduced elevation of circulating norepinephrine (NE) in women, 
during orthostatic challenge, compared to men. Nevertheless, specific data pertaining to 
SAHC gender differences remain unclear. 
4.1.4 Hemodynamic measurements 
A large study by Weiss et al. (2005) showed measured differences in cerebral tissue 
saturation index (cTSI), measured by near-infrared spectroscopy (NIRS), correlated 
significantly to accurate changes in arterial oxygen saturation, arteriovenous oxygen 
extraction, and central venous oxygen saturation. If one assumes a constant cerebral 
metabolic rate, NIRS-derived cerebral perfusion presents as a useful tool in 
differentiating physiological response to an orthostatic challenge;  where a drop below a 
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measured threshold leads to pre- and eventual syncope (Van Lieshout et al., 2003). In 
addition, strain gauge plethysmography (SGP) remains the gold standard for 
quantification of peripheral limb volume changes and a surrogate to understand the 
extent of volume removed from the central circulation (Joyner et al., 2001). Similarly, 
heart rate (HR) and blood pressure (BP) are accurate for quantifying overall systemic 
cardiovascular response and observations of presyncopal symptoms (PSS) in individuals 
can be used as an indicator of (reduced) g-tolerance. 
Thus, in the present study, we investigated the effect of a shift in RAP (and resultant g-
gradients) upon systemic cardiovascular response using HR and BP, peripheral fluid 
displacement using SGP, cerebral perfusion with NIRS, and orthostatic tolerance by 
observing PSS on the newly-constructed SAHC at the German Aerospace Centre (DLR, 
Cologne, Germany; Figure 2.2). 
4.1.5 Aims 
The aim of the study was to conduct a systematic comparative analysis of three 
standardised g-gradients (RAPs) to provide context, with the two extremities (P1 vs. 
P3) being used for comparative purposes. Specifically, to assess significant differences 
in cardiovascular responses, as a result of g-gradients. In addition, gender variances 
were examined to ascertain if RAP specific changes in hemodynamic response were 
affected by sex.  
In general, the present study set out to characterise hemodynamic response to altered 
hydrostatic gradients during SAHC. Specifically, to provide a better insight for future 
artificial gravity (AG) research by investigating the third variable in human 
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centrifugation studies; namely g-gradient in addition to duration and magnitude of 
exposure. 
4.1.6 Hypothesis 
We hypothesized that RAP shift from the head to heart (altered g-gradient) during 
SAHC, with a comparable g-level at the feet, would improve g-tolerance through a 
reduction of peripheral fluid shifts, supported cerebral perfusion and thus attenuated 
systemic cardiovascular response. 
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4.2 Methods 
4.2.1 Study design and participants 
Twenty (10 male) healthy normotensive, non-smoking participants (Table 4.1) gave 
written informed consent to participate in the study that conformed to the declaration of 
Helsinki and was approved by the Ethics Committee of the North Rhine Medical 
Association in Düsseldorf, Germany. 
 
Table 4.1 Participant individual data. 
  
Age on first experimental day; height and weight measured immediately 
before centrifuge run. 
 
 
 
            
 
   Sex Age (yrs) Height (m) Weight (kg) BMI (kg/m
2)  
  
 
P01 M 24.1 1.75 65 21.2 
 
 
P02 F 28.0 1.60 57 22.3 
 
 
P03 F 26.4 1.71 64 21.9 
 
 
P04 F 23.6 1.68 72 25.5 
 
 
P05 F 21.8 1.64 70 26.0 
 
 
P06 F 26.5 1.70 58 20.1 
 
 
P07 F 29.4 1.61 51 19.7 
 
 
P08 F 20.5 1.70 65 22.5 
 
 
P09 F 26.4 1.60 60 23.4 
 
 
P10 M 35.9 1.86 80 23.1 
 
 
P11 M 22.5 1.73 69 23.1 
 
 
P12 M 23.5 1.81 75 22.9 
 
 
P13 F 24.1 1.73 65 21.7 
 
 
P14 F 31.6 1.70 67 23.2 
 
 
P15 M 33.2 1.85 82 24.0 
 
 
P16 M 25.6 1.78 73 23.0 
 
 
P17 M 29.2 1.75 75 24.5 
 
 
P18 M 26.3 1.84 87 25.7 
 
 
P19 M 21.7 1.75 65 21.2 
 
 
P20 M 25.9 1.72 68 23.0 
 
 
Mean ± 
SD 
- 26.3 ± 4.0 1.73 ± 0.08 68 ± 9 22.9 ± 1.7  
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Before being enrolled into the study, all participants underwent medical screening 
which consisted of a clinical-chemical blood analysis described in detail in section 
2.6.1.1. Further inclusion tests included: a resting electrocardiogram (ECG), adapted 
Bruce Protocol with cycle ergometry to verify appropriate aerobic fitness (for age and 
gender) and cardiac function (Bruce et al., 1963), standing test for orthostatic tolerance 
assessment, and a medical history.  Female participants additionally had to test negative 
on a urine-based pregnancy test before each session. Prior to testing each participant 
was familiarized with all aspects of the study, including the methodology, personnel 
involved and the short-arm human centrifuge (SAHC; Figure 4.3A). 
4.2.2 Experimental protocol 
Participants underwent ten passive 10 min SAHC runs over two experimental sessions 
on separate days (2 months apart) with rest phases of at least 25 min between each of 
the five runs per day (Figure 4.4). Each participant was tested on both occasions either 
in the morning (0900-1300) or afternoon (1300-1700). Prior to centrifugation 
participants were instructed to eat a light breakfast, or lunch 1 h before and, in the 
preceding 24 h period, consume no alcohol or caffeine. Participants were fixed to the 
centrifuge, in the supine position feet facing outwards, with an adjustable parachute 
harness and bicycle saddle. Centrifugation took place in the dark with participants asked 
to remain silent and completely still throughout unless experiencing discomfort. 
Monitoring took place via several infrared cameras on the face, chest and legs. 
Each centrifuge run was performed at one of three centres of rotation an identical 
distance apart (above the head, P1; apex of the head, P2 and at the heart, P3) thereby 
generating three differing g-gradients across the body, standardised against the 
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anatomical position of the heart (fourth intercostal space), in each participant. Gz forces 
were measure directly using a tri-axial accelerometer (SS26LB, Biopac Systems, 
Goleta, CA, USA) at the feet and heart-level. G-gradients are expressed as the 
percentage difference of g-level at the head in relation to g-level at the feet. At 2.4 +Gz 
at the feet the g-level at the head is +0.5 at P1, 0.0 at P2 and -0.7 Gz at P3. These give 
rise to differences of +1.9, +2.4 and +3.1 Gz (P1, P2 and P3 respectively) and g-
gradients of +81 %, P1; +100 %, P2; and +130 %, P3 (Table 4.2; and grey shaded area, 
Figure 4.3B). In addition, three standardised g-levels at the feet (1.0 +Gz, 1.7 +Gz and 
2.4 +Gz) were tested in a random combination and order for nine total centrifuge 
profiles with the addition of a tenth familiarisation run at the start. 
 
Table 4.2 Effective g-level and gradient for participant at 2.4 +Gz. 
  
P1, above head; P2, head apex; and P3, heart-level. G-gradient, defined 
as the percentage difference between g-level at the head and feet at 2.4 +Gz. 
 
 
 
  
G-level at 
Head (+/-Gz) 
G-level at 
Feet (+Gz) 
Delta G-level 
(+Gz) 
G-gradient 
(%) 
     
P1 +0.5 +2.4 +1.9 +81 
P2 +0.0 +2.4 +2.4 +100 
P3 -0.7 +2.4 +3.1 +130 
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Figure 4.3 Protocol overview. 
  
A, short-arm human centrifuge (SAHC) with unique capability to alter 
rotational axis position and thus g-gradient (at DLR, Cologne, Germany); B, 
Nine centrifuge profiles in total (3x3) - three centres of rotation: P1, above the 
head; P2, apex of head; and P3 at heart-level and three g-levels at the feet: 
G1, 1.0 +Gz; G2, 1.7 +Gz; and G3, 2.4 +Gz.  
 
Grey shaded area, altered g-gradient across the body at each rotational axis position: 
P1, +81 %; P2, +100 %; and P3, +130 % (at 2.4 +Gz; Table 4.2). 
 
 
Each of the two testing days consisted of five centrifuge profiles (Figure 4.4A), 
randomly assigned with an online randomizer (random.org, 2016). Each centrifuge 
profile was split into five distinct phases (Figure 4.4B) with a fixed ramp-up and -down 
time (120 s) irrespective of g-level. Comparable physiological responses relating to g-
tolerance have been shown to be dependent on the g-onset time (Whinnery & Forster, 
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2013) and the approach taken in this study removes the prospect of this having an 
influencing factor. 
 
 
Figure 4.4 Protocol duration with constituent centrifuge profile phases 
  
A, protocol consisting of five randomised centrifuge profiles (34 min each), 
with no less than 25 min rest between them, thus constituting a protocol of 3 
h 10 min; B, single profile over 34 min consisting of five phases: baseline, 
ramp-up, centrifuge run, ramp-down and recovery. 
 
 
4.2.2.1 Cerebral perfusion 
Cerebral near-infrared spectroscopy of the left prefrontal cortex immediately below the 
forehead hairline of each participant (cNIRS; PortaLite, Artinis Medical Systems, The 
Netherlands; Figure 4.5C) was used to determine the absolute ratio of oxy- (O2Hb) and 
deoxyhemoglobin (HHb). Taking into account participant frontal cranium thickness, 
based on age and gender, the cerebral tissue saturation index (cTSI) was deduced 
(Lynnerup et al., 2005), which has been shown to correlate well to prefrontal cortex 
cerebral perfusion (Weiss et al., 2005). 
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Figure 4.5 Experimental setup. 
  
A, centrifuge cover hood with mounted infrared camera; B, blood pressure cuff 
for medical monitoring; C, near infrared spectroscopy (NIRS) of the prefrontal 
cortex; D, Finapres continuous blood pressure monitor; E, participant ‘seated’ in 
a bicycle saddle to prevent muscle pump activation; F, NIRS of the calf muscle; 
G, emergency alarm for participant safety; H, strain gauge plethysmography of 
the calf; and I, Accelerometer measuring accurate +Gz level at the feet. 
 
4.2.2.2 Peripheral fluid displacement 
Movement of fluid to the lower extremities, and away from the central compartment, 
was quantified using strain gauge plethysmography (SGP; EC6 Strain Gauge 
Plethysmograph, Hokanson Inc., Bellevue, WA, USA); positioned around the calf 
midpoint (directly between the tibiae tuberosity and medial malleolus bony 
prominences) of each participant (Figure 4.5H). Claydon and Hainsworth (2005) 
demonstrated individuals with orthostatic intolerance (OI) exhibited subconscious 
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strategies in which venous return was improved. As such, a bike saddle was installed on 
the centrifuge to limit leg ‘muscle-pump’ activation (Figure 4.5E). 
4.2.2.3 Systemic cardiovascular measurements 
Continuous beat-by-beat heart rate (HR) via a standard 3-lead electrocardiogram (ECG; 
Biopac Systems, Goleta, CA, USA) and mean arterial finger blood pressure (MAP) was 
recorded with a Finometer (Finapres Medical Systems, Amsterdam, The Netherlands). 
The Finometer finger cuff was placed around the third finger of the right hand and fixed 
by a sling at the level of the fourth intercostal space at the level of the heart (Figure 
4.5D). Finometer BP measurements were corroborated with absolute arterial BP 
measurements obtained by an automated sphygmomanometer (Intellivue MMS X2, 
Philips, Best, The Netherlands) prior to starting the profile. Stroke volume (SV) and 
total peripheral resistance (TPR) were estimated from the arterial BP waveform using 
the Modelflow method (Leonetti, et al. 2004) via Beatscope software (TNO-TPD, 
Biomedical Instrumentation, Amsterdam, The Netherlands). 
4.2.2.4 Presyncopal symptoms (PSS) 
Participants were retrospectively classified as experiencing presyncopal symptoms 
(PSS+) or not (PSS-) when one (or more) of the following was observed: (i) continuous 
HR and BP decrements for longer than 15 s; (ii) nausea, paleness, dizziness; and/or (iii) 
participant requested run termination. 
4.2.3 Statistical analysis 
Following a pilot study of the measures used in this paper in which fluid shifts were 
induced, an error probability (α) of 0.05, power (1 - β) of 0.80 with an average effect 
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size (d) of 0.05, power calculation, using G* Power (Erdfelder, Faul, & Buchner, 1996), 
yielded a participant number of 15. However, due to the challenging nature of the 
experiment an additional 25% were recruited to mitigate any attrition.  
All continuously recorded data were analysed in 10 s frames and artefacts were 
removed offline with a custom made Matlab (R2015a, The Mathworks Inc., MA, USA) 
script using the following criteria: (i) conservative and plausible physiological limits 
(Table 2.2); and (ii) maximal percentage of change in relation to the standard deviation 
of the signal. Data was resampled at 4Hz (piecewise cubic spline interpolation) as long 
as >95% of data were valid yielding 15 complete sets of data for further analysis. Data 
presented are delta values of each 1 min mean of the 24 min measurements following 
ramp-up from mean of the last fives minutes of the 10 min baseline immediately before 
each corresponding profile. 
R (R Foundation for Statistical Computing, Vienna, Austria) and lme4 (Bates et al., 
2012) were used to perform linear mixed effect (LME) analysis of the relationship 
between each cardiovascular parameter and the time course of each centrifuge run. 
Time, position and g-level at the feet (with 2 and 3-way interactions) were entered into 
the model with intercepts for each participant as a random effect, with a second model 
incorporating participant sex to explore gender effects. Visual inspection of residual 
plots did not reveal any obvious deviations from homoscedasticity or normality of 
residuals. P-values were obtained by likelihood ratio tests of the full model with the 
effect (time, position and g-level at the feet) in question, against the model without that 
effect. 
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To reduce complexity of the models, a secondary analysis was performed with data both 
averaged for each 2 min increment of centrifugation and compared for differences 
arising due to position at that moment. To evaluate the specific differences induced (P1 
vs. P3; and male vs. female), one-way analysis of variance (ANOVAs) were conducted, 
followed by post hoc tests with preventive post hoc control of the type I error rate 
(Tukey’s Honestly Significant Difference, HSD).  
Linear regression analysis was used to estimate the relationships among hemodynamic 
variables and a chi-square test of independence was used to estimate equality of 
proportions between RAP, and gender. The data are presented as mean (±SEM) unless 
otherwise stated with the level of significance set at p≤0.05. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Four  Short-arm human centrifugation 
- 147 - 
4.3 Results 
Twenty participants completed all short-arm human centrifuge (SAHC) profiles, during 
g-levels from 1.0 to 2.4 +Gz at the feet in position 1 (P1, above head), position 2 (P2, 
head-apex), and position 3 (P3, heart-level). The greatest difference in cardiovascular 
response occurred at the highest g-level (2.4 +Gz) with the largest attenuations observed 
between SAHC in P1 and P3. Initially data are presented for all g-gradients (P1-3) and 
g-levels (1.0-2.4 +Gz) with further analysis consisting of P1/P3 time-course 
comparisons across the whole 24 min run (ramp-up, centrifugation, ramp-down, and 
recovery). Baseline values, prior to the start of experimentation, for all participants are 
outline in  
 
 
Table 4.3. 
 
 
 
Table 4.3 Participant absolute mean baseline (BL) values for all parameters. 
  
Measured BL is a mean of the last minute immediately before start of the 
experiment in all participants (n=20). 
 
HR, heart rate; SV, stroke volume; TPR, total peripheral resistance; MAP, 
mean arterial pressure; CC, calf circumference; mTSI, muscle tissue 
saturation index; cTSI, cerebral tissue saturation index. 
 
 
    
 
  Parameter 
Absolute mean  
baseline (BL) ± SEM  
  
 
HR 65 ± 2 bpm 
 
 
SV 86.8 ± 3.6 mL 
 
 
TPR 1181 ± 73 dyn.s.cm-5 
 
 
MAP 74 ± 2 mmHg 
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CC 338 ± 3 mm 
 
 
mTSI 64.78 ± 0.90 % 
 
 
cTSI 68.20 ± 1.77 % 
     
 
 
4.3.1 G-level / g-gradient effect on cardiovascular response 
G-level (+Gz) as a fixed effect was shown by the linear mixed effects model to be 
highly significant for changes from baseline (BL) in mean heart rate (ΔHR), averaged 
mean arterial pressure (ΔMAP), mean stroke volume (ΔSV), and mean total peripheral 
resistance (ΔTPR; Table 4.4A). Significant main effects of rotation axis position (RAP), 
giving rise to a specific g-gradient (P1-3), were found in ΔHR, ΔMAP, ΔSV and ΔTPR 
(Table 4.4A) with several two and three-way interactions between variables also 
observed (Time:Position:G-level; Table 4.4B). 
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Table 4.4 Effects and their standard errors of cardiovascular variables as a result of time, position and g-level. 
 
 
 
A, main effects tabulated linear mixed effects statistics; and B, interaction effects. 
 
HR, heart rate; SV, stroke volume; TPR, total peripheral resistance; MAP, mean arterial pressure. 
Time, measured in seconds from the start of the centrifuge phase; position, expressed as multiple of the distance from heart-level 
to the apex of the head (in relation to the rotational axis); g-level, +Gz experienced during each profile at the feet. 
 
 
 
 
  
 
 
  (Intercept) Time (s) Position (HL) G-level (+Gz) 
 n 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
ΔHR 
(bpm) 
20 
-8.98 
± 1.77 
54.0 < 0.001 
0.009 
± 0.004 
658 < 0.05 
-2.63 
± 0.60 
6365 < 0.001 
3.53 
± 0.80 
13038 < 0.001 
ΔSV 
(mL) 
20 
17.4 
± 2.1 
409 < 0.001 
-0.015 
± 0.005 
78.6 < 0.001 
-9.70 
± 0.85 
1949 < 0.001 
-16.6 
± 1.15 
3037 < 0.001 
ΔTPR 
(dyn.s.cm-5) 
20 
-239.2 
± 51.1 
136 < 0.001 
0.241 
± 0.135 
44.1 < 0.001 
199.0 
± 20.9 
678 < 0.001 
222.7 
± 28.1 
14.6 < 0.001 
ΔMAP 
(mmHg) 
20 
-9.56 
± 1.39 
3.65 0.056 
0.011 
± 0.003 
3.58 0.058 
3.13 
± 0.53 
3537 < 0.001 
1.48 
± 0.71 
196 < 0.001 
 
 
 
  
 
 
Time (s) : Position (HL) Time (s) : G-level (+Gz) Position (HLs) : G-level (+Gz) 
Time (s) : Position (HL) :  
G-level (+Gz) 
 n 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
ΔHR 
(bpm) 
20 
-0.010 
± 0.002 
221 < 0.001 
-0.008 
± 0.002 
277 < 0.001 
4.30 
± 0.36 
1782 < 0.001 
0.011 
± 0.001 
112 < 0.001 
ΔSV 
(mL) 
20 
0.011 
± 0.002 
27.5 < 0.001 
-0.010 
± 0.003 
44.4 < 0.001 
3.52 
± 0.51 
12.3 < 0.001 
-0.009 
± 0.001 
35.0 < 0.001 
ΔTPR 
(dyn.s .cm-5) 
20 
-0.040 
± 0.061 
0.221 0.638 
-0.195 
± -.081 
24.9 < 0.001 
-75.1 
± 12.5 
122 < 0.001 
0.019 
± 0.037 
0.258 0.611 
ΔMAP 
(mmHg) 
20 
-0.002 
± 0.002 
0.001 0.982 
-0.007 
± 0.002 
32.4 < 0.001 
0.772 
± 0.318 
53.5 < 0.001 
0.001 
± 0.001 
2.07 0.151 
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Specific baseline (BL) changes:  Post hoc analysis revealed SAHC at P1 resulted in 
positive changes from BL in ΔHR across all g-levels (1.0-2.4 +Gz: p<0.01-0.001); with 
a similar observation at P2 during 1.7 +Gz (p<0.001) and 2.4 +Gz (p<0.001) but not 1.0 
+Gz (p=0.110; Figure 4.6A). ΔHR at P3 compared to BL was only significantly positive 
at the highest g-level (1.0 +Gz: p=0.318; 1.7 +Gz: p=0.169; and 2.4 +Gz: p<0.001; 
Figure 4.6A). ΔMAP at P1 was significantly positive during 1.0 +Gz (p=0.018) and 1.7 
+Gz (p<0.001) but not at 2.4 +Gz (p=0.071) compared to BL; whilst at P2 ΔMAP was 
unchanged during all g-levels (1.0-2.4 +Gz: 0.292<p<0.612; Figure 4.6B). ΔMAP at P3 
was unchanged during 1.0 +Gz (p=0.135) but significantly negative at 1.7 +Gz 
(p=0.017) and 2.4 +Gz (p<0.001; Figure 4.6B).  
In all positions (P1-3) and across all g-levels (1.0-2.4 +Gz) ΔSV was significantly 
negative compared to BL (p<0.01-0.001; Figure 4.6C). Conversely, in all positions (P1-
3) and across all g-levels (1.0-2.4 +Gz) ΔTPR was significantly positive compared to 
BL (p<0.05-0.001; Figure 4.6D). 
Rotational axis position comparison (RAP, Pn1 vs. Pn2): Post hoc analysis revealed ΔHR 
was no different at P1 compared to P2 (P1 vs. P2) during 1.0 +Gz (p=0.949) but 
significantly greater at 1.7 +Gz (p<0.001) and 2.4 +Gz (p<0.001; Figure 4.6A). 
Similarly, ΔHR was significantly greater at P2 compared to P3 (P2 vs. P3) during 1.7 
+Gz (p=0.001) and 2.4 +Gz (p<0.001) but not 1.0 +Gz (p=0.059; Figure 4.6A). During 
all g-levels at P1, ΔHR was significantly higher compared to P3 (P1 vs. P3, 1.0-2.4 
+Gz: p<0.05-0.001) with the greatest difference during 2.4 +Gz (45 ± 4 vs. 8 ± 2 bpm, 
p<0.001; Figure 4.6A). 
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ΔMAP was no different at P1 compared to P2 (P1 vs. P2) during all g-levels (1.0-2.4 
+Gz: 0.096<p<0.306; Figure 4.6B). However, ΔMAP was significantly greater at P2 
compared to P3 (P2 vs. P3) during 1.7 +Gz (p=0.025) and 2.4 +Gz (p=0.014) but not 
1.0 +Gz (p=0.143; Figure 4.6B). During all g-levels at P1, ΔMAP was significantly 
higher compared to P3 (P1 vs. P3, 1.0-2.4 +Gz: p<0.05-0.001) with the greatest 
difference during 1.7 +Gz (6 ± 1 vs. -5 ± 2 mmHg, p<0.001; Figure 4.6B). 
ΔSV was no different at P1 compared to P2 (P1 vs. P2) during all g-levels (1.0-2.4 
+Gz: 0.128<p<0.647; Figure 4.6C). However, ΔSV was significantly lower at P2 
compared to P3 (P2 vs. P3) during 1.0 +Gz (p=0.011) and 2.4 +Gz (p=0.007) but not 
1.7 +Gz (p=0.206; Figure 4.6C). During all g-levels at P1, ΔSV was significantly lower 
compared to P3 (P1 vs. P3, 1.0-2.4 +Gz: p<0.05-0.001) with the greatest difference 
during 2.4 +Gz (-34.7 ± 2.4 vs. -19.2 ± 1.6 mL, p<0.001; Figure 4.6C). 
ΔTPR was no different at P1 compared to P2 (P1 vs. P2; 0.309<p<0.879), or P2 
compared to P3 (P2 vs. P3; 0.153<p<0.381) during all g-levels (1.0-2.4 +Gz; Figure 
4.6D). Similarly, ΔTPR at P1 compared to P3 (P1 vs. P3) during 1.0 +Gz and 2.4 +Gz 
showed no difference (1.0 +Gz: p=0.065; and 2.4 +Gz: p=0.312) but was significantly 
greater during 1.7 +Gz (346 ± 67 vs. 153 ± 38 dyn.s.cm-5, p=0.040; Figure 4.6D). 
 
 
 
 
Chapter Four  Short-arm human centrifugation 
- 152 - 
 
 
 
 
Figure 4.6 Mean changes from baseline (BL) for cardiovascular measures in the final minute (min 
10) of short-arm human centrifugation (SAHC, 1.0 to 2.4 +Gz) at position 1 (P1, above the head), 
position 2 (P2, apex of head), and position 3 (P3, heart-level). 
 
 
 
  
A, changes from baseline (BL) in mean heart rate (ΔHR); B, changes from BL in averaged 
mean arterial pressure (ΔMAP); C, changes from BL in mean stroke volume (ΔSV); and D, 
changes from BL in mean derived total peripheral resistance (ΔTPR). 
 
Mean at each g-level (± SEM) is calculated as a final minute (min 10) mean delta from the final minute 
(min 10) mean of the baseline (BL) immediately before each respective centrifuge run. Black square, at 
position 1 (P1, above head); white square, at position 2 (P2, apex of head); and grey triangle, at 
position 3 (P3, heart-level). Baseline (*): * p < 0.05, ** p < 0.01, *** < p <0.001. Position (#): # p < 0.05, ## 
p < 0.01, ### p < 0.001. n = 20. 
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4.3.2 G-level / g-gradient effect on lower-limb peripheral fluid displacement 
G-level (+Gz) as a fixed effect was shown by the linear mixed effects model to be 
highly significant for changes from baseline (BL) in calf circumference (ΔCC; Table 
4.5A). Significant main effects of rotation axis position (RAP), giving rise to a specific 
g-gradient (P1-3), were also found in ΔCC with significant two and three-way 
interactions also observed (Time:Position:G-level; Table 4.5B). 
Specific baseline (BL) changes:  Post hoc analysis revealed SAHC in all positions (P1-
3) and across all g-levels (1.0-2.4 +Gz) ΔCC was significantly positive compared to BL 
(p<0.01-0.001; Figure 4.7). 
Rotational axis position comparison (RAP, Pn1 vs. Pn2): Post hoc analysis revealed ΔCC 
was no different at P1 compared to P2 (P1 vs. P2) during all g-levels (0.191<p<0.429; 
Figure 4.7). However, ΔCC was significantly greater at P2 compared to P3 (P2 vs. P3) 
during 1.0 +Gz (p=0.035) and 2.4 +Gz (p=0.038) but not 1.7 +Gz (p=0.741; Figure 4.7). 
ΔCC at P1 was significantly higher compared to P3 (P1 vs. P3) only at the highest g-
level (2.4 +Gz: 5.2 ± 0.6 vs. 3.0 ± 0.4 mm, p=0.005; Figure 4.7). 
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Table 4.5 Effects and their standard errors of calf circumference (CC) as a result of time, position and g-level. 
  
A, main effects tabulated linear mixed effects statistics; 
B, interaction effects tabulated linear mixed effects statistics. 
 
Time, measured in seconds from the start of the centrifuge phase; position, expressed as multiple of the distance from heart-level 
to the apex of the head (in relation to the rotational axis); g-level, +Gz experienced during each profile at the feet. 
 
 
 
   
 
  
 
 
  (Intercept) Time (s) Position (HL) G-level (+Gz) 
 n 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
ΔCC 
(mm) 
20 
0.102 
± 0.431 
32.0 < 0.001 
0.001 
± 0.001 
1793 < 0.001 
-0.112 
± 0.115 
1035 < 0.001 
0.379 
± 0.155 
2938 < 0.001 
 
 
  
 
 
 
Time (s) : Position (HL) Time (s) : G-level (+Gz) Position (HLs) : G-level (+Gz) 
Time (s) : Position (HL) :  
G-level (+Gz) 
 n 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
ΔCC 
(mm) 
20 
-0.001 
± 0.000 
175 < 0.001 
0.000 
± 0.000 
291 < 0.001 
0.156 
± 0.069 
262 < 0.001 
0.001 
± 0.000 
45.8 < 0.001 
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Figure 4.7 Mean changes from baseline (BL) for calf circumference (ΔCC) in the final 
minute (min 10) of short-arm human centrifugation (SAHC, 1.0 to 2.4 +Gz) at position 
1 (P1, above the head), position 2 (P2, apex of head), and position 3 (P3, heart-level). 
  
Mean at each g-level (± SEM) calculated as a final minute (min 10) mean delta from final 
minute (min 10) mean of the baseline (BL) immediately before each respective centrifuge 
run. Black square, at position 1 (P1, above head); white square, at position 2 (P2, apex 
of head); and grey triangle, at position 3 (P3, heart-level). Baseline (*): * p < 0.05, ** p < 
0.01, *** < p <0.001. Position (#): # p < 0.05, ## p < 0.01, ### p < 0.001. n = 20. 
 
 
4.3.3 G-level / g-gradient effect on cerebral perfusion  
G-level (+Gz) as a fixed effect was shown by the linear mixed effects model to be 
highly significant for changes from baseline (BL) in prefrontal cortex cerebral tissue 
saturation index (ΔcTSI; Table 4.6A). Significant main effects of rotation axis position 
(RAP), giving rise to a specific g-gradient (P1-3), were also found in ΔcTSI with 
significant two and three-way interactions also observed (Time:Position:G-level; Table 
4.6B). 
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Table 4.6 Effects and their standard errors of prefrontal cortex cerebral tissue saturation index (cTSI) as a result of time, position 
and g-level (fixed effects). 
  
A, main effects tabulated linear mixed effects statistics; 
B, interaction effects tabulated linear mixed effects statistics. 
 
Time, measured in seconds from the start of the centrifuge phase; position, expressed as multiple of the distance from heart-level 
to the apex of the head (in relation to the rotational axis); g-level, +Gz experienced during each profile at the feet. 
 
 
 
   
 
  
 
 
  (Intercept) Time (s) Position (HL) G-level (+Gz) 
 n 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
ΔcTSI 
(%) 
20 
2.42 
± 0.33 
18.8 < 0.001 
-0.002 
± 0.001 
6.55 <0.05 
-0.66 
± 0.12 
1194 < 0.001 
-1.46 
± 0.16 
2452 < 0.001 
 
 
  
 
 
 
Time (s) : Position (HL) Time (s) : G-level (+Gz) Position (HLs) : G-level (+Gz) 
Time (s) : Position (HL) :  
G-level (+Gz) 
 n 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
ΔcTSI 
(%) 
20 
0.002 
± 0.000 
7.56 < 0.01 
0.002 
± 0.000 
20.1 < 0.001 
0.120 
± 0.70 
45.2 < 0.001 
-0.001 
± 0.000 
34.5 < 0.001 
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Specific baseline (BL) changes:  Post hoc analysis revealed SAHC at P1 resulted in 
negative changes from BL in ΔcTSI during only the highest g-level (1.0 +Gz: p=0.504; 
1.7 +Gz: p=0.091; and 2.4 +Gz: p=0.001); with a similar observation at P2 (1.0 +Gz: 
p=0.160; 1.7 +Gz: p=0.964; and 2.4 +Gz: p<0.001); and P3 1.0 +Gz: p=0.158; 1.7 +Gz: 
p=0.698; and 2.4 +Gz: p=0.003; Figure 4.8). 
Rotational axis position comparison (RAP, Pn1 vs. Pn2): Post hoc analysis revealed 
ΔcTSI was no different at P1 compared to P2 (P1 vs. P2) during 1.0 +Gz (p=0.544) and 
1.7 +Gz (p=0.213) but significantly lower at 2.4 +Gz (p=0.011; Figure 4.8). Similarly, 
ΔcTSI was significantly lower at P2 compared to P3 (P2 vs. P3) during 1.0 +Gz 
(p=0.046) only and not 1.7 +Gz (p=780) or 2.4 +Gz (p=0.130; Figure 4.8). ΔcTSI at 
P1was significantly lower compared to P3 (P1 vs. P3) at the highest g-level only (2.4 
+Gz: -3.54 ± 0.50 vs. -0.96 ± 0.31 %, p<0.001; Figure 4.8). 
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Figure 4.8 Mean changes from baseline (BL) for near-infrared spectroscopy (NIRS) 
measured prefrontal cortex cerebral tissue saturation index (ΔcTSI) in the final minute 
(min 10) of short-arm human centrifugation (SAHC, 1.0 to 2.4 +Gz) at position 1 (P1, 
above the head), position 2 (P2, apex of head), and position 3 (P3, heart-level). 
  
Mean at each g-level (± SEM) calculated as a final minute (min 10) mean delta from final 
minute (min 10) mean of the baseline (BL) immediately before each respective centrifuge 
run. Black square, at position 1 (P1, above head); white square, at position 2 (P2, apex 
of head); and grey triangle, at position 3 (P3, heart-level). Baseline (*): * p < 0.05, ** p < 
0.01, *** < p <0.001. Position (#): # p < 0.05, ## p < 0.01, ### p < 0.001. n = 20. 
 
 
4.3.4 Attenuated cardiovascular response and duration 
Time (s) as a fixed effect was shown by the linear mixed effects model to be highly 
significant for changes from baseline (BL) in mean heart rate (ΔHR), mean stroke 
volume (ΔSV), and mean total peripheral resistance (ΔTPR) but not averaged mean 
arterial pressure (ΔMAP; Table 4.4A). 
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Specific baseline (BL) changes:  Post hoc analysis revealed ΔHR was significantly 
positive at P1 (above head) during all 2.4 +Gz 10 min short-arm human centrifugation 
(SAHC) compared to baseline (BL, min 0-10, p<0.05); as was ΔHR at position 3 (P3) 
but to a lesser extent (BL, min 0-10, p<0.05; Figure 4.9A). During ramp-down and 
recovery (RR: min 10-22), ΔHR at P1 was significantly negative compared to BL (min 
14-22: p<0.05), and unchanged from min 14-22 at P3 (0.081<p<0.978; Figure 4.9A)   
ΔMAP was significantly positive during min 1-5 of SAHC compared to baseline (BL, 
p<0.05); conversely, at P3 ΔMAP was significantly negative (min 0-10, p<0.05; Figure 
4.9B). During RR, ΔMAP at P1 was unchanged as was P3 compared to BL (min 14-22; 
Figure 4.9B).  
ΔSV was significantly negative at P1 during min 1-11 SAHC compared to baseline 
(BL, p<0.05) as was ΔSV at P3 but to a lesser extent (BL, min 0-11, p<0.05; Figure 
4.9C). During RR, ΔSV at P1 was unchanged apart for a significant increase at min 15 
compared to BL (p<0.05); however, at P3 ΔSV was completely unchanged (Figure 
4.9C). ΔTPR was significantly positive at P1 during min 0-8 SAHC compared to 
baseline (BL, p<0.05) as was ΔTPR at P3 at min -1, 1-10 (p<0.05; Figure 4.9D). During 
RR, ΔTPR at P1 was unchanged; however, min 13 at P3 was significantly negative 
compared to BL (Figure 4.9D).  
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Figure 4.9 Mean changes from baseline (BL) for cardiovascular measures during ten 
minutes short-arm human centrifugation (SAHC, 2.4 +Gz) with two minutes ramp-up and –
down; and recovery (RR, 10 min). 
 
 
  
A, changes from baseline (BL) in mean heart rate (ΔHR); B, changes from BL in 
averaged mean arterial pressure (ΔMAP); C, changes from BL in mean derived stroke 
volume (ΔSV); and D, changes from BL in mean derived total peripheral resistance 
(ΔTPR). 
 
Mean ± SEM is 60 s mean delta from final minute (min 10) mean of the baseline (BL) before 
each respective centrifuge run. Black square, at position 1 (P1, above head); grey triangle, at 
position 3 (P3, heart-level). Shaded areas: light grey, two minute centrifuge ramp-up and -down 
(min -2 to 0 and 10 to 12); dark grey, ten minutes centrifugation (SAHC: min 0-10); white, ten 
minutes recovery (RR: min 12-22). Baseline (*): * p < 0.05. Position (#): # p < 0.05. n = 20. 
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Rotational axis position comparison (RAP, Pn1 vs. Pn2): Post hoc analysis revealed ΔHR 
at P3 was significantly lower than P1 (P3 vs. P1) during 2.4 +Gz SAHC (min 0-11, 
p<0.05) and significantly higher during RR (min 14-17, p<0.05) with the greatest 
difference at min 6 (6 ± 1 vs. 47 ± 5 bpm, p<0.001; Figure 4.9A). Similarly, ΔMAP at 
P3 was significantly lower than P1 (P3vs. P1) during SAHC (min 0-9 and 10, p<0.05) 
with the greatest difference at min 4 (-4 ± 1 vs. 9 ± 3 mmHg, p<0.001); but no 
difference during RR (min 12-22: 0.233<p<0.973; Figure 4.9B). 
ΔSV at P3 was significantly higher than P1 (P3 vs. P1) during SAHC at min 0-11 
(p<0.05) with the greatest difference at min 7 (-18.6 ± 1.6 vs. -37.5 ± 3.6 mL, p<0.001; 
but no difference during RR (min 12-22: 0.135<p<0.978; Figure 4.9C). Conversely, 
ΔTPR at P3 was significantly lower than P1 (P3 vs. P1) only at the start of SAHC (min 
0-1: p<0.05) with the greatest difference at min 0 (25 ± 37 vs. 199 ± 59 dyn.s.cm-5, 
p=0.013; and no difference during RR (min 12-22: 0.154<p<0.888; Figure 4.9D). 
4.3.5 Reduced peripheral fluid displacement and duration 
Time (s) as a fixed effect was shown by the linear mixed effects model to be highly 
significant for changes from baseline (BL) in mean calf circumference (ΔCC; Table 
4.5). 
Specific baseline (BL) changes:  Post hoc analysis revealed ΔCC was significantly 
positive at P1 (above head) during min 3-12 of 2.4 +Gz short-arm human centrifugation 
(SAHC) compared to baseline (BL, p<0.05); similarly, at P3 ΔCC was significantly 
positive but to a lesser degree (min 0-12, p<0.05; Figure 4.10). During recovery (RR), 
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ΔCC at P1 remained significantly positive (min 12-21, p<0.05); however, at P3 
compared to BL there was no difference (min 14-22; Figure 4.10). 
Rotational axis position comparison (RAP, Pn1 vs. Pn2): ΔCC at P3 was significantly 
lower than P1 (P3 vs. P1) during SAHC (min 5-10, p<0.05) and also significantly lower 
during RR (min 12-21) with the greatest difference in the final minute of SAHC (min 
10: 2.9 ± 0.4 vs. 5.8 ± 0.4 mm, p<0.001; Figure 4.10). 
 
 
 
Figure 4.10 Mean changes from baseline (BL) for calf circumference (ΔCC) during ten 
minutes short-arm human centrifugation (SAHC, 2.4 +Gz) with two minutes ramp-up 
and -down; and recovery (RR, 10 min). 
  
Mean ± SEM is 60 s mean delta from final minute (min 10) mean of the baseline (BL) 
before each respective centrifuge run. Black square, at position 1 (P1, above head); grey 
triangle, at position 3 (P3, heart-level). Shaded areas: light grey, two minute centrifuge 
ramp-up and -down (min -2 to 0 and 10 to12); dark grey, ten minutes centrifugation 
(SAHC: min 0-10); white, ten minutes recovery (RR: min 12-22).  Baseline (*): * p < 0.05. 
Position (#): # p < 0.05. n = 20. 
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4.3.6 Ameliorated cerebral perfusion and time-course 
Time (s) as a fixed effect was shown by the linear mixed effects model to be highly 
significant for changes from baseline (BL) in prefrontal cortex cerebral tissue saturation 
index (ΔcTSI; Table 4.6). 
Specific baseline (BL) changes:  ΔcTSI was significantly negative at P1 (above head) 
during min 1-11 of 2.4 +Gz short-arm human centrifugation (SAHC) compared to 
baseline (BL, p<0.05); similarly, at P3 ΔcTSI was significantly negative but to a lesser 
degree (min 1-11, p<0.05; Figure 4.11). During recovery (RR), ΔcTSI at P1 was 
unchanged as was P3 compared to BL (min 12-22; Figure 4.11). 
Rotational axis position comparison (RAP, Pn1 vs. Pn2): ΔcTSI at P3 was significantly 
higher than P1 (P3 vs. P1) during SAHC (min 1-11, p<0.05) with the greatest difference 
at min 5 (-0.72 ± 0.38 vs. -3.61 ± 0.58 %, p<0.001; but no significant difference during 
RR (min 12-22; Figure 4.11). 
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Figure 4.11 Mean changes from baseline (BL) for near-infrared spectroscopy (NIRS) 
measured prefrontal cortex cerebral tissue saturation index (ΔcTSI) during ten 
minutes short-arm human centrifugation (SAHC, 2.4 +Gz) with two minutes ramp-up 
and -down; and recovery (RR, 10 min). 
  
Mean ± SEM is 60 s mean delta from final minute (min 10) mean of the baseline (BL) 
before each respective centrifuge run. Black square, at position 1 (P1, above head); grey 
triangle, at position 3 (P3, heart-level). Shaded areas: light grey, two minute centrifuge 
ramp-up and -down (min -2 to 0 and 10 to12); dark grey, ten minutes centrifugation 
(SAHC: min 0-10); white, ten minutes recovery (RR: min 12-22). Baseline (*): * p < 0.05. 
Position (#): # p < 0.05. n = 20. 
 
4.3.7 Individual responses to altered g-gradients 
Individual changes from baseline (BL) in heart rate (ΔHR) at 2.4 +Gz in position 1 
(P1, above head) show a majority of participants display large positive changes from 
BL with large interindividual variability (Figure 4.12A). Conversely, individual 
ΔHR at 2.4 +Gz in position 3 (P3, heart-level) shows a majority of participants 
display small positive changes from BL; with reduced interindividual variability 
(Figure 4.12B). 
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Figure 4.12 Individual participant changes from baseline (BL) for heart rate (ΔHR) during 
ten minutes short-arm human centrifugation (SAHC, 2.4 +Gz) with two minutes ramp-up 
and –down; and recovery (RR, 10 min). 
  
Individual mean at each data point is calculated as a 60 s mean delta from the final minute 
(min 10) mean of the baseline (BL) immediately before each respective centrifuge run. 
Shaded areas: light grey, two minute centrifuge ramp-up and -down (min -2 to 0 and 10 to 
12); dark grey, ten minutes centrifugation (SAHC: min 0 to 10); white, ten minutes 
recovery (RR: min 12 to 22); n = 20. 
 
Individual changes from baseline (BL) in calf circumference (ΔCC) at 2.4 +Gz in 
position 1 (P1, above head) shows a majority of participants display large positive 
changes from BL with large interindividual variability (Figure 4.13A). However, 
individual ΔCC at 2.4 +Gz in position 3 (P3, heart-level) shows a majority of 
participants display small positive changes from BL; with reduced interindividual 
variability (Figure 4.13B). 
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Figure 4.13 Individual participant changes from baseline (BL) for calf circumference 
(ΔCC) during ten minutes short-arm human centrifugation (SAHC, 2.4 +Gz) with two 
minutes ramp-up and –down; and recovery (RR, 10 min). 
  
Individual mean at each data point is calculated as a 60 s mean delta from the final 
minute (min 10) mean of the baseline (BL) immediately before each respective centrifuge 
run. Shaded areas: light grey, two minute centrifuge ramp-up and -down (min -2 to 0 
and 10 to 12); dark grey, ten minutes centrifugation (SAHC: min 0 to 10); white, ten 
minutes recovery (RR: min 12 to 22); n = 20. 
 
 
Individual changes from baseline (BL) in prefrontal cortex cerebral tissue saturation 
index (ΔcTSI) at 2.4 +Gz in position 1 (P1, above head) shows a majority of 
participants display large negative changes from BL with large interindividual 
variability (Figure 4.14A). Individual ΔcTSI at 2.4 +Gz in position 3 (P3, heart-level) 
shows a majority of participants display small negative changes from BL; with reduced 
interindividual variability (Figure 4.14A). 
 
 
 
Chapter Four  Short-arm human centrifugation 
- 167 - 
 
 
 
Figure 4.14 Individual participant changes from baseline (BL) for near-infrared spectroscopy 
(NIRS) measured prefrontal cortex cerebral tissue saturation index (ΔcTSI) during ten 
minutes short-arm human centrifugation (SAHC, 2.4 +Gz) with two minutes ramp-up and –
down; and recovery (RR, 10 min). 
  
Individual mean at each data point is calculated as a 60 s mean delta from the final minute 
(min 10) mean of the baseline (BL) immediately before each respective centrifuge run. 
Shaded areas: light grey, two minute centrifuge ramp-up and -down (min -2 to 0 and 10 to 
12); dark grey, ten minutes centrifugation (SAHC: min 0 to 10); white, ten minutes 
recovery (RR: min 12 to 22); n = 20. 
 
4.3.8 Gender variances in hemodynamic response 
Gender as a fixed effect was shown by the linear mixed effects model to not be 
significant for changes from baseline (BL) in mean heart rate (ΔHR), averaged mean 
arterial pressure (ΔMAP), mean stroke volume (ΔSV), mean total peripheral resistance 
(ΔTPR), or mean cerebral tissue saturation index (ΔcTSI); but highly significant in delta 
mean calf circumference (ΔCC; Table 4.7).                                                           .
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Table 4.7 Effects and their standard errors of hemodynamic variables as a result of time, and gender (fixed effects). 
  
Time, in seconds from the start of the centrifuge phase; 
gender, expressed as binary integer for male and female; 
 
cTSI, cerebral tissue saturation index; CC, calf circumference - strain gauge plethysmography; HR, heart rate; SV, stroke volume;  
TPR, total peripheral resistance; MAP, mean arterial pressure. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  (Intercept) Time (s) Gender (M/F) 
 n 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
Effect 
± SE 
F-value p-value 
ΔHR 
(bpm) 
20 
3.91 
± 5.04 
54.5 < 0.001 
0.011 
± 0.001 
255 < 0.001 
2.63 
± 2.36 
1.23 0.282 
ΔSV 
(mL) 
20 
-15.5 
± 4.4 
338 < 0.01 
-0.006 
± 0.001 
77.9 < 0.001 
-0.760 
± 2.068 
0.135 0.718 
ΔTPR 
(dyn.s.cm-5) 
20 
136.0 
± 90.9 
128 < 0.001 
-0.111 
±  0.014 
59.4 < 0.001 
36.5 
± 42.6 
0.734 0.404 
ΔMAP 
(mmHg) 
20 
-5.00 
± 3.01 
2.96 0.085 
-0.002 
± 0.000 
19.7 < 0.001 
2.45 
± 1.42 
3.00 0.102 
           
ΔCC 
(mm) 
20 
-1.60 
± 1.31 
37.5 < 0.001 
0.003 
± 0.000 
1112 < 0.001 
1.39 
± 0.66 
5.03 < 0.05 
ΔcTSI 
(%) 
20 
-1.58 
± 0.58 
20.1 < 0.001 
0.000 
± 0.000 
1.77 0.183 
0.422 
± 0.386 
1.17 0.295 
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4.3.8.1 Central hemodynamics 
Specific baseline (BL) changes:  Post hoc analysis revealed ΔHR was significantly 
positive in males at positions 1, 2, and 3 (P1-3) during 2.4 +Gz short-arm human 
centrifugation (SAHC) compared to baseline (BL; P1, P3, and P3, p<0.05-0.001); and 
also in females (P1-3: p<0.05-0.001; Figure 4.15A). However, ΔMAP was significantly 
positive in males only at position 1 during 2.4 +Gz SAHC compared to baseline (BL; 
P1, p=0.039; P2, p=0.193; and P3, p=0.147); but significantly negative in females only 
at P3 (P1, p=0.831; P2, p=0.997; and P3, p<0.001; Figure 4.15B). 
ΔSV was significantly positive in males at all positions during 2.4 +Gz SAHC 
compared to baseline (BL; P1, P3, and P3, p<0.05-0.001); and also in females (P1-3: 
p<0.05-0.001; Figure 4.15C). Similarly, ΔTPR was significantly positive in males at 
all positions during 2.4 +Gz SAHC compared to baseline (BL; P1-3, p<0.05); and also 
in females (P1-3: p<0.05-0.01; Figure 4.15D). 
Gender comparison (Male vs. Female): Post hoc analysis revealed ΔHR in males was 
no different than females (male vs. female) at all positions (P1: p=0.139; P2: p=0.222; 
and P3: p=0.215; Figure 4.15A). However, ΔMAP in males was significantly greater 
than females (male vs. female) at P1 (16 ± 2 vs. 1 ± 2 mmHg, p=0.020) and P3 (-2 ± 1 
vs. -5 ± 1 mmHg, p=0.045) but not P2 (p=0.314; Figure 4.15B). 
ΔSV in males was no different than females (male vs. female) at all positions (P1: 
p=0.071; P2: p=0.425; and P3: p=0.857; Figure 4.15C). Similarly, ΔTPR in males was 
no different than females (male vs. female) at all positions (P1: p=0.927; P2: p=0.906; 
and P3: p=0.928; Figure 4.15D). 
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Figure 4.15 Mean changes from baseline (BL) for cardiovascular measures in the final 
minute (min 10) of 2.4 +Gz short-arm human centrifugation (SAHC) at rotational axis 
position (RAP) 1 (P1, above the head), position 2 (P2, apex of head), and position 3 
(P3, heart-level) between males and females. 
  
A, changes from baseline (BL) in mean heart rate (ΔHR); B, changes from BL in 
averaged mean arterial pressure (ΔMAP); C, changes from BL in mean stroke 
volume (ΔSV); and D, changes from BL in mean derived total peripheral 
resistance (ΔTPR). 
 
Mean at each g-level (± SEM) is calculated as a final minute (min 10) mean delta from the final 
minute (min 10) mean of the baseline (BL) immediately before each respective centrifuge run. 
Black triangle, males; and white circle, females. Baseline (*): * p < 0.05, ** p < 0.01, *** p 
<0.001. Gender (#): # p < 0.05, ## p < 0.01, ### p < 0.001; n = 20 (10 male). 
 
 
Chapter Four  Short-arm human centrifugation 
- 171 - 
4.3.8.2 Peripheral fluid displacement 
Specific baseline (BL) changes:  Post hoc analysis revealed ΔCC was significantly 
positive in males at all positions during 2.4 +Gz SAHC compared to baseline (BL; P1-
3, p<0.01-0.001); and also in females (P1-3, p<0.05-0.001; Figure 4.16).  
Gender comparison (Male vs. Female): Post hoc analysis revealed ΔCC in males was 
significantly greater than females (male vs. female) at P3 (3.8 ± 0.4 vs. 2.2 ± 0.3 mm, 
p=0.027); with no difference at P1 (p=0.482) and P2 (p=0.105; Figure 4.16). 
 
 
 
 
Figure 4.16 Mean changes from baseline (BL) in calf circumference (ΔCC) in the final 
minute (min 10) of short-arm human centrifugation (SAHC, 1.0 to 2.4 +Gz) at 
rotational axis position (RAP) 1 (P1, above the head), position 2 (P2, apex of head), 
and position 3 (P3, heart-level) between males and females. 
  
Mean at each g-level (± SEM) is calculated as a final minute (min 10) mean delta from the final 
minute (min 10) mean of the baseline (BL) immediately before each respective centrifuge run. 
Black triangle, males; and white circle, females. Baseline (*): * p < 0.05, ** p < 0.01, *** p 
<0.001. Gender (#): # p < 0.05, ## p < 0.01, ### p < 0.001; n = 20 (10 male). 
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4.3.8.3 Cerebral perfusion 
Specific baseline (BL) changes:  Post hoc analysis ΔcTSI was significantly negative in 
males at all positions during 2.4 +Gz SAHC compared to baseline (BL; P1-3, p<0.05-
0.01); and also in females (P1-3: p<0.05; Figure 4.17).  
Gender comparison (Male vs. Female): Post hoc analysis ΔcTSI in males was no 
different than females (male vs. female) at all positions (P1: p=0.151; P2: p=0.730; and 
P3: p=0.902; Figure 4.17). 
 
 
 
 
Figure 4.17 Mean changes from baseline (BL) for near-infrared spectroscopy (NIRS) 
measured prefrontal cortex cerebral tissue saturation index (ΔcTSI) in the final minute 
(min 10) of short-arm human centrifugation (SAHC, 1.0 to 2.4 +Gz) at rotational axis 
position (RAP) 1 (P1, above the head), position 2 (P2, apex of head), and position 3 
(P3, heart-level) between males and females. 
  
Mean at each g-level (± SEM) is calculated as a final minute (min 10) mean delta from the final 
minute (min 10) mean of the baseline (BL) immediately before each respective centrifuge run. 
Black triangle, males; and white circle, females. Baseline (*): * p < 0.05, ** p < 0.01, *** p 
<0.001. Gender (#): # p < 0.05, ## p < 0.01, ### p < 0.001; n = 20 (10 male). 
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4.3.8.4 Presyncopal symptoms 
The proportion of male participants experiencing presyncopal symptoms (PSS+) 
compared to females was statistically no different at P1: χ2(1, n=10)=2.31, p=0.129;  
P2: χ2(1, n=10)=0.35, p=0.554; or P3: χ2(1, n=10)=NaN, p=1.000 across all g-levels 
(Figure 4.18). 
 
 
 
Figure 4.18 G-tolerance in each rotational axis position (RAP, P1-3) across all short-arm 
human centrifugation (SAHC) foot g-levels (1.0, 1.7 and 2.4 +Gz) in males and females. 
  
Male and female participants were exposed to nine centrifuge profiles giving rise 
to 90 separate centrifuge runs in each gender group, consisting of 30 in each 
position: P1, rotational axis position (RAP) above head; P2, RAP head apex; P3, 
RAP heart-level.  
 
Participants classified as having experienced presyncopal symptoms (PSS+, white) or not 
experiencing PSS (PSS-, black).  male: n = 10; female: n = 10. 
 
 
4.3.9 Increased overall g-tolerance 
The proportion of participants experiencing presyncopal symptoms (PSS+) was 
significantly higher at P1 compared to P3 across all g- levels: χ2(1, n=20)=8.57, 
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p=0.003; but not compared to P2: χ2(1, n=20)=3.08, p=0.079; or P2 vs. P3: χ2(1, 
n=20)=2.50, p=0.114 (Figure 4.19). 
 
 
 
Figure 4.19 G-tolerance in each rotational axis position (RAP, P1-3) across all short-arm 
human centrifugation (SAHC) foot g-levels (1.0, 1.7 and 2.4 +Gz) in all participants. 
  
All participants were exposed to nine centrifuge profiles giving rise to 180 
separate centrifuge runs, consisting of 60 in each position: P1, rotational axis 
position (RAP) above head; P2, RAP head apex; P3, RAP heart-level.  
 
Participants classified as having experienced presyncopal symptoms (PSS+, white) or 
not experiencing PSS (PSS-, black).  Chi-squared, * p < 0.05; n = 20. 
 
4.3.10 Unsupported cerebral perfusion 
The relationship between ΔHR and ΔCC, at increasing +Gz levels, shows a strong 
positive linear relationship unaffected by changing position (Figure 4.20A), 
conversely, the relationship between ΔcTSI and ΔCC, whilst unaffected by position, 
demonstrated a negative relationship but also unaffected by position changes 
demonstrated by an unchanging slope gradient in P1-3 (Figure 4.20B). 
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Figure 4.20 Relationship between mean changes from baseline (BL) in heart rate (Δ 
HR) and prefrontal cortex cerebral tissue saturation index (ΔcTSI) vs. calf circumference 
(Δ CC) during centrifugation at all g-levels (1.0-2.4 +Gz) and positions (P1-3). 
  
A, mean changes from baseline (BL) in heart rate (ΔHR) against calf 
circumference (ΔCC); B, mean changes from baseline (BL) in prefrontal cortex 
cerebral tissue saturation index (ΔcTSI) against ΔCC. 
 
Mean at each g-level and position (± SEM) is calculated as a final minute (min 10) mean 
delta from the final minute (min 10) mean of the baseline (BL) immediately before each 
respective centrifuge run. Black line: rotational axis position above head (P1); grey line: 
rotational axis position at apex of head (P2); dotted line: rotational axis position at heart-
level (P3); white circle: g-level 1.0 +Gz at feet (G1); light grey circle: g-level 1.7 +Gz at 
feet (G2); dark grey circle: g-level 2.4 +Gz at feet (G3). n = 20. 
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4.4 Discussion 
The purpose of this study was to investigate the effect of induced g-gradients, across the 
body during short-arm centrifugation, upon cardiovascular regulation and orthostatic 
tolerance. Specifically, we aimed: (i) to determine physiological differences, in response 
to g-gradients, by measuring cerebral tissue oxygenation, peripheral fluid displacement, 
systemic cardiovascular responses and the emergence of presyncopal symptoms (PSS); 
and (ii) provide a better insight for future artificial gravity (AG) research by 
characterising a third variable of human centrifugation studies; namely g-gradient in 
addition to duration and magnitude of exposure. All participants included in analysis 
were able to tolerate the three g-gradients (P1-P3) at 2.4 +Gz with none experiencing 
any neurovestibular disturbances leading to motion sickness. 
We observed that shifting the centre of centrifugal force to heart-level helped maintain 
cerebral perfusion, as estimated by cNIRS, whilst attenuating the increase in HR and 
occurrence of PSS. In general, this research provides strong evidence of the significant 
effect increasing g-gradient, by moving rotational axis position (RAP) towards the 
body, has on reducing cardiovascular response and increasing overall g-tolerance. To 
our knowledge, this is the first study to: (i) investigate the cardiovascular and cerebral 
responses to an altered g-gradient during short-arm human centrifugation (SAHC); and 
(ii) place the centre of rotation within the body whilst measuring cardiovascular and 
cerebral responses in addition to indicators of g-tolerance (i.e. PSS). 
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4.4.1 G-level response 
Significant main effects of increasing levels of +Gz were revealed in the present study. 
Specifically, increases in heart rate (ΔHR), total peripheral resistance (ΔTPR), mean 
arterial pressure (ΔMAP), as well as calf circumference (ΔCC) were observed in 
agreement with previous research (Goswami et al., 2015a). Conversely, stroke volume 
(ΔSV) and prefrontal cortex cerebral tissue saturation index (ΔcTSI) were significantly 
lower with increasing +Gz, which was also in agreement with recent studies (Iwasaki et 
al., 2012; Smith et al., 2013). The time-course response of ΔCC (slow) and ΔHR (fast) 
differed greatly; suggesting the baroreceptor response to the future central hypovolemia 
were occurring through central pathways subserving feed‐forward or ‘central command’ 
responses (Dampney et al., 2002). 
At the highest g-level (2.4 +Gz), ΔCC was unchanged by position in the initial stages up 
until minute five (Figure 4.10), whilst ΔcTSI was significantly lower in P1 than P3 
from the first minute onwards (Figure 4.11). Thus, cerebral perfusion was attenuated 
earlier in the centrifuge run than ΔCC, presumably due to a varied peripheral  vascular 
response  to  early orthostatic  stimulation (Watenpaugh et al., 2004).  By the last 
minute, a concurrent ΔCC increase with ΔcTSI decrease was observed providing 
evidence of a simple measure of peripheral fluid shifts having utility as a proxy of 
cerebral hemodynamics during SAHC. 
4.4.2 Attenuated fluid displacement 
Based on previous research, a strong consequential systemic response to calf pooling, 
and thus decreased cardiac return (pre-load), filling pressure, and increased HR, was 
expected (Rowell et al., 1996). In the present study, and in agreement, a robust strong 
Chapter Four  Short-arm human centrifugation 
- 178 - 
relationship between peripheral displacement (ΔCC) and systemic response (ΔHR), was 
observed. Research has demonstrated that deep veins of the lower extremities can hold 
large volumes of blood (Gunga et al., 2016); however, it remains unclear how this 
anatomy affects calf circumference to sequential filling. Nevertheless, the unaffected 
association between ΔCC and ΔHR suggests that peripheral displacement was 
quantified in its entirety by calf circumference; and not sequestered elsewhere, during 
orthostatic challenge, such as the splanchnic circulation. A comparable relationship was 
presented by Hachiya et al., (2010) during LBNP; however, modulation of splanchnic 
region constriction led to differences in tolerance (‘right-ward shift’) and intolerance 
(‘left-ward shift’) of HR responses when compared to CC (Figure 4.20).  
Previous research has shown the importance of splanchnic region vasoconstriction in 
response to an orthostatic challenge (Hinghofer-Szalkay et al., 2008); and the buffering 
role of splanchnic vascular beds to fluid shifts has been demonstrated (Blaber et al., 
2013a). However, in the present study a strong relationship between ΔCC and ΔHR was 
observed that was unaffected by g-level or g-gradient. This apparent contradiction to the 
published literature indicates the splanchnic region may have less of an effect, on 
hemodynamic response to SAHC, than anticipated. Furthermore, ΔCC may be a 
reasonable surrogate measure of central hypovolemia during SAHC and current data 
indicates support for a simplistic two compartment model of fluid shifts.  
4.4.3 Unsupported cerebral tissue oxygenation 
It was hypothesized that cerebral perfusion would be supported to a greater extent at P3 
than P2 and P1 with a smaller reduction in cTSI for a given increase in CC; however, 
this was not the case in the present study. One possible explanation is that increased 
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arterial headward pressure results in venous congestion (Davis et al., 2008), thereby 
limiting cerebral blood flow and hence cerebral oxygenation. Further work is required 
to confirm this and to determine the relationship between cerebral venous drainage (e.g. 
jugular vein congestion) and cerebral hemodynamics. 
Additionally, attention must be brought to the limitations of the NIRS measurement. 
This method requires accurate measurement of rapid changes in arterial O2Hb 
concentrations by a NIR spectrometer; with limitations of this monitor contributing to 
errors in measurement of perfusion and the calculated TSI (Elwell et al., 1992). 
Measured changes in O2Hb concentration do not differentiate between arterial inflow 
and venous outflow and there is an assumption of a steady-state in O2 consumption of 
the cerebral tissue being measured (Pellicer & del Carmen Bravo, 2011). 
Reproducibility of measured results is highly dependent on placement of the light 
probes; with pictures taken between measurements on different days and placement of 
the probe on one day unmoved to mitigate against this. An index of perfusion (TSI) was 
used to measure changes experienced over a given period as opposed to absolute values. 
The classical view of cerebral autoregulation is that for a MAP between 50-150 mmHg 
CBF is maintained (Lassen, 1959); however, the measured responses in relation to MAP 
and TSI do not line up with this. Willie et al. (2014) stated that CBF control is more 
complex and multifactorial than the parochial cerebral autoregulation model. Results 
from the current research seem to suggest other factors for TSI change should be 
considered, such as: i) potential increased/decreased arterial CO2 (PaCO2) levels, which 
have been shown to increase/decrease CBF, respectively (Ide et al., 2003; Battisti‐
Charbonney et al., 2011); ii) the role of the sympathetic nervous system (SNS), where 
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research has shown extensive sympathetic activation of the larger cerebral arteries is 
especially important in providing sufficient buffering to large transient increases in 
cerebral perfusion pressure (Cassaglia et al., 2008a, b; Ainslie, 2009; Tzeng et al., 
2010). Whilst not directly measured/addressed in this study; future research would 
benefit from considering these additional factors. 
4.4.4 Gravitational tolerance 
The ‘total gravitational exposure’ across the body changes with rotational position 
despite a comparable +Gz level at the feet. It is known that the hydrostatic gradient is of 
great importance in determining an orthostatic challenge, particularly during a passive 
stress (Hinghofer-Szalkay, 2011). Thus, resultant modification of aortic and carotid 
baroreceptor feedback may explain similar cardiovascular responses at P3 and P1, 
during a high and low +Gz level, respectively. Similarly, research by Hallgren et al. 
(2016) demonstrating reduced otolith system input on an increased OI occurrence in 
returning astronauts can be compared to the differential inputs to the otolith organs 
expected at both P3 and P1 in the current study. Collectively, P3 has been shown to 
reduce the overall orthostatic challenge through a significantly reduced proportion of 
participants exhibiting PSS+ to those not (PSS-). Thus, the g-gradient of P3 was shown 
to increase g-tolerance despite g-level at the feet remaining the same (2.4 +Gz) for a set 
duration of ten minutes. 
Significant attenuations in cerebral perfusion, central hypovolemia and systemic 
cardiovascular response occurred at P3, the most prominent of which was ΔHR. 
Interestingly, it has been postulated that the hydrostatic gradient between the carotid and 
aortic baroreceptors is a potent determinant of HR responses to orthostatic challenge 
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(Ferguson et al., 1985). At P3 in the present study the hydrostatic gradient was reversed, 
suggesting (in isolation) that bradycardia should ensue. However, ΔHR at P3 
represented a ‘dampened’ increase, likely due to the removal of central blood volume 
having an opposing effect on ΔHR. Whilst not explored in the present study, this 
working hypothesis could be tested by prevention of the fluid shift during centrifugation 
via use of anti-g trousers. 
Large inter-individual differences were present during 2.4 +Gz in ΔHR, ΔCC, and 
ΔcTSI; with the greatest deviation between participants during SAHC at P1. A large 
variation in HR response and the mechanisms involved during an orthostatic stress have 
been implicated in reduced tolerance to LBNP (Convertino et al., 2012), and SAHC 
(Goswami et al., 2015a). Hachiya et al. (2012) suggested reduced tolerance in woman 
was due to a diminished sympathetic outflow to the periphery; with men demonstrating 
comparatively less calf blood pooling. In addition, Goswami et al. (2015b) 
demonstrated the benefits of individualised centrifuge training which supports the idea 
of a large range of responses between individuals. It is postulated that participants who 
exhibit a faster HR response, in which the peak was achieved sooner, reached their so-
called ‘orthostatic challenge capacity’ earlier on and placed them at a greater risk of 
hemodynamic collapse (Stewart, 2013). In general, it is postulated that centrifuge 
training improves orthostatic tolerance through a combination of decreased vascular 
resistance and enhanced cardiac function (Evans et al., 2004; Stenger et al., 2007). 
Several studies have explored gender inconsistencies of systemic response, with various 
explanations offered as the reason for and observed reduced orthostatic tolerance in 
women. Shoemaker et al. (2001) postulated gender differences could be explained by a 
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reduced sympathetic outflow to the peripheral vasculature in women causing a reduced 
tolerance. Additionally, a reduction in circulating norepinephrine (NE) was shown 
during an orthostatic challenge when comparing men to women (Convertino, 1998). 
There is also pharmacological evidence to suggest that women display a greater 
responsiveness to cardiac β-adrenoceptors (Convertino, 1998; Phillips, 2010) and this 
may be a contributory factor. Differences in the elevation of HR are obviously not 
enough to predict orthostatic tolerance and it has been suggested that women also 
display a lower venous return and cardiac filling compared to males (Fu et al., 2004). 
However, significant gender differences during SAHC in ΔHR, ΔMAP, ΔSV, ΔTPR, 
and ΔcTSI were not observed in the present study. Only ΔCC was significantly greater 
in men. The difference in ΔCC between genders is likely explained by anthropometric 
differences where a larger mean muscle mass in men is capable of greater fluid 
displacement than a smaller one. Furthermore, Russomano et al. (2015) postulated 
increased lower-limb venous compliance amongst females was a contributory factor in 
gender-dependant tolerance. Nevertheless, significant differences in peripheral fluid 
shift between genders had no significant effect on systemic and cerebral hemodynamics 
in the current cohort. These findings seemingly contradict the literature which suggest 
fundamental differences in cardiovascular response to an orthostatic challenge between 
men and women (Montgomery et al., 1977; Frey & Hoffler, 1988; White et al., 1996; 
Convertino, 1998; Fong et al., 2007); and that any observed differences to LBNP were 
not due to anthropometric variations (Lawler et al., 1998). However, it is postulated that 
significant alterations to the g-gradient may explain previously reported differences 
observed during SAHC. Changing the RAP whilst maintaining the g-level at the feet 
was shown to have a significant effect on systemic, peripheral and cerebral 
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hemodynamics. Past SAHC research reporting g-level at the heart (Iwase, 2005; 
Goswami et al., 2015b) neglects to report the RAP meaning g-level at the feet will 
differ greatly between participants.  
It is believed a paradigm shift in what constitutes the magnitude of g-level, during 
SAHC, is required. Current research outlines the significance of distance from the 
centre of rotation on hemodynamic response. Furthermore, it is suggested that total 
gravitational exposure across the body is a better determinant of orthostatic challenge to 
SAHC than magnitude of g-level at a specific point. Therefore, it seems reasonable to 
assume men and women, typically of differing average heights, would therefore actually 
experience a different magnitude of exposure to the currently standardized g-level. It is 
postulated that past observations of gender based differences to SAHC exposure may 
arise due to anthropometric differences (specifically height) currently not taken into 
account during experimental design. Thus, it is suggested that differences in 
hemodynamic response arise as a result of insufficient SAHC standardisation, instead of 
gender. There was no significant height difference or cardiovascular response between 
genders in the present study; however, further research is required to explore this 
specific hypothesis. 
4.4.5 Future application 
A key theme in SAHC research is ensuring any “cure is not worse than the disease” 
(Aubert et al., 2016); and with this consideration the present research outlines a 
promising case for SAHC as a future spaceflight countermeasure. It was found that, for 
the same +Gz level delivered to the feet of participants, an increased g-tolerance could 
be achieved. Thus, the significance of this observation means an associated high 
Chapter Four  Short-arm human centrifugation 
- 184 - 
stimulus, to the muscle and bones of the legs, can be delivered without the risk of 
syncope. Research has shown that the higher the g-level delivered the greater the 
potential ‘training benefit’ consisting of an enhanced cardiac function and reduced 
vascular resistance (Evans et al., 2004). Therefore, if this experimental paradigm was 
combined with exercise a higher g-level could be administered and a greater potential 
benefit to the musculoskeletal system could be achieved. Future direction for this 
research could explore the same hemodynamic parameters but, instead of passive 
SAHC, with the addition cycle ergometry or sliding plate squats. Several SAHCs 
around the world now have the ability to exercise during exposure, including resistive 
exercise, supine squats (Frett et al., 2014) and self-powered cycling (Diaz et al., 2015). 
SAHC at P3 has been shown to be a reduced orthostatic challenge, in relation to 
attenuated hemodynamic response, despite the foot g-level remaining unaltered. 
However, the physiological training value of this potential countermeasure must be 
tested on its ability to maintain cardiovascular function in the face of unloading; and 
determine if any benefit, through orthostatic intolerance (OI) reduction, can be 
achieved. 
4.4.6 Conclusion 
Our results suggest that rotational axis position, and thus g-gradient warrants further 
investigation.  Currently, magnitude of centrifugation as an index of g-stress is 
commonly quantified by +Gz level experienced at a specific point (i.e. the feet or heart) 
for a specific period (Caiozzo et al., 2004; Smith et al., 2013; Diaz et al., 2015). 
However, in addition to g-level magnitude and duration (Clément & Bukley, 2007), we 
present physiological data demonstrating g-gradient as an important third factor. 
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Standardisation of short- and long-arm centrifugation studies would benefit from the 
above findings in order for physiological data to be comparable. Furthermore, the 
unique and quantifiable orthostatic challenge, presented by a changing gravitational 
gradient, could be used to better explore and understand the interrelationship between 
carotid and aortic baroreceptor control. 
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5 LOWER-BODY NEGATIVE PRESSURE EFFECTS ON 
PERIPHERAL AND CEREBRAL HEMODYMANICS 
DURING HEAD-DOWN TILT INDUCED JUGULAR 
VENOUS CONGESTION 
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5.1 Introduction 
Current spaceflight countermeasure regimes targeting the negative physiological effects 
of unloading are now relatively effective in maintaining muscle mass (Akima et al., 
2000; Mulder et al., 2006) and bone density (Leblanc et al., 2013) within healthy levels. 
Increased intensity, nutritional supplementation, and pharmacological interventions are 
all additional methods in which countermeasure regime effectiveness has been 
improved (Hargens et al., 2013). Thus, potentially decreasing the need to schedule up to 
2 hours exercise a day (Clément, 2011), freeing up crew time without any negative 
physiological consequence. However, potentially mission critical deleterious effects are 
still observed despite substantial crew time devoted to preserving physiological 
function. Specifically, the increased incidence of orthostatic intolerance (OI) on return 
(Buckey Jr et al., 1996; Blaber et al., 2011) and the emergence of Visual impairment 
and intracranial pressure (VIIP) syndrome (Polk, 2009); which has been termed the first 
true ‘space sickness’ (Michael & Marshall-Bowman, 2015). 
Cycling (Cycle Ergometer with Vibration Isolation and Stabilization, CEVIS), running 
(Combined Operational Load Bearing External Resistance Treadmill, COLBERT), and 
resistive exercise (Advanced Resistive Exercise Device, ARED) form the core hardware 
for astronaut exercise regimes on board the International Space Station (ISS) (Clément, 
2011). These countermeasures individually act to maintain the load-bearing muscle size, 
aerobic capacity, and other specific muscles through resistive training. Collectively they 
are termed specific countermeasures, which act on singular body systems, in contrast to 
a holistic approach acting on multiple. Crucially, current countermeasures provide the 
reintroduction of a force, absent in weightlessness, whilst failing to directly counteract 
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increased cephalic volume. It is postulated that a present failure to reverse headward 
fluid shifts in space is leading to the high incidence of VIIP (Wiener, 2012). It is also 
postulated that intermittent exercise, coupled with inadvertent transient peripheral fluid 
shifts, may exacerbate the problem by daily preventing a ‘long-term protective’ 
adaptation. Thus, increased exercise intensity may ameliorate muscle and bone loss but 
to the detriment of visual acuity. It has also been suggested that high levels of resistive 
exercise, specifically using ARED (Figure 5.1), may exacerbate VIIP (Fogarty et al., 
2011); however, the precise contributory role remains unclear. 
 
 
Figure 5.1 NASA's Advanced Resistive Exercise Device (ARED) for the 
International Space Station (ISS). Adapted from NASA. 
  
ARED uses vacuum cylinders to simulate free weights for resistive 
exercise to maintain muscle and bone strength while in space. 
 
 
 
Since humans first went into space in 1961 there have been just under 600 astronauts 
exposed to the harsh conditions of spaceflight (NASA, 2017). Over the past 50 years, 
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ample evidence has been obtained, and knowledge gained, to the precise physiological 
effects of weightlessness. At the birth of human spaceflight it was clear, early on, that 
unloading had a significant effect on the body. However, relatively new observations of 
deleterious adaptations have been made, such as the discovery of VIIP syndrome within 
the last 10 years (Polk, 2009; Mader et al., 2011). Access to human spaceflight data 
remains limited, as do the types of experiment that can be performed due to 
technological restrictions. However, some mechanisms involved in spaceflight effects 
can be replicated on Earth to increase the number of observations and data collected. 
Specifically, spaceflight analogues can be used to gain a better understanding, of human 
physiology in microgravity, without ever leaving the Earth’s surface. 
5.1.1 Spaceflight analogues 
Ground based studies, such as head-down bed rest (HDBR), are a useful tool for 
exploring physiological deconditioning and in particular muscle atrophy, bone loss, and 
reduced baroreceptor function among others (Pavy-Le Traon et al., 2007). However, 
past spaceflight analogue research has been unable to experimentally replicate clinically 
significant vision problems, experienced by astronauts in space, here on Earth (Taibbi et 
al., 2013) (Table 1.1). Previous bed rest studies use a standardized methodology 
(Sundblad & Orlov, 2015) in order to recreate the unloading and headward fluid shifts 
seen in weightlessness. A precise head-down tilt (HDT) angle of -6° is commonly used 
in an attempt to replicate spaceflight fluid shifts and a lack of gravitational force along 
the main column of blood (Kakurin et al., 1976). Hydrostatic forces can be estimated 
through calculations; however, a precise comparable force in HDBR is unachievable 
due the persistence of a hydrostatic gradient (Figure 5.2B). 
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Figure 5.2 Hydrostatic pressure gradients standing on Earth, during head-down bed 
rest (HDBR), and weightlessness. Adapted from Gradwell and Rainford (2016). 
 
  
A, standing on Earth; B, head-down bed rest (HDBR) spaceflight analogue; 
and C, initial weightlessness. 
 
CVP, central venous pressure. Mean arterial pressures (MAP) expressed in mmHg.  
 
 
Wiener (2012) suggested internal jugular vein (IJV) compression, leading to venous 
congestion, as a contributing factor in spaceflight induced VIIP. An absence of 
congestion during -6° HDT bed rest supports this hypothesis where it is likely not 
enough fluid is displaced. It is postulated that fluid shifted from the periphery toward 
the head at -6° does not reach a threshold in which venous congestion occurs on Earth. 
HDBR at greater angles of HDT is likely required to elicit a fluid shift inducing venous 
congestion comparable to that observed during spaceflight. The precise reason for this 
discrepancy remains unclear; however, a better understanding of the role venous 
congestion during HDT may prove beneficial to elucidating the unknown mechanisms 
involved in VIIP. 
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5.1.2 Fluid displacement 
A significant cephalic fluid shift in space brings about a multitude of responses 
immediately upon entering microgravity. Specifically, astronauts experience a feeling of 
facial fullness as a result of “chicken legs” and a “puffy face” (Aubert et al., 2016). 
Paradoxically, central venous pressure (CVP) in weightlessness, during the immediate 
short-term, has been shown to actually decrease despite concurrent atrial diameter 
increases (Buckey et al., 1996a). However, measurements of interpleural pressure 
during parabolic flight demonstrated greater decreases than CVP. Thus, suggesting 
transmural CVP increased during short periods of microgravity (Videbaek & Norsk, 
1997). Cardiovascular adaptations to microgravity occur readily within the first few 
weeks, the most prominent of which is a significant reduction in circulating blood 
volume (Johnston & Dietlein, 1977). During spaceflight, hemodynamic functional 
adaptation was thought to reach a steady state within a few days and remain broadly and 
clinically insignificant thereafter (Charles & Lathers, 1991); however, the emergence of 
VIIP (Mader et al., 2011) and high incidence of OI in returning astronauts (Buckey Jr et 
al., 1996; Blaber et al., 2011) seem to suggest otherwise. 
Previous research has demonstrated the ability of periodically shifting fluid to the 
periphery at improving orthostatic tolerance (Goswami et al., 2015b). However, the 
degree to which this can improve physiological function in space, and specifically 
ameliorate against VIIP, is still to be elucidated. LBNP as a spaceflight countermeasure 
(Figure 5.3) is currently being investigated on board the International Space Station 
(ISS), in an experiment called ‘Fluid Shifts’ (Stenger et al., 2016). 
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Figure 5.3 Lower-body negative pressure (LBNP) device, also called the Chibis, on 
board the International Space Station (ISS). Adapted from Roscosmos. 
  
Russian Cosmonaut Yuri Malenchenko wears the Chibis device. 
 
 
 
This experiment aims to explore the precise role of fluid redistribution, measured using 
tracer dilution techniques (deuterium oxide, 2H2O; and sodium bromide, NaBr); and 
ultrasound quantified venous congestion, on the emergence of VIIP. Pre-, flight-, and 
post-data collection, over three 6-month missions, is ongoing with the last results 
expected in September 2017 (Stenger et al., 2016). Similarly, investigating the 
association of fluid displacement, from the peripheral to central compartments, with 
indicators of jugular venous congestion has not been systematically tested on Earth.  
Nevertheless, a spaceflight analogue experiment exploring the association between 
venous congestion and immediate peripheral fluids may provide an insight into the 
causal mechanisms of VIIP. The cephalic fluid shift experienced in spaceflight (and also 
with HDT) is opposable by LBNP (Baisch & Petrat, 1993); furthermore, it is likely that 
great angles of HDT would be proportional to an opposite relocation of fluid with 
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increasing LBNP values. Similar findings were observed by Hinghofer-Szalkay et al. 
(2004) where the ability of LBNP to neutralize the cardiovascular effects of HDT were 
demonstrated. Specifically, LBNP levels of -15 to -35 mmHg were shown to correlate 
to HDT angles of -6 to -24° in heart rate (HR), specific volume regulating hormone 
aldosterone, and fluid displacement measured by thoracic impedance (Hinghofer-
Szalkay et al., 2004). 
5.1.3 Venous congestion 
Significant increases in cross-sectional area (CSA) of the internal jugular vein (IJV) 
during spaceflight are typical and have been observed in all astronauts, without 
exception, when measured (Grigoriev et al., 2011) (Figure 1.4). Increased IJV-CSA 
occurs as a consequence of the cephalic fluid shift and provides evidence of venous 
congestion; however, the effect this has on cerebral hemodynamics is less clear. 
It is postulated that the emergence of cerebral venous congestion, to headward fluid 
shift increases, is likely dependent on individual IJV anatomy. Large differences 
between right and left IJV-CSA have been observed with the maximal right IJV-CSA 
greater than the left (Lichtenstein et al., 2001) and also larger in males (Maratea et al., 
2013). Interestingly, research has shown the incidence of VIIP in men to be around 70% 
and only 40% in females predominantly in the right eye of both genders (Marshall-
Bowman et al., 2013). Female IJV-CSA is smaller than males under the same condition 
but most probably not disproportionately, and also more variable in size (Maratea et al., 
2013). However, greater vascular compliance and higher plasma volume loss have been 
measured in females (Waters et al., 2002; Fu et al., 2004) and may explain the potential 
gender variances observed in VIIP. 
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Asymmetric IJV anatomy and variances in magnitude of peripheral displacement further 
support the idea of venous congestion as a primary contributing factor to VIIP and key 
target for any future therapeutic countermeasure. However, whether manipulation of 
venous congestion has any effect on cerebral hemodynamics remains to be seen. 
Headward fluid shifts, such as those occurring during HDT and weightlessness, cause a 
reduced outflow of blood from the head (Gisolf et al., 2005); in space this has been 
hypothesised to set off a cascade phenomenon termed space obstructive syndrome 
(SOS) (Wiener, 2012). 
Venous and arterial pressures vary greatly across the body and with postural changes 
(Figure 1.10). In order for a spaceflight analogue to be useful, with respect to simulating 
spaceflight venous congestion, similar pressures across the body must be recreated. In 
theory, comparable venous and arterial pressures across the body can be created during 
HDT. However, the remaining gravitational vector during HDT on Earth is in contrast 
to the complete absence of a hydrostatic gradient in weightlessness. Nevertheless, 
during HDT various levels of IJV distension occur and it is postulated, with a sufficient 
angle of tilt, spaceflight venous congestion can be simulated. 
Headward venous and arterial pressure increases occur as a result of HDT leading to a 
reversal of the standing hydrostatic pressure gradient. However, the angle of tilt in 
which sufficient fluid is displaced, leading to the emergence of venous congestion 
remains unknown. The inability of -6° HDBR to replicate the symptoms of spaceflight 
VIIP (Pavy-Le Traon et al., 2007) could indicate hydrostatic pressures are insufficiently 
recreated at this level; and provide evidence of the role fluid shifts may play in VIIP. It 
is postulated an increase in angle of HDT would replicate comparable pressure changes 
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and emergence of vision problems in the long-term. The precise angle at which venous 
congestion can be induced by peripheral fluid shifts is unknown; and how this is 
associated to cerebral hemodynamics remains unclear. 
5.1.4 Aims 
The aim of this study was to assess the effect of lower-body negative pressure (LBNP at 
-40 mmHg) on jugular venous congestion induced by angles of tilt from +12° head-up 
tilt (HUT), 0° supine, to -6°, -12°, -18°, and -24° head-down tilt (HDT). Specifically, to 
differentiate the effects of arterial and venous pressure increases in the neck upon 
cerebral autoregulation and tissue oxygenation. It is known HDT elicits a cephalic fluid 
shift opposable by LBNP; however, the effect this has on venous congestion and 
cerebral hemodynamics has yet to be fully elucidated. 
Changes in systemic (heart rate, HR; and mean arterial pressure, MAP) and peripheral 
(calf circumference, CC; and calf muscle tissue oxygenation, mTSI) measurements, to 
increasing angles of tilt, were compared with values at baseline (BL). Additionally, 
venous congestion was assessed through measurements of the internal jugular vein 
cross-sectional area (CSA) with (-40 mmHg) and without (0 mmHg) LBNP; and 
changes from BL in cerebral hemodynamics (cerebral oxygenation, cTSI; and blood 
flow velocity, cBFV), under all conditions, determined. 
5.1.5 Hypothesis 
It was hypothesised that venous congestion induced by HDT, and measurable by an 
increased jugular vein CSA, would be abolished by the addition of LBNP. Secondly, the 
specific HDT angle, with the emergence of congestion, would be greater than the 
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currently accepted spaceflight analogue of -6°. Thirdly, the LBNP level required for 
venous congestion removal would be tilt-dependent and consisting of a suitable 
pressure/tilt match. Specifically, an unmatched LBNP and tilt, either too great or too 
small, would be detrimental to appropriate cerebral blood flow. 
5.2 Methods 
5.2.1 Study design and participants 
Sixteen (8 male) healthy normotensive, non-smoking participants (Table 5.1) gave 
written informed consent to participate in the study that conformed to the declaration of 
Helsinki and was approved by the Ethics Committee of the North Rhine Medical 
Association in Düsseldorf, Germany. 
Before being enrolled into the study, all participants underwent medical screening 
which consisted of: clinical-chemical blood analysis described in detail in section 
2.6.1.1. Further analysis included: urine (glucose, protein, urobilinogen, drugs); resting 
electrocardiogram (ECG); adapted Bruce Protocol with cycle ergometry to verify 
appropriate aerobic fitness (for age and gender) and cardiac function (Bruce et al., 
1963); a stand test to assess orthostatic tolerance; and, a complete medical history. Prior 
to testing each participant was familiarized with all aspects of the study, including the 
methodology, personnel involved and the electronic tilt-table and lower-body negative 
(LBNP) chamber (Figure 5.4A). 
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 Table 5.1 Individual participant data. 
  
Age on first experimental day; height and weight measured immediately 
before centrifuge run. 
 
 
 
 
            
 
 
  Sex Age (yrs) Height (m) Weight (kg) 
BMI 
(kg/m2)  
  
 
P01 M 23.6 1.73 69 23.1 
 
 
P02 M 37.0 1.86 80 23.1 
 
 
P03 F 27.6 1.71 64 21.9 
 
 
P04 F 21.6 1.70 61 21.1 
 
 
P05 M 27.4 1.84 87 25.7 
 
 
P06 M 27.2 1.85 75 21.9 
 
 
P07 M 26.6 1.96 100 26.0 
 
 
P08 F 27.5 1.60 58 22.7 
 
 
P09 F 30.5 1.61 51 19.7 
 
 
P10 F 24.7 1.65 54 19.8 
 
 
P11 F 22.9 1.64 70 26.0 
 
 
P12 F 21.2 1.70 60 20.8 
 
 
P13 F 27.6 1.70 62 21.5 
 
 
P14 M 25.2 1.76 68 22.0 
 
 
P15 M 27.0 1.72 73 24.7 
 
 
P16 M 28.5 1.75 72 23.5 
 
 
Mean  
± SD 
- 26.6 ± 3.8 1.74 ± 0.10 69 ± 13 22.7 ± 2.1  
  
        
 
 
5.2.2 Experimental protocol 
Participants underwent 5 min tilt-table testing (+12 to -24°) without and with lower-
body negative pressure (-40 mmHg; TILT+LBNP) during the experiment with rest 
phases of at least 10 min between the twelve runs in the session (Figure 5.5). Each 
participant was tested either in the morning (0900-1200) or afternoon (1300-1600). 
Prior to experimentation participants were instructed to eat a light breakfast, or lunch 1 
h before and, in the preceding 24 h period, consume no alcohol or caffeine. Participants 
were asked to remain silent and completely still throughout TILT±LBNP unless 
experiencing discomfort. 
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Each tilt was performed at one of six angles, including +12° head-up tilt (HUT), supine 
(0°), and head-down tilt (HDT) in -6° increments from -6 to -24° (Figure 5.4B). 
Participants were not strapped in but the LBNP seal around the iliac crest provided 
sufficient stability as did the rubberised table during tilt. 
 
 
Figure 5.4 Experimental overview. 
  
A, electronic tilt-table with lower-body negative pressure (LBNP) chamber (at 
DLR, Cologne, Germany); B, six angles of tilt (+12 to -24°) without and with -
40 mmHg lower-body negative pressure (±LBNP).  
 
Grey shaded area, area of -40 mmHg +LBNP application. 
 
 
Each experimental day consisted of twelve tilt profiles (Figure 5.5A), randomly 
assigned with an online randomizer (random.org, 2016). Each tilt profile was split into 
five phases (Figure 5.5B) with a standardised onset and offset time (60 s) irrespective of 
tilt angle or ±LBNP. 
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Figure 5.5 Protocol duration with constituent tilt / pressure phases. 
  
A, protocol consisting of twelve randomised tilt / pressure profiles (17 min 
each), with no less than 10 min rest between them, thus constituting a 
protocol of 3 h 24 min; B, single profile over 17 min consisting of five phases: 
baseline, start tilt (onset), tilt / pressure, stop tilt (offset), and recovery. 
 
 
5.2.2.1 Systemic cardiovascular measurements 
Continuous beat-by-beat heart rate (HR) via a standard 3-lead electrocardiogram (ECG; 
Biopac Systems, Goleta, CA, USA) and mean arterial finger blood pressure (MAP) 
were recorded with a Finometer (Finapres Medical Systems, Amsterdam, The 
Netherlands). The Finometer finger cuff was placed around the third finger of the left 
hand (Figure 5.6B) and continuous calibration adjustments at each angle of tilt made 
using a height correction sensor (Figure 5.6D). Finometer BP measurements were 
corroborated with absolute arterial BP measurements obtained by an automated 
sphygmomanometer (Intellivue MMS X2, Philips, Best, The Netherlands) prior to 
starting each profile. Stroke volume (SV) and total peripheral resistance (TPR) was 
estimated from the arterial BP waveform using the Modelflow method (Leonetti, et al. 
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2004) via Beatscope software (TNO-TPD, Biomedical Instrumentation, Amsterdam, 
The Netherlands). 
 
 
Figure 5.6 Electronic tilt-table experimental setup. 
  
A, lower-body negative pressure (LBNP) chamber (Figure 5.7); B, Finapres 
continuous blood pressure monitor; C, LBNP chamber in line with iliac crest 
and secured to waist; D, Finapres height correction for blood pressure; E, 3-
lead electrocardiogram (ECG); F, Ultrasonography for internal jugular vein; G, 
near infrared spectroscopy (NIRS) of the prefrontal cortex; H, Transcranial 
Doppler (TCD) sensor. 
 
5.2.2.2 Peripheral fluid displacement 
Lower-limb muscle oxygenation was measured using near-infrared spectroscopy 
(mNIRS; PortaMon, Artinis Medical Systems, Einsteinweg, The Netherlands) of the 
calf muscle to obtain the tissue saturation index (mTSI, Figure 5.7C). Movement of 
fluid to the lower extremities, and away from the central compartment, was quantified 
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using strain gauge plethysmography (SGP; EC6 Strain Gauge Plethysmograph, 
Hokanson Inc., Bellevue, WA, USA). In each participant the gauge was positioned 
around the calf midpoint (directly between the tibiae tuberosity and medial malleolus 
bony prominences) to record accurate changes in calf circumference (CC, Figure 5.7B). 
 
 
Figure 5.7 Lower-body negative pressure (LBNP) chamber experimental setup. 
  
A, pressure, humidity and temperature sensor; B, strain gauge 
plethysmography; C, near infrared spectroscopy (NIRS) of the calf muscle 
with light shielding. 
 
5.2.2.3 Venous congestion 
Right and left internal jugular vein cross-sectional areas (CSA-R and CSA-L) were 
recorded using ultrasonography (MyLab Gamma, Esoate SpA, Genoa, Italy). The 
ultrasound probe was placed at an angle of approximately 90° at the cricoid level, 
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parallel to the clavicle, to obtain transversal views of the neck during baseline and 
TILT±LBNP phases.  
Measurements were made in B-mode (brightness mode) with the probe on the 
participant’s neck with a thick layer of ultrasonic gel; ensuring complete coupling 
between the transducer and the participant’s skin, and thereby exert virtually no 
compressive force at all. Thus, significant and excessive pressure, potentially changing 
the shape and dimension of the vein, was avoided; whilst image quality, free from black 
cones and dark areas, was maintained. 
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Figure 5.8 Screenshot from ultrasonography video sequence of the internal jugular vein. 
  
SCM, sternocleidomastoid muscle; IJV, internal jugular vein; CA, carotid 
artery. 
 
 
Short video sequences were stored and offline measurements of the pulse-triggered 
maximal right and left internal jugular vein cross-sectional area were made using the 
manual area trace function of the machine (Figure 5.8). One operator was used for all 
measurements, with an average of three screenshots taken for each value, and blinded to 
the experimental condition. 
5.2.2.4 Cerebral perfusion 
Cerebral near-infrared spectroscopy of the left prefrontal cortex immediately below the 
forehead hairline of each participant (cNIRS; PortaLite, Artinis Medical Systems, 
Einsteinweg, The Netherlands; Figure 5.6B) was used to determine the absolute ratio of 
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oxy- (O2Hb) and deoxyhemoglobin (HHb). Taking into account participant frontal 
cranium thickness, based on age and gender, the cerebral tissue saturation index (cTSI) 
was deduced (Lynnerup et al., 2005) with an inference on global cerebral perfusion 
(Weiss et al., 2005). 
Cerebral blood flow velocity (cBFV) in the middle cerebral artery (MCA) was 
continuously measured using transcranial Doppler (TCD; DWL Multi-Dop T digital, 
Compumedics GmbH, Singen, Germany) attached to the participant’s head (Figure 
5.6H). 
5.2.3 Statistical analysis 
Following previous studies of the measures used in this paper in which fluid shifts were 
induced, an error probability (α) of 0.05, power (1 - β) of 0.80 with an average effect 
size (d) of 0.05, power calculation, using G* Power (Erdfelder, Faul, & Buchner, 1996), 
yielded a participant number of 15. 
All continuously recorded data were analysed in 30 s frames and artefacts removed with 
a custom made Matlab (R2015a, The Mathworks Inc., MA, USA) script using the 
following criteria: (i) physiologically plausible limits (Table 2.2); and (ii) maximal 
percentage of change in relation to the standard deviation of the signal. Data was 
resampled at 4Hz (piecewise cubic spline interpolation) as long as >95% of data were 
valid yielding 15 complete sets of data for further analysis. 
Data at specific tilt angles without and with pressure (TILT±LBNP) were analysed 
using the changes from the respective last minute baseline (BL) mean to a 1 min mean 
in the last minute of each TILT±LBNP (min 5). Data presented during the entire run are 
delta values of each 30 s mean of the 12 min measurements following TILT±LBNP 
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onset from the last minute BL mean. A mean of the three absolute internal jugular vein 
cross sectional area measurements were made for the last minute of BL and 
TILT±LBNP. 
Matlab (R2015a, The Mathworks Inc., MA, USA) was used to perform statistical 
analysis. Visual inspection of residual plots did not reveal any obvious deviations from 
homoscedasticity or normality of residuals. The tests applied were one-way analysis of 
variance (ANOVA, repeated measures), post hoc tests with preventative post hoc 
control of the type I error rate (Tukey’s Honestly Significant Difference, HSD) and t-
test (independent, by groups). Linear and non-linear peak Gaussian regression analyses 
were used to estimate the relationships among variables. Furthermore, a test for equality 
of slopes and intercepts was performed to assess significant difference (Sokal & Rohlf, 
1969). The data are presented as mean (±SEM) unless otherwise stated with the level of 
significance set at p≤0.05. 
5.3 Results 
5.3.1 Cardiovascular response 
Data below are presented as changes from the baseline (BL) in mean heart rate (ΔHR), 
averaged mean arterial pressure (ΔMAP), mean stroke volume (ΔSV), and total 
peripheral resistance (ΔTPR), measured continuously, during all angles and head-down 
tilt (TILT, +12 to -24°) without lower-body negative pressure (0 mmHg) and with (+-40 
mmHg). Baseline values, prior to the start of experimentation, for all participants are 
outline in  
Table 5.2. 
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Table 5.2 Participant absolute mean baseline (BL) values for all parameters. 
  
Measured BL is a mean of the last minute immediately before start of the 
experiment in all participants (n=16). 
 
HR, heart rate; SV, stroke volume; TPR, total peripheral resistance; MAP, 
mean arterial pressure; CC, calf circumference; mTSI, muscle tissue 
saturation index; cTSI, cerebral tissue saturation index; CSA-RMAX, maximum 
cross-sectional area of the right jugular vein; CSA-LMAX, maximum cross-
sectional area of the left jugular vein. 
 
 
 
    
 
  Parameter 
Absolute mean  
baseline (BL) ± SEM  
  
 
HR 65 ± 2 bpm 
 
 
SV 82.2 ± 3.5 mL 
 
 
TPR 1402 ± 99 dyn.s.cm-5 
 
 
MAP 86± 2 mmHg 
 
 
CC 348 ± 7 mm 
 
 
mTSI 80.77 ± 1.47 % 
 
 
cTSI 75.12 ± 2.83 % 
  CSA-RMAX 86 ± 11 mm
2  
 CSA-LMAX 71 ± 7 mm
2  
    
 
 
Changes from baseline (BL): TILT without LBNP (0 mmHg) resulted in no deviations 
in ΔHR during all angles of tilt (+12 to -24°: 0.127<p<0.926; Figure 5.9A). However, 
ΔMAP without LBNP was significantly positive and negative at +12° and -24° 
respectively (p<0.05) but unchanged at all other angles of tilt (0.066<p<0.365; Figure 
5.9B). ΔSV without LBNP was no different at all angles of tilt (+12 to -24°: 
0.111<p<0.691; Figure 5.9C) in a similar observation of ΔTPR without LBNP (+12 to -
24°: 0.350<p<0.763; Figure 5.9D) 
With the addition of LBNP (-40 mmHg) ΔHR was significantly positive at -12° and 
above (-12 to +12°, p<0.05-0.001; Figure 5.9A). ΔMAP was significantly negative with 
LBNP at all tilt angles (+12 to -24°, p<0.05-0.001; Figure 5.9B) as was ΔSV (+12 to -
24°, p<0.01-0.001; Figure 5.9C). However, ΔTPR with LBNP was significantly positive 
(-24 to +12°, p<0.05-0.001; Figure 5.9D). 
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Figure 5.9 Mean changes from baseline (BL) for cardiovascular measures in the final minute 
(min 5) of head-down tilt (HDT, -6 to -24°), supine (0°) and head-up tilt (+12°) with (-40 
mmHg) and without (0 mmHg) lower-body negative pressure (LBNP). 
 
  
A, changes from baseline (BL) in mean heart rate (ΔHR); B, changes from BL in 
averaged mean arterial pressure (ΔMAP); C, changes from BL in mean stroke 
volume (ΔSV) significantly negative with LBNP (-40 mmHg) at all tilt angles; and D, 
changes from BL in mean total peripheral resistance (ΔTPR). 
 
Mean at each angle (± SEM) is calculated as a final minute (min 5) mean delta from the final 
minute (min 5) mean of the baseline (BL) immediately before each respective tilt/pressure. 
Black square, without LBNP (0 mmHg); grey triangle, with LBNP (-40 mmHg). vs. Baseline 
(*): * p < 0.05, ** p < 0.01, *** < p <0.001. vs. LBNP+/- (#): # p < 0.05, ## p < 0.01, ### < p 
<0.001; n = 16. 
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Pressure comparison (-40 mmHg vs. 0 mmHg): ΔHR with LBNP was significantly 
greater than without (-40 mmHg vs. 0 mmHg) at -12° and above (-12 to +12°, p<0.05-
0.001) with the greatest difference at 0° (9 ± 2 vs. 1 ± 0 bpm; F(1,30)=18.35, p<0.001; 
Figure 5.9A). However, ΔMAP with LBNP was significantly lower than without at -12° 
and above (-12 to +12°, p<0.05-0.001) with the greatest difference at -6° (-6 ± 1 vs. 2 ± 
1 mmHg; F(1,30)=22.75, p<0.001; Figure 5.9B). 
ΔSV with LBNP was significantly lower than without (-40 mmHg vs. 0 mmHg) at all 
angles (+12 to -24°, p<0.01-0.001) with the greatest difference at -6° (-24.5 ± 4.1 vs. 3.4 
± 2.3 mL; F(1,30)=11.86, p=0.002; Figure 5.9C). Conversely, ΔTPR with LBNP was 
significantly greater than without (-40 mmHg vs. 0 mmHg) at 0° and below (0 to -24°, 
p<0.05-0.001) with the greatest difference at -12° (308 ± 82 vs. -12 ± 38 dyn.s.cm-5; 
F(1,30)=24.31, p<0.001; Figure 5.9D). 
5.3.2 Lower-limb response 
Data below are presented as changes from the baseline (BL) in mean calf circumference 
(ΔCC) and calf muscle tissue saturation index (ΔmTSI), measured continuously,  during 
all angles and head-down tilt (TILT, +12 to -24°) without lower-body negative pressure 
(0 mmHg) and with (-40 mmHg). 
Changes from baseline (BL): TILT without LBNP (0 mmHg) resulted in no deviations 
in ΔCC during all angles of tilt (+12 to -24°: 0.057<p<0.286; Figure 5.10A); and similar 
observations were made in ΔmTSI (+12 to -24°: 0.102<p<0.628; Figure 5.10B). 
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With the addition of LBNP (-40 mmHg) ΔCC was significantly positive at -12° and 
above (-12 to +12°, p<0.05-0.001) and negative at -24° (p=0.009; Figure 5.10A). 
ΔmTSI was significantly negative with LBNP at tilt angles above -6 ° (-6 to +12°, 
p<0.05-0.001); however, no change was measured below (-12 to -24: 0.193<p<0.480); 
Figure 5.10B). 
 
 
 
 
Figure 5.10 Mean changes from baseline (BL) for parameters in the lower-limb of the final 
minute (min 5) of head-down tilt (HDT, -6 to -24°), supine (0°) and head-up tilt (+12°); with 
(-40 mmHg) and without (0 mmHg) lower-body negative pressure (LBNP). 
  
A, changes from baseline (BL) in mean calf circumference (ΔCC); and B, 
changes from BL in mean calf muscle tissue saturation index (ΔmTSI). 
 
Mean at each angle (± SEM) is calculated as a final minute (min 5) mean delta from the 
final minute (min 5) mean of the baseline (BL) immediately before each respective 
tilt/pressure. Black square, without LBNP (0 mmHg); grey triangle, with LBNP (-40 
mmHg). vs. Baseline (*): * p < 0.05, ** p < 0.01, *** < p <0.001. vs. LBNP+/- (#): # p < 
0.05, ## p < 0.01, ### < p <0.001; n = 16. 
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Pressure comparison (-40 mmHg vs. 0 mmHg): ΔCC with LBNP was significantly 
greater than without (-40 mmHg vs. 0 mmHg) at -18° to 0° (p<0.05-0.001) with the 
greatest difference at 0° (1.5 ± 0.3 vs. -0.1 ± 0.1 mm; F(1,30)=29.42, p<0.001; Figure 
5.10A). However, ΔmTSI with LBNP was significantly lower than without at -6° and 
above (-6 to +12°, p<0.01) with the greatest difference at -6° (-2.70 ± 0.95 vs. 1.07 ± 
0.57 %; F(1,30)=10.09, p=0.004; Figure 5.10B). 
5.3.3 Emergence and removal of venous congestion 
Data below are mean absolute values of internal jugular vein cross-sectional area on the 
right (CSA-R) and left (CSA-R), taken from three repeated ultrasound measurements in 
the final minute (min 5), at all angles and head-down tilt (TILT, +12 to -24°) without 
lower-body negative pressure (0 mmHg) and with (-40 mmHg). 
Changes from baseline (BL): CSA-R during TILT without LBNP (0 mmHg) was 
significantly greater than baseline (BL) at -18° and below (-18 to -24°: p<0.001), less at 
+12° (p<0.001) and no change between 0 to -12° (0.054<p<0.926; Figure 5.11A). 
Similarly, CSA-L without LBNP was significantly greater than baseline (BL) at -12° 
and below (-12 to -24°: p<0.01-0.001), less at +12° (p<0.001) and no change at 0° and -
6° (0.098<p<0.935; Figure 5.11B). 
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With the addition of LBNP (-40 mmHg) CSA-R was significantly lower at -12° and 
above compared to BL (-12 to +12°, p<0.05-0.001) with no change at -18 and -24° 
(0.412<p<0.757; Figure 5.11A). CSA-L was significantly less at -6 ° and above (-6 to 
+12°, p<0.001) compared to BL but no change was measured at -12° and below (-12 
to -24: 0.056<p<0.700); Figure 5.11B).  
 
 
Figure 5.11 Mean absolute internal jugular vein cross-sectional area (CSA, left and right) 
of the final minute (min 5) of head-down tilt (HDT, -6 to -24°), supine (0°) and head-up tilt 
(+12°); with (-40 mmHg) and without (0 mmHg) lower-body negative pressure (LBNP). 
  
A, mean absolute right internal jugular vein cross-sectional area (CSA-R); 
and B, mean absolute left internal jugular vein cross-sectional area (CSA-L). 
 
Mean at each angle (± SEM) is calculated as an average of three individual maximum 
measurements in the final minute (min 5) of each tilt/pressure and the baseline (BL) 
immediately before each respective tilt/pressure. Black square, without LBNP (0 
mmHg); grey triangle, with LBNP (-40 mmHg). vs. Baseline (*): * p < 0.05, ** p < 0.01, 
*** < p <0.001. vs. LBNP+/- (#): # p < 0.05, ## p < 0.01, ### < p <0.001; n = 16.  
-6 to -24°: Linear regression polynomial (f = y0+a*x). 
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Pressure comparison (-40 mmHg vs. 0 mmHg): CSA-R with LBNP was significantly 
lower than without (-40 mmHg vs. 0 mmHg) at all tilt angles (+12° to -24°: p<0.05-
0.001) with the greatest difference at -6° (39 ± 6 vs. 104 ± 12 mm2; F(1,30)=23.93, 
p<0.001; Figure 5.11A). Similarly, CSA-L with LBNP was significantly lower than 
without at 0° and below (0 to -24°, p<0.01) with the greatest difference also at -6° (30 ± 
3 vs. 81 ± 8 mm2; F(1,30)=38.01, p<0.001; Figure 5.11B). 
CSA-R regression lines with (R2=0.999, F3,32=3946, p<0.001, m=-3.52) and without 
LBNP (R2=0.999, F3,32=7047, p<0.001; m=-3.65) showed no difference in slope 
(F1,4=1.09, p=0.356) but significantly different y-intercepts (82 vs. 17 mm
2; F1,4=13021, 
p<0.001; Figure 5.11A). Similarly, CSA-L regression lines with (R2=141.3, p<0.001, 
p=0.003, m=-3.13) and without LBNP (R2=0.893, F3,32=16.67, p=0.045, m=-2.48) also 
showed no difference in slope (F1,4=3.53, p=0.134; Figure 5.11B) but significantly 
different y-intercepts (72 vs. 11 mm2; F1,4=1.09, p=0.356; Figure 5.11B). 
5.3.3.1 Reduction of right-left internal jugular vein asymmetry by LBNP 
Differences between right and left internal jugular vein cross-sectional area (ΔR-L 
CSA) were consistently positive, even at baseline (0°, 0 mmHg). However, there was no 
significant difference in ΔR-L CSA without LBNP at all angles of tilt apart from -24° 
significantly positive (p=0.030). With the addition of LBNP at -24° compared to 
without (-40 mmHg vs. 0 mmHg) this asymmetry was abolished (43.9 ± 18.3 vs. 14.9 ± 
9.5 mm2, F(1,30)=1.98, p=0.170; Figure 5.12). 
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Figure 5.12 Mean difference in absolute cross-sectional area of the right (CSA-R) 
and left (CSA-L) internal jugular veins in the final minute (min 5) of head-down tilt 
(HDT, -6 to -24°), supine (0°) and head-up tilt (+12°); with (-40 mmHg) and 
without (0 mmHg) lower-body negative pressure (LBNP). 
  
Mean at each angle (± SEM) is calculated as an average of three individual maximum 
ultrasound measurements in the final minute (min 5) of each tilt/pressure and the 
baseline (BL) immediately before each respective tilt/pressure. Delta is calculated as 
CSA-R minus CSA-L. Black, without LBNP (0 mmHg); grey, with LBNP (-40 mmHg). 
CSA-R vs. CSA-L (*): * p < 0.05; n = 16. 
 
 
5.3.4 Cerebral hemodynamics 
Data below are presented as changes from the baseline (BL) in mean prefrontal cortex 
cerebral tissue saturation index (ΔcTSI), mean middle cerebral artery blood flow 
velocity (ΔcBFV), and calculated changes from baseline in cerebrovascular 
conductance (ΔCVC; flow/pressure: MAP/cBFV), measured continuously, during all 
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angles and head-down tilt (TILT, +12 to -24°) without lower-body negative pressure (0 
mmHg) and with (-40 mmHg). 
Changes from baseline (BL): ΔcTSI during TILT without LBNP (0 mmHg) was no 
different at all angles of tilt (+12 to -24°: 0.215<p<0.755; Figure 5.13); with the same 
observation in ΔcBFV (+12 to -24°, 0.125<p<0.736; Figure 5.14). 
 
 
 
 
Figure 5.13 Mean changes from baseline (BL) for near-infrared spectroscopy (NIRS) 
measured prefrontal cortex cerebral tissue saturation index (ΔcTSI) in the final minute 
(min 5) of head-down tilt (HDT, -6 to -24°), supine (0°)  and head-up tilt (+12°); with (-40 
mmHg) and without (0 mmHg) lower-body negative pressure (LBNP). 
  
Mean at each angle (± SEM) is calculated as a final minute (min 5) mean delta from 
the final minute (min 5) mean of the baseline (BL) immediately before each 
respective tilt/pressure. Black square, without LBNP (0 mmHg); grey triangle, with 
LBNP (-40 mmHg). vs. Baseline (*): * p < 0.05, ** p < 0.01, *** < p <0.001. vs. 
LBNP+/- (#): # p < 0.05, ## p < 0.01, ### < p <0.001; n = 16. 
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With the addition of LBNP (-40 mmHg) ΔcTSI was significantly negative at all tilt 
angles (+12 to -24°, p<0.05-0.001; Figure 5.13); however, no change was measured in 
ΔcBFV with LBNP apart from -12° significantly positive (p=0.031); Figure 5.14). 
 
 
 
Figure 5.14 Mean changes from baseline (BL) for transcranial Doppler (TCD) measured 
middle cerebral artery blood flow velocity (ΔcBFV) in the final minute (min 5) of head-
down tilt (HDT, -6 to -24°), supine (0°) and head-up tilt (+12°); with (-40 mmHg) and 
without (0 mmHg) lower-body negative pressure (LBNP). 
  
Mean at each angle (± SEM) is calculated as a final minute (min 5) mean delta from the 
final minute (min 5) mean of the baseline (BL) immediately before each respective 
tilt/pressure. Black square, without LBNP (0 mmHg); grey triangle, with LBNP (-40 
mmHg). vs. Baseline (*): * p < 0.05, ** p < 0.01, *** < p <0.001. vs. LBNP+/- (#): # p < 
0.05, ## p < 0.01, ### < p <0.001; n = 16. 
 
 
Pressure comparison (-40 mmHg vs. 0 mmHg): ΔcTSI with LBNP was significantly 
lower than without (-40 mmHg vs. 0 mmHg) at -6° and above (-6° to +12°: p<0.05-
0.001) with the greatest difference at -6° (-1.83 ± 0.32 vs. -0.03 ± 0.25 %; F(1,30)=16.69, 
p<0.001; Figure 5.13). ΔcBFV with LBNP was significantly higher than without at -12° 
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(4.12 ± 1.36 vs. -0.71 ± 0.56 cm.s-1; F(1,30)=7.37, p=0.013) with no difference at all other 
angles (+12°: p=0.979; 0°: p=0.397; -6°: p=0.841; -18°: p=0.754; and -24°: p=0.398; 
Figure 5.14). Similarly, ΔCVC was significantly lower than without LBNP at -18° (1.25 
± 0.74 vs. -0.45 ± 0.42 cm.s-1.mmHg-1; F(1,30)=6.24, p=0.045) with no difference at all 
other angles (Figure 5.15). 
 
 
 
Figure 5.15 Mean changes from baseline (BL) for calculated cerebrovascular 
conductance (ΔCVC; flow/pressure) in the final minute (min 5) of head-down tilt (HDT, -6 
to -24°), supine (0°) and head-up tilt (+12°); with (-40 mmHg) and without (0 mmHg) 
lower-body negative pressure (LBNP). 
  
Mean at each angle (± SEM) is calculated as a final minute (min 5) mean delta from the 
final minute (min 5) mean of the baseline (BL) immediately before each respective 
tilt/pressure. Black square, without LBNP (0 mmHg); grey triangle, with LBNP (-40 
mmHg). vs. Baseline (*): * p < 0.05, ** p < 0.01, *** < p <0.001. vs. LBNP+/- (#): # p < 
0.05, ## p < 0.01, ### < p <0.001; n = 16. 
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5.3.4.1 Cerebral blood flow time course 
The entire 12 minute run profile consisted of: (i) start onset of TILT±LBNP (min -1.0 to 
0.0); (ii) orthostatic challenge exposure (TILT±LBNP: min 0.0 to 5.0); (iii) end offset of 
tilt pressure (min 5.0 to 6.0); and (iv) recovery (RR: min 6.0 to 11.0; Figure 5.16).  
Data below are presented as changes from baseline (BL) in continuously measured 
mean middle cerebral artery blood flow velocity (ΔcBFV) at 30 second intervals across 
the whole run profile duration (min -1.0 to 11.0). ΔcBFV time course at head-up tilt 
(HUT, +12°), supine (0°), and head-down tilt (HDT, -6 to -24°) without lower-body 
negative pressure (0 mmHg) and with (-40 mmHg) are plotted (Figure 5.16). 
Changes from baseline (BL): ΔcBFV without LBNP (0 mmHg) during all angles of tilt 
(TILT, min 0.0-5.0) was no different (+12 to -24), apart from significantly negative in 
min 0 at +12° (p=0.013; Figure 5.16A), 0° (p=0.004; Figure 5.16B), and -12° (p=0.006; 
Figure 5.16D).  
ΔcBFV without LBNP during ramp-down and recovery (RR, min 5.0-11.0) was 
unchanged at 0° (0.086<p<0.901; Figure 5.16B) and -24° (0.093<p<0.852; Figure 
5.16F). However, ΔcBFV was significantly negative at +12° (min 9.0-10.0, p<0.05; 
Figure 5.16A), -6° (min 8.5, p<0.05; Figure 5.16C), and -12° (min 6, 8.5, 9.5-10.5, 
p<0.05; Figure 5.16D). Conversely, ΔcBFV was significantly positive at -18° (min 8.5, 
p<0.05; Figure 5.16E). 
With the addition of LBNP (-40 mmHg) ΔcBFV was no different at all angles of tilt 
(+12 to -24°, p<0.05-0.001) apart from significantly positive at -12° in the final minute 
of HDT (min 4.5, p<0.05; Figure 5.16D). During RR with LBNP, ΔcBFV was 
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significantly negative during 0° (min 7, p<0.05; Figure 5.16B), -6° (min 6.5-9.0, and 
10.0-11.0, p<0.05; Figure 5.16C), and -24° (min 6.5, p<0.05; Figure 5.16F); with no 
change during +12° (0.065<p<0.811, Figure 5.16A), -12° (0.399<p<0.923, Figure 
5.16D), or -18° (0.212<p<0.952, Figure 5.16E). 
Pressure comparison (-40 mmHg vs. 0 mmHg): ΔcBFV with LBNP was no different 
than without (-40 mmHg vs. 0 mmHg), across all time points, at +12° (F(24,375)=0.39, 
p=0.536; Figure 5.16A), 0° (F(24,375)=0.68, p=0.418; Figure 5.16B), -6° (F(24,375)=0.66, 
p=0.426; Figure 5.16C), -18° (F(24,375)=0.03, p=0.864; Figure 5.16E), -24° 
(F(24,375)=0.31, p=0.582; Figure 5.16F). However, at -12°, ΔcBFV was significantly 
greater with the addition of LBNP to TILT at min 0.0-1.0, 2.5, and 3.5-4.5 
(F(24,375)=5.39, p=0.031) with the greatest difference in the final minute (min 4.5: 4.12 ± 
1.36 vs. -0.71 ± 0.56 cm.s-1, p=0.013; Figure 5.16D). During RR, ΔcBFV was no 
different at all angles of tilt. 
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Figure 5.16 Mean changes from baseline (BL) for middle cerebral artery blood flow velocity 
(ΔcBFV) during five minutes head-up tilt (HUT, +12°), supine (0°), and  head-down tilt (HDT, 
-6 to -24°) with (-40 mmHg) and without (0 mmHg) lower-body negative pressure (LBNP), 
and recovery (RR, 0° and 0 mmHg). 
 
  
A, mean middle cerebral artery blood flow velocity (ΔcBFV) during +12° head-up tilt (HUT); 
B, ΔcBFV during 0° supine; C, ΔcBFV during -6° head-down tilt (HDT); D, ΔcBFV during -
12° HDT; E, ΔcBFV during -18° HDT; and F, ΔcBFV during -24° HDT. 
 
Mean ± SEM is 30 s mean delta from final minute (min 5) mean of each baseline (BL) before tilt. 
Black square, without LBNP (0 mmHg); grey triangle, with LBNP (-40 mmHg). Shaded areas: 
light grey, one minute onset of tilt/pressure (min -1.0-0 and 5.0-6.0); dark grey, five minutes tilt 
(HDT: min 0.0-5.0); white, five minutes recovery (RR: min 6.0-11.0). vs. Baseline (*): * p < 0.05. 
vs. LBNP+/- (#): # p < 0.05; n = 16. 
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5.3.5 Time effect at 12° head-down tilt 
Data below are presented as changes from baseline (BL) in continuously measured 
mean heart rate (ΔHR), averaged mean arterial pressure (ΔMAP), mean calf 
circumference (ΔCC), and prefrontal cortex cerebral tissue saturation index (ΔcTSI) at 
30 second intervals across the whole run profile duration (min -1.0 to 11.0). Parameter 
time course at -12° head-down tilt (HDT) without lower-body negative pressure (0 
mmHg) and with (-40 mmHg) are plotted (Figure 5.17). 
Changes from baseline (BL): ΔHR without LBNP (0 mmHg) was unchanged during -
12° HDT (min 0.0-5.0: 0.127<p<0.997; Figure 5.17A); as was ΔMAP (min 0.0-5.0: 
0.271<p<0.966; Figure 5.17B). 
ΔCC without LBNP (0 mmHg) was no different during -12° HDT apart from 
significantly negative at min 0.5 (p<0.05; Figure 5.17C); whilst ΔcTSI was also 
significantly negative at min 1.0-1.5 and 3.5-4.5 (p<0.0.5; Figure 5.17D). 
ΔHR without LBNP during ramp-down and recovery (RR, min 5.0-11.0) was 
unchanged apart from significantly positive at min 10.0 (p<0.05; Figure 5.17A). 
Similarly, ΔMAP and ΔcTSI changes were insignificant during RR (ΔMAP: p<0.05, 
Figure 5.17B; and ΔcTSI: p<0.05, Figure 5.17D). However, ΔCC without LBNP during 
the final minute of RR was significantly negative (min 11.0, p<0.05; Figure 5.17C). 
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With the addition of LBNP (-40 mmHg) during -12° HDT, ΔHR was significantly 
positive at min 0.5-5.0 (p<0.05; Figure 5.17A); as was ΔCC in the first stages of LBNP 
(min 0.0-2.0, p<0.05; Figure 5.17C). Conversely, ΔMAP and ΔcTSI were both 
significantly negative with the addition of LBNP during -12° HDT (ΔMAP: min 0.5, 
and 1.5-2.5, p<0.05, Figure 5.17B; and ΔcTSI: min 1.0-4.0, and 5.0, p<0.05, Figure 
5.17D). 
During RR with LBNP, ΔHR was significantly negative (min 8.5, 10.0-11.0, p<0.05; 
Figure 5.17A), but ΔMAP and ΔcTSI were significantly positive (ΔMAP: min 7.5, 8.5 
and 10.0-10.5, p<0.05, Figure 5.17B; and ΔcTSI: min 6.5-8.5, p<0.05, Figure 5.17D). 
However, ΔCC during this RR period was no different from BL (0.490<p<0.931; Figure 
5.17C). 
Pressure comparison (-40 mmHg vs. 0 mmHg): ΔHR with LBNP was significantly 
greater than without (-40 mmHg vs. 0 mmHg) at -12° HDT in min 0.5-5.0 
(F(24,375)=7.83, p=0.009) with the greatest difference at min 4.5 (7 ± 1 vs. 0 ± 1 bpm; 
p<0.001; Figure 5.17A); however, ΔMAP and ΔcTSI were no different (ΔMAP: 
F(24,375)=2.36, p=0.135, Figure 5.17B; and ΔcTSI: F(24,375)=0.13, p=0.723; Figure 
5.17D). ΔCC was significantly greater with the addition of LBNP to HDT at min 0.0-
3.0 (F(24,375)=6.29, p=0.019) with the greatest difference at min 1.5 (0.9 ± 0.2 vs. -0.4 ± 
0.2 mm; p<0.001; Figure 5.17C). During RR, only ΔHR and ΔMAP were significantly 
lower and greater respectively when comparing 0 to -40 mmHg; with the greatest 
difference in ΔHR at min 10 (-3 ± 1 vs. 3 ± 1 bpm; p=0.003; Figure 5.17A) and in 
ΔMAP at min 10.5 (3 ± 1 vs. -1 ± 1 mmHg; p=0.021; Figure 5.17B). 
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Figure 5.17 Mean changes from baseline (BL) for systemic, peripheral and cerebral 
hemodynamic measures during five minutes head-down tilt (HDT, -12°) with (-40 mmHg) 
and without (0 mmHg) lower-body negative pressure (LBNP), and recovery (0°, 0 mmHg). 
 
 
  
A, mean heart rate (ΔHR) during -12° head-down tilt (HDT); B, averaged mean 
arterial pressure (ΔMAP) during -12° HDT; C, mean calf circumference (ΔCC) during 
-12° HDT; and D, mean pre-frontal cortex cerebral tissue saturation index (ΔcTSI) 
during -12° HDT. 
 
Mean ± SEM is 30 s mean delta from final minute (min 5) mean of each baseline (BL) before 
tilt. Black square, without LBNP (0 mmHg); grey triangle, with LBNP (-40 mmHg). Shaded 
areas: light grey, one minute onset of tilt/pressure (min -1.0-0 and 5.0-6.0); dark grey, five 
minutes tilt (HDT: min 0.0-5.0); white, five minutes recovery (RR: min 6.0-11.0). vs. Baseline 
(*): * p < 0.05. vs. LBNP+/- (#): # p < 0.05; n = 16. 
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5.3.6 Individual responses and correlations 
Significant positive changes from BL in mean middle cerebral artery (MCA) blood flow 
velocity (ΔcBFV) are corroborated by agreement of the interindividual trends for 
ΔcBFV to increase with -40 mmHg LBNP at -12° HDT (Figure 5.18B). Without LBNP 
(0 mmHg) about half of all participants exhibit a fall in ΔcBFV below the respective 
baseline (BL) immediately before (Figure 5.18A). In contrast, with the addition of -40 
mmHg LBNP that trend is reversed and over half of participants show a tendency for 
increasing ΔcBFV above BL during the orthostatic challenge (min 0-5; Figure 5.18B). 
 
 
 
Figure 5.18 Individual participant changes from baseline (BL) for middle cerebral artery blood 
flow velocity (ΔcBFV) during five minutes head-down tilt (HDT, -12°) with (-40 mmHg) and 
without (0 mmHg) lower-body negative pressure (LBNP), and recovery (0°, 0 mmHg). 
  
A, Individual changes from baseline (BL) in middle cerebral artery blood flow 
velocity (ΔcBFV) at -12° head-down tilt (HDT) without LBNP (0 mmHg); and 
B, Individual ΔcBFV at -12°HDT with LBNP (-40 mmHg). 
 
Mean at each data point (± SEM) is calculated as a 60 s mean delta from the final 
minute (min 5) mean of the baseline (BL) immediately before each respective 
tilt/pressure. Shaded areas: light grey, one minute onset of tilt/pressure (min -1 to 0; 
and min 5 to 6); dark grey, five minutes tilt/pressure (HDT: min 0 to 5); white, five 
minutes recovery (RR: min 6 to 11). 
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Without LBNP there was no correlation between changes from BL in mean heart rate 
(ΔHR) and mean calf circumference (ΔCC; Figure 5.19A) or mean prefrontal cortex 
cerebral tissue saturation index (ΔcTSI) and ΔCC (Figure 5.19B) at all tilt angles tested 
(-24 to +12°). Similarly, there was no significant correlation between ΔHR and ΔCC 
during -40 mmHg (Figure 5.19C); however, a significant negative correlation between 
ΔcTSI and ΔCC was observed with LBNP (R2=0.735, F1,6=11.1, p=0.029; Figure 
5.19D). 
There was no relationship between changes from BL in ΔcBFV and ΔCC without 
LBNP (0 mmHg; Figure 5.20A). However, a significant peak Gaussian model fit was 
shown between ΔcBFV and ΔCC (R2=0.970, F1,6=48.1, p=0.005) during LBNP (-40 
mmHg) in the final minute means (min 5) of each tilt/pressure profile; demonstrating 
ΔCC effect (at -40 mmHg) on positively changing ΔcBFV at a point with diminishing 
effect either side (Figure 5.20B). 
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Figure 5.19 Relationship plots between mean changes from baseline (BL) for delta 
heart rate (ΔHR) and pre-frontal cortex cerebral tissue saturation index (ΔcTSI), against 
delta calf circumference (ΔCC) in the final minute (min 5) of head-down tilt (HDT, -6 to -
24°) with (-40 mmHg) and without (0 mmHg) lower-body negative pressure (LBNP). 
  
A, mean heart rate (ΔHR) vs. mean calf circumference (ΔCC) without LBNP 
(0 mmHg); B, mean pre-frontal cortex cerebral tissue saturation index 
(ΔcTSI) vs. ΔCC without; C, ΔHR vs. ΔCC with LBNP (-40 mmHg); and D, 
ΔcTSI) vs. ΔCC with LBNP. 
 
Mean at each angle (± SEM) is calculated as a final minute (min 5) mean delta from 
the final minute (min 5) mean of the baseline (BL) immediately before each 
respective tilt/pressure. Marker shading: white to dark grey, +12, 0, -6, -12, -18 and 
-24° respectively. Linear regression polynomial (f = y0+a*x). 
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Figure 5.20 Relationship plots between mean changes from baseline (BL) for delta middle 
cerebral artery blood flow velocity (ΔcBFV) against mean delta calf circumference (ΔCC) in 
the final minute (min 5) of head-down tilt (HDT, -6 to -24°) with (-40 mmHg) and without (0 
mmHg) lower-body negative pressure (LBNP). 
  
A, mean delta middle cerebral artery blood flow velocity (ΔcBFV) vs. mean delta 
calf circumference (ΔCC) without LBNP (0 mmHg); and B, ΔcBFV vs. ΔCC with 
LBNP (-40 mmHg). 
 
Mean at each angle (± SEM) is calculated as a final minute (min 5) mean delta from the 
final minute (min 5) mean of the baseline (BL) immediately before each respective 
tilt/pressure. Marker shading: white to dark grey, +12, 0, -6, -12, -18 and -24° 
respectively. Nonlinear regression peak Gaussian (f = a*exp(-.5*((x-x0)/b)^2)). 
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In summary, all 16 participants took part in every aspect of the study, exposed to six 
different tilt angles from head-up tilt (HUT, +12°), supine (0°) and head-down tilt (-6 to 
-24°) without (0 mmHg) and with lower-body negative pressure (-40 mmHg). No 
participant experienced syncope or exhibited presyncopal symptoms even at the +12° 
tilt angle in the presence of LBNP for five minutes. In general, HDT (without LBNP) 
had little effect on the central, systemic and cerebral hemodynamic measures; however, 
significant increases in cross-sectional area were measured in the jugular vein (on both 
sides). This ‘venous engorgement’ magnitude manifested as a function of decreasing 
angles of HDT (-6 to -24°) and a significant alleviation of these increases was measured 
with the addition of LBNP. In addition, ΔcBFV was significantly positive at -12° HDT 
with LBNP (-40 mmHg) compared to 0 mmHg, where a similar observation at +12°, 0°, 
-6°, -18° and -24° was not recorded. 
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5.4 Discussion 
The purpose of this study was to investigate the effect of lower-body negative pressure 
(LBNP) on head-down tilt (HDT) induced venous congestion. Specifically, (i) to 
determine the HDT level at which venous congestion occurs; (ii) establish whether or 
not LBNP could abolish this congestion and to what benefit; and (iii) provide a better 
insight into mechanistic targets for future more effective spaceflight countermeasures; 
namely a greater focus on fluid shifts instead of the current simple emphasis on 
reintroduction of forces to the bones and muscles. Thus, providing a truly holistic 
spaceflight countermeasure with increased effectiveness. 
The main findings of this study were that headward venous and arterial pressure 
increases, during HDT at -12° and below, was sufficient to elicit significant internal 
jugular vein (IJV) distension and thus venous congestion. Furthermore, tilt induced 
congestion was abolished when the quantity of fluid shifted to the periphery 
counteracted the magnitude of IJV distension; and surprisingly resulted in a marked 
increase in cerebral blood flow velocity (cBFV). Specifically at -12° HDT, lower-body 
negative pressure (LBNP) at -40 mmHg was sufficient to remove venous congestion but 
too low to induce central hypovolemia associated cerebral hemodynamic changes. 
5.4.1 Emergence of venous congestion 
In the present study, significant increases in IJV cross-sectional area (CSA) were 
measured only at -12° HDT and below. Previous research has reported maximal IJV 
distension occurs at around -25° and found to be significantly greater at -10° and below 
(Clenaghan et al., 2005). Agreement with past research suggests HDT induced venous 
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congestion is likely to occur at a point between -10° and -12°. Additionally, further 
increases in the angle of HDT would intensify venous congestion up to -25°. 
Head-down bed rest (HDBR) studies attempt to simulate unloading, and crucially the 
fluid shifted in space, with a standardised tilt angle of -6° (Sundblad & Orlov, 2015). 
However, justification for this angle of tilt is limited to theoretical calculations on the 
expected fluid shift (Clément, 2011) and an initial agreement in measurements made on 
Earth at -6° and in space (At'kov & Bednenko, 1992). An angle of -6° was decided upon 
as a suitable compromise taking into consideration participant comfort and magnitude 
of response (Pavy-Le Traon et al., 2007). Crucially however, the stipulation for 
acceptable “magnitude of response” was pertaining to muscle atrophy and bone loss 
(At'kov & Bednenko, 1992); with no consideration of, the then undiscovered, visual 
impairment and intracranial pressure (VIIP) syndrome. It is postulated the inability of 
current HDBR models to elicit symptoms of VIPP is due to a lack of venous congestion 
affecting cerebral hemodynamics, intracranial, and intraocular pressure at -6°. Based on 
previous research and current data, it is suggested future HDBR research would need to 
reassess the magnitude of response and participant comfort dichotomy, especially if 
VIIP effects was the focus. 
Wiener (2012) suggested HDT research was not useful, in exploring mechanisms 
associated with VIIP, as cerebral congestion could not be achieved where  significant 
IJV engorgement occurs in spaceflight (Grigoriev et al., 2011). However, in the present 
study, at HDT angle -12° and below, IJV-CSA was significantly increased. This finding 
further supports the idea at -6° (current HDBR standard) is insufficient to elicit venous 
congestion and therefore symptoms of VIIP. 
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Anatomical differences between both IJVs have been observed with mean CSA 
significantly higher on the right (Lichtenstein et al., 2001), and also a higher incidence 
of VIIP in the right side (Marshall-Bowman et al., 2013). In the present study, similar 
observations in IJV asymmetry were observed with a significantly greater mean CSA 
recorded in the right IJV, at -24° only, in all participants. Interestingly, with the addition 
of -40 mmHg LBNP the asymmetry was abolished providing confirmation of the 
potential beneficial effect fluid displacement has on ameliorating the effects of VIIP. 
5.4.2 Beneficial fluid displacement 
Removal of fluid from central compartment is usually associated with negative 
physiological responses that eventually lead to presyncopal symptoms and ultimately 
hemodynamic collapse. However, the addition of LBNP at -40 mmHg during -12° HDT 
actually increased cerebral blood flow velocity (cBFV) with jugular venous congestion 
removed. Specifically, an increased cBFV occurred as a result of LBNP induced 
peripheral fluid displacement and its beneficial effect on significant venous congestion 
at this point (-12° HDT). Supported by the observation that there was no significant 
difference in cBFV at all angles apart from -12°, which was significantly greater with 
the addition of LBNP. Additionally, there is evidence in the present study suggesting 
the cephalic fluid shift (HDT) is balanced by relocation of circulating volume to the 
lower periphery (LBNP). Measured HR, as an indicator of central hypovolemia, showed 
no difference between +/- LBNP conditions below -12° HDT as did the CC, as an 
indicator of fluid shifted to the lower periphery, at the greatest angle of tilt (-24°). 
In the present study, significant fluid shifts measured by increases in calf circumference 
(ΔCC) were observed at tilt angles of -12° and above. Below -12° no change was 
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measured demonstrating a point in which the LBNP induced peripheral fluid shift was 
counteracted by a concurrent headward fluid shift induced by tilt. Therefore, the 
significance of -12° HDT, as a cross-over point with regard to hydrostatic pressure and 
venous congestion, is indicated. Similar findings were observed by Hinghofer-Szalkay 
et al. (2004) where the ability of LBNP to neutralize the cardiovascular effects of HDT 
were demonstrated. Specifically, LBNP levels of -15 to -35 mmHg were shown to 
correlate to HDT angles of -6 to -24° in heart rate (HR), specific volume regulating 
hormone aldosterone, and fluid displacement measured by thoracic impedance 
(Hinghofer-Szalkay et al., 2004). 
Current data showed a difference in ΔHR between -40 mmHg and angles of tilt above -
12°, with no difference at -18° and -24°; indicative of agreement to past research. 
Similarly, fluid displacement measured by ΔCC during -18° and -24° HDT was 
counteracted by -40 mmHg; similar to thoracic impedance changes at -24° with -35 
mmHg (Hinghofer-Szalkay et al., 2004). The present research responses to HDT+LBNP 
were broadly similar to past research and, despite measuring ΔCC, demonstrated the 
ability of -40 mmHg LBNP to neutralize fluids shifts induced by -12° and greater HDT. 
Furthermore, a fluid balance was revealed during -12° HDT and provides explanatory 
substantiation for the unexpected increases in cerebral hemodynamics measurements 
made at this point. 
5.4.3 Cerebral hemodynamics 
Cerebral hemodynamics are tightly regulated by autoregulation and as such cBFV 
remains relatively resistant to small changes in systemic cardiovascular response to an 
orthostatic challenge. However, when mean arterial pressure (MAP) deviates from 
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between control levels (50-150 mmHg) a significant disruption can be observed. 
Similarly, a significant alteration to autoregulation may occur if the stimulus presents a 
unique challenge, such as altered hydrostatic pressures along the main column of blood 
within the body (Laing et al., 2016). It is postulated venous congestion, induced by -12° 
HDT and above, leads to a significant disruption to normal autoregulatory response. 
Whilst this was not directly measured in the present study, Zhang (2013) demonstrated a 
marked deviation from the expected autoregulatory response when exposed to 
microgravity, in which the hydrostatic gradient is completely removed. Therefore, 
current short-term changes observed in cBFV may be explained by impaired 
cerebrovascular autoregulation brought about by venous congestion and rapid removal 
with LBNP. Further research is needed to explore other contributory mechanisms 
including the effect of blood gas concentrations on neuronal metabolisms affecting CBF 
and the role of the autonomic nervous system in regulation. Additionally, limitations of 
the NIRS methodology must be noted; measured changes in O2Hb concentration do not 
differentiate between arterial inflow and venous outflow and there is an assumption of a 
steady-state in O2 consumption of the cerebral tissue being measured (Pellicer & del 
Carmen Bravo, 2011). 
The hypothesized space obstructive syndrome (SOS) proposed by Wiener (2012) 
facilitates the explanation of the significance of observed findings in the present study 
for spaceflight (Figure 5.21). 
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Figure 5.21 Hypothesised space obstructive syndrome (SOS) cascade phenomenon 
adapted from Wiener (2012). 
 
  
HDT, head-down tilt, IJV, internal jugular vein; CSA, cross-sectional area; IOP, 
intraocular pressure; ICH, intracranial hypertension; and VIIP, vision impairment and 
intracranial pressure syndrome. Green box/text, adapted for present study. 
 
 
An initial induced venous congestion, leading to the start of a detrimental cascade, may 
explain the emergence of VIIP in space and HDT below -6°. Confirmation in the 
validity of this process was supported by current data, where disruption to venous 
congestion elicited opposite responses to the hypothesised cascade. Specifically, 
published data from the present study revealed a significant decrease in intraocular 
pressure (IOP) when LBNP was applied to participants at the same angle of tilt. In 
addition, the divergence in IOP occurred at -12°, -18°, and -24° (Marshall-Goebel et al., 
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2017) corroborating the existence and precise tilt/pressure combination for the abolition 
of venous congestion. 
A significant negative correlation was observed between ΔCC and changes in prefrontal 
cortex cerebral tissue saturation index (ΔcTSI) as expected. LBNP as an orthostatic 
challenge was expected to reduce ΔcTSI and similar findings, of a reduction, have been 
observed during postural change from supine to standing (Kawai et al., 1996). However, 
the relationship between ΔCC and changes in ΔcBFV were more complex. A peripheral 
fluid shift was expected to reduce ΔcBFV in a similar manner to ΔcTSI; however, when 
LBNP matched HDT it actually had a beneficial effect and an increase in ΔcBFV was 
recorded. Specifically, ΔcBFV was unchanged at angles above and below -12° HDT 
with LBNP at -40 mmHg; however, at precisely -12° an increase in ΔcBFV was 
measured. A non-linear peak Gaussian regression line of best fit was significant, 
demonstrating too little or too much fluid shifted to the periphery had no effect. 
However, LBNP pressure of -40 mmHg induced the ideal amount of fluid to remove 
venous congestion and significantly increase cBFV at -12°. 
5.4.4 Future direction 
The present research reinforces the important role venous congestion plays in cerebral 
hemodynamics on Earth with obvious implications for spaceflight induced VIIP. 
Furthermore, mechanisms that specifically target venous congestion may prove 
beneficial in ameliorating VIIP during long-duration missions. 
Recommendations for future research focus include artificial gravity (AG) measures 
such as short-arm human centrifugation (SAHC) which, depending on the configuration, 
could diminish venous congestion whilst providing a gravitational stimulus to bones and 
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muscles. Additionally, results from NASA’s ‘Fluid Shifts’ experiment (Stenger et al., 
2016) may deliver data confirming similar outcomes to those observed in the present 
study. Specifically, that blood shifted to the periphery has a benefit on venous 
congestion and VIIP; however, results are pending. 
Finally, pharmacological/therapeutic interventions to reduce localised venous 
congestion may prove beneficial even if the reduction is small. Due to the long-term 
nature of VIIP pathology, minute changes in pressure may have a large impact on 
clinical outcome. We speculate administration of β-adrenergic antagonists could 
provide a therapeutic benefit on long-term localised venous congestion and therefore 
VIIP associated pathology; however, this has yet to be tested. Recent research has 
suggested the daily fluctuations (sleep/wake) in regional intracranial pressure may be 
exacerbating pathology associated with VIIP (Lawley et al., 2017). The development of 
improved countermeasures would benefit from considering these findings, along with 
knowledge of venous congestion importance; ultimately leading to imaginative 
strategies, aimed at controlling ocular problems associated with microgravity. 
5.4.5 Conclusions 
Our results suggest that jugular venous congestion can be abolished with the addition of 
LBNP. Specifically, in the present study it was found venous congestion induced by 
HDT to -12° was abolished with the addition of -40 mmHg LBNP. However in order to 
benefit, from the relieving effect of fluid displacement, the LBNP level must be 
sufficiently matched against the severity of HDT induced venous congestion. It remains 
unclear what level of LBNP is required to remove microgravity induced venous 
congestion; with future research benefiting from a focus in this area. In summary: 
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 The inability of HDT to elicit VIIP on Earth is explained by insufficient venous 
congestion at the -6° tilt typically used. 
 Significant increase in internal jugular vein (IJV) cross-sectional area (CSA) 
indicated venous congestion and coincided with a reduction in cerebral 
hemodynamics. 
 Cerebral blood flow velocity (cBFV) increased during HDT+LBNP, 
demonstrating the successful abolition of venous congestion. However, 
significant cBFV increases were only measured when peripheral fluid shift 
matched congestion magnitude. 
 LBNP behaves as a countermeasure, increasing cBFV, when significant IJV 
distension is present. However, prolonged LBNP would act as an orthostatic 
challenge, decreasing cBFV, when there is no congestion. 
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6.1 Summary 
The unifying hypothesis of this thesis is: 
Orthostatic challenge induced peripheral fluid shifts offer protection to headward 
pressure increases and cerebral hemodynamics, by restoring hydrostatic gradients 
to Earth-like upright norms. 
The data presented in this thesis are consistent with the hypothesis; and although the 
significance of jugular venous congestion was not initially stated, it was explored in 
detail in Chapter 5. The significance of venous congestion, taken together with the 
findings of the other experimental chapters, is addressed in the next section (section 
6.2). 
Chapter 3 was focused on venous cuff occlusion (VCO) and an investigation into this 
method as a simulated orthostatic challenge; with the aim: 
(i) to investigate VCO induced fluid shift effects, on systemic cardiovascular 
response, and quantifying central blood relocation importance to orthostatic 
challenge. 
The main findings of this study are as follows: (i) VCO pressures of 20-120 mmHg on 
both legs induced lower periphery vein distension; (ii) the magnitude of systemic 
response (heart rate, HR), mean arterial pressure (MAP), and total peripheral resistance 
(TPR) were not linked to increased leg volume; and (iii) cerebral tissue saturation index 
(cTSI) was unaffected by VCO and specifically the volume of fluid shifted to the 
periphery.  
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An established orthostatic challenge, such as lower-body negative pressure (LBNP), 
leads to an increased sympathetic outflow to the peripheral vasculature; despite an 
unchanged MAP (Frey et al., 1994). However, in the present study whilst MAP was 
unchanged there was no evidence of sympathetic activation up to 100 mmHg. At VCO 
pressures of 120 mmHg an increase in TPR was measured but was present with 
participant discomfort suggesting pain activated sympathetic activity. Yamamoto et al. 
(1992) demonstrated the pain related response on TPR through the cold pressor test with 
an immediate systemic cardiovascular response measured in the absence of elevated 
TPR; with prolonged cold exposure causing a significant increase in TPR, playing an 
essential role to elevate MAP. 
During a five minute sit-to-stand (STS) test ~157 mL of circulating volume is shifted to 
both lower limbs (Frey et al., 1994); which is similar in magnitude to a head-up tilt 
(HUT) test to 53° for 30 minutes of ~192 mL (Laszlo et al., 2001). In both STS and 
HUT, significant changes to the cardiovascular response (HR, MAP, and volume 
regulating hormones) were measured. However, in the present study a calculated ~135 
mL volume of fluid was shifted to the periphery without any significant changes in HR, 
MAP, SV or TPR. In general, it was found VCO elicits significant fluid shifts, as 
measured by calf circumference, but is an inadequate orthostatic challenge; despite 
being used in the past as a spaceflight countermeasure (Arbeille et al., 1995; Herault et 
al., 2000). 
Chapter 4 investigated the effect of a changing rotational axis position (RAP) during 
short-arm human centrifugation (SAHC) on hemodynamic response; with the aim: 
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(ii) to determine the effect of an altered gravitational gradient, due to a shift in 
rotational axis position (RAP) from head to heart-level during SAHC, on 
central, peripheral, and cerebral response. 
The main findings of this study are as follows: (i) increasing the g-gradient, independent 
of g-level, elicits a comparable attenuation of central, peripheral, and cerebral response; 
in a similar manner to reducing g-level; (ii) cerebral oxygenation, during heart-level 
SAHC, was unsupported suggesting emergence of venous congestion; and (iii) overall 
increased tolerance to higher g-levels indicates suitability of this SAHC regime as part 
of a safe future spaceflight countermeasure. 
It was hypothesised that SAHC with the centre of rotation at heart-level, whilst 
maintaining the same g-level at the feet, would have a beneficial effect on cerebral 
perfusion during the orthostatic challenge. Specifically, headward arterial pressure 
increases would act to maintain appropriate cerebral oxygenation despite significant 
central volume shifted to the periphery. However, this was not observed and it was 
thought concurrent headward venous pressure increases negated any arterial benefit and 
perhaps led to the emergence of jugular venous congestion, as described by Davis et al. 
(2008). Interestingly, venous congestion has also be implicated in visual impairment 
and intracranial pressure (VIIP) syndrome of astronauts (Wiener, 2012) and warranted 
further investigation. 
Finally, chapter 5 explored jugular venous congestion induced by head-down tilt (HDT) 
and the effect lower-body negative pressure (LBNP); with the aim: 
(iii) to evaluate the importance of venous congestion in microgravity and 
spaceflight analogues; and assess suitable amelioration methods. 
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It was hypothesised that venous congestion induced by HDT, and measurable by an 
increased internal jugular vein (IJV) cross-sectional area (CSA), would be abolished by 
the addition of LBNP. Secondly, the specific HDT angle, with the emergence of 
congestion, would be greater than the currently accepted spaceflight analogue of -6°. 
Thirdly, the LBNP level required for venous congestion removal would be tilt-
dependant and consisting of a suitable pressure/tilt match. Specifically, an unmatched 
LBNP and tilt, either too great or too small, would be detrimental to appropriate 
cerebral blood flow. 
The main findings of this study are as follows: (i) HDT induced jugular venous 
congestion occurred only at -12° and below; (ii) peripheral fluid shifts induced by -40 
mmHg LBNP abolished venous congestion; and (iii) cerebral blood flow velocity 
(cBFV) increased when HDT-headward (-12°) and LBNP-peripheral (-40 mmHg) fluid 
shifts were balanced. 
LBNP as an orthostatic challenge removed fluid from the central compartment and 
prolonged exposure would have led to a reduced venous return, cardiac pre-load, and 
eventual drop in cBFV (Hachiya et al., 2012). In the present study, it was surprising to 
measure an increase in cBFV with the addition -40 mmHg LBNP. However, this 
observation was only made at a specific angle of tilt (-12°) for the LBNP used (-40 
mmHg). Based on present data it is postulated, not only was venous congestion 
removed, but a favourable hydrostatic gradient was elicited; allowing for greater 
cerebral drainage and thus increased cBFV. 
During weightlessness, the hydrostatic gradient of the central column of blood within 
the body is absent; and thought to be a contributory factor in venous congestion (Zhang 
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& Hargens, 2014) and, later on, the emergence of VIIP (Mader et al., 2011). During -6° 
head-down bed rest (HDBR), visual acuity is unaffected (Nicogossian et al., 1994) and 
also not able to elicit significant IJV dissention (Clenaghan et al., 2005). Previous and 
present data, pertaining to venous congestion, suggest -6° HDT is insufficient to mimic 
spaceflight fluid shifts affecting mechanisms associated with VIIP pathology (Taibbi et 
al., 2013). Based on the present study, HDBR research would benefit from an increase 
in the current standardized angle of -6° HDT. Specifically, -12° is suggested as a more 
suitable angle for HDT in order to elicit venous congestion and pressure changes across 
the body comparable to spaceflight (Figure 6.1B, C). 
 
 
Figure 6.1 Schematic representation of expected hydrostatic gradients within the arterial 
and venous vasculature under different conditions. 
  
A, standing on Earth; B, supine (0°) and head-down bed rest (HDBR); C, 
weightlessness; and D, countermeasures. Red, arterial; blue, venous. 
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6.2 Further studies 
The importance of fluid shifts in relation to spaceflight-related hemodynamic changes 
has been outlined; and how this is related to hydrostatic gradient changes and venous 
congestion. Future research would benefit from directly measuring the expected 
hydrostatic gradients depicted in Figure 6.1; and provide supporting evidence of the 
significant role, fluid shifts, altered hydrostatic gradients and venous congestion have on 
spaceflight adaptation. Otto et al. (2015) outlined the possibly of irreversible 
degradation, related to visual acuity, with Nelson et al. (2014) suggesting poor cerebral 
drainage as a contributory factor. Further research into the potentially beneficial effect 
of shifting fluids to the periphery, and removing venous congestion, must be completed 
before future holistic countermeasures, focused on fluid redistribution, are finalised. 
Fluid shift alone is unable to elicit significant hemodynamic changes (as shown in 
Chapter 3); however, when taken in the context of venous congestion, a correctly 
matched shift from the central to peripheral compartment can have beneficial effects. 
The findings of the present study are also importance to consider when simulating the 
effects of spaceflight on Earth and in particular to the first true “space sickness” of VIIP 
(Wiener, 2012). 
However, implementation of HDBR at -12° HDT may be successful in simulating fluid 
shifts and venous congestion but, with the knowledge of irreversible visual acuity 
problems, would not be appropriate taken alone on ethical grounds. A more suitable 
approach would be to concurrently develop an improved and holistic SAHC 
countermeasure; specifically aimed at addressing cephalic fluid shifts, whilst 
maintaining suitable artificial gravity (AG), in order to minimise muscle and bone loss. 
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Furthermore, SAHC at heart-level could be used intermittently in space, exploring 
increased g-levels without reduced tolerance. Specifically, whether a greater intensity 
exercise and g-level could be successfully favoured over total duration of exposure; 
thus, potentially freeing up valuable crew time. 
In conclusion, this thesis suggests that VCO is a poor model of gravitational fluid 
shifting but large g-gradient SAHC, via heart-level-RAP, is effective; and crucially, 
more tolerable at higher g-levels. Venous congestion may play an important role in 
microgravity fluid shift related OI and VIIP, which -6° bed rest studies fail to induce. 
Thus, AG with optimal RAP and venous congestion amelioration, may be a tolerable 
and more effective holistic spaceflight countermeasure. 
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“Zero-G and I feel fine!” 
 
 
John Herschel Glenn, Jr. (1921-2016) 
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